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Introduction 
The Alaska Department of Health and Social Services (DHSS), Division of Public Health (DPH), Chronic 
Disease Prevention and Health Promotion Section asked the Institute of Social and Economic Research 
(ISER) to conduct a preventive screenings gap analysis for the following ten screenings/clinical 
guidelines: 
1. Type 2 Diabetes Screening 
2. Screening for High Blood Pressure 
3. Lipid Disorder Screening 
4. Aspirin for the Prevention of Cardiovascular Disease (CVD) 
5. Prevention of Tobacco Use and Tobacco Cessation – Ask, Advise, Refer 
6. Colorectal Cancer Screenings 
7. Breast Cancer Screenings 
8. Cervical Cancer Screenings 
9. Obesity/Body Mass Index – Ask, Advise 
10. Falls Screening 
  
A gap analysis forces an organization to reflect on where an issue is now and to ask where the 
organization wants it to be in the future. The DHSS is seeking information on methods and practices to 
encourage Alaska residents to increase the rate of preventive screenings from the current levels to 
desired levels for specified screenings/guidelines. 
 
This analysis focuses on: 
 Identifying factors that impact preventive screening rates, such as: current practices, evidence based 
practices, barriers to access, consumer motivation for getting/not getting screenings, and provider 
knowledge.  
 Listing factors recommended to achieve the goal of increasing the use of the preventive screenings. 
 Highlighting gaps that currently exist in Alaska that may, if filled, increase the use of preventive 
screening/guidelines. 
 
This report summarizes the results from reviews of the literature and key informant interviews.  ISER has 
reviewed the relevant literature for each of the ten preventive screenings/guidelines, as well as reports, 
documents, and publications provided by DHSS, and conducted interviews with key informants 
identified by DHSS based both in Anchorage and urban areas outside of Anchorage.  Where relevant, 
additional information has been included in this document to inform DHSS, including data on rates of 
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Methodology 
Current practices, best practices, and barriers to increasing screening rates have been investigated 
through key informant interviews and reviews of the relevant literature.  This study was approved by the 
Institutional Review Board of the University of Alaska Anchorage  
 
Key Informant Interviews 
An effective method to examine the reasons underlying behaviors is through in-depth interviews.  Key 
informant interviews are in-depth interviews with individuals who are identified as very knowledgeable 
about a given topic, capable of sharing a depth of information.  Results of key informant interviews are 
used to supplement and contextualize additional findings from surveys, focus groups, etc.  In this study, 
key informant interviews were used to gather data as one part of an initial assessment of potential 
strategies to improve preventive screening rates in Alaska. 
 
While the identification of key informants is not random, selected individuals must be able to provide 
well-informed perspectives about the study topic, be fairly representative of the various groups in the 
study population, and provide a diversity of perspectives.  DHSS staff identified key informants who had 
available information on best practices, barriers, consumer motivation, and knowledge of preventive 
health screenings and guidelines.  For this study of medical providers in urban Alaska, the following 
criteria were established prior to the selection of potential respondents: 
 
 Key informants must provide at least 20 hours of direct patient care per week 
 Key informants practice in urban areas of Alaska, identified as either Anchorage or non-
Anchorage (including Fairbanks, Juneau, Soldotna, and Palmer) 
 Medical provider occupations included physician, nurse practitioner, registered nurse, physician 
assistant, licensed practical/vocational nurse, and medical social worker 
 
DHSS provided the names of 25 potential key informants to ISER for consideration.  DHSS staff 
subsequently excluded four potential key informants due to a lack of current contact information, and 
one potential key informant due to the individual’s perceived lack of knowledge about healthcare 
outside of the tribal system.  DHSS staff contacted the remaining 20 key informants to invite their 
participation, including 10 in Anchorage, and 10 located in urban areas outside of Anchorage.  One key 
informant was identified by DHSS as an individual who would provide contact information for an 
additional key informant for a total of 21 key informants (11 in Anchorage, 10 outside Anchorage).   
ISER followed up with each of the invited key informants to determine a convenient time for an 
interview.  Of these contacts, ISER conducted 20 to 90 minute interviews with 10 key informants in 
Anchorage and 7 non-Anchorage key informants who graciously volunteered their time.  Two of these 
were determined to work less than 20 hours of direct patient care per week, and have been excluded 
from the analysis.  Key informants responded to a series of interview questions and prompts (See 
Appendix A for the interview guide), that invited them to share their perspectives on current practices, 
best practices, and barriers to increasing screening rates.  The table below summarizes characteristics of 
the 15 analyzed key informants:  
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Table 1. Key Informant Characteristics 
Characteristic Count 
Gender  7 Women 
 8 Men 
Age   1 aged 30-39 
 5 aged 40-49 
 5 aged 50-59 
 3 aged 60-69 
 1 aged 70-79  
Years of Practice  2 in practice 0-9 years 
 4 in practice 10-19 years 
 4 in practice 20-29 years 
 4 in practice 30-39 years 
 1 in practice 40-49 years 
Years of Practice in Alaska  5 practicing in Alaska 0-9 years 
 4 practicing in Alaska 10-19 years 
 3 practicing in Alaska 20-29 years 
 3 practicing in Alaska 30-39 years 
Location  8 providers based in Anchorage 
 7 providers based in urban areas outside 
of Anchorage: 
o 2 providers based in Juneau 
o 4 providers based in Fairbanks 
o 1 provider based in Palmer 
Occupation  10 Physicians 
 4 Nurse Practitioners 
 1 Medical Social Worker 
Primary Specialty  6 Family Medicine 
 7 OB/GYN or Women’s Health 
 1 Surgery 
 1 Social Work 
 
Literature Review 
A two-part literature review was conducted to identify and summarize relevant peer-reviewed articles 
on each of the ten screenings/guidelines.  An initial Alaska specific PubMed search focused on best 
practices and barriers to improving preventive screening rates for each of the ten key screenings/clinical 
guidelines.  This search generated 165 unique articles when using key words for each of the ten key 
screenings/clinical guidelines (See Appendix B for complete list of key word searches and Appendix C for 
annotated bibliography of results).  After a review of titles and abstracts, 25 articles were found to have 
a non-Alaska specific focus, 54 articles were found to be about disease statistics, and 5 articles were on 
methods evaluating different screening techniques.  Removing these three groups from the sample 
resulted in 81 unique articles.  Of these unique articles, 61 (75%) were published in the year 2000 or 
later, while 52 (64%) were Alaska Native specific.  These 81 articles were exported to EndNote, 
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A second literature review was conducted to fill gaps identified in the search for Alaska-specific 
literature, and to contextualize themes that emerged during the key informant interviews.  A key word 
search for articles and systematic reviews was conducted on PubMed (see Appendix D for complete list 
of key word searches and Appendix E for annotated bibliography of results).  A systematic review is a 
document created from a “rigorous, replicable” evaluation of the available scientific literature on a given 
topic, and provides a summary of the relevant literature (CPSTF, 2013).  An additional 130 articles were 
found from the key word searches.  After a review of titles and abstracts, 15 were identified as relevant, 
and are incorporated into this report where relevant. 
 
In response to comments from DHSS on an initial draft of this report, additional key word searches were 
conducted in PubMed to determine specific responses. (see Appendix D for complete list of key word 
searches and E for annotated bibliography of results).  An additional two articles were identified, and 
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Screening Rates 
This study has been conducted to support DHSS efforts in reaching target goals for each of the ten 
specified screenings.  DHSS goals are estimated at an increase of 5% from the baseline data gathered in 
2008 and 2009 by the Behavioral Risk Factor Surveillance System (BRFSS).  Known BRFSS indicators for 
each of the ten screenings, baseline Alaska rates, and DHSS goal rates are summarized below.  These 
rates have been provided by DHSS staff to represent the target populations specified by the U.S. 
















Adults with high blood 
pressure 
Proportion of adults without 
diabetes who have had a test 
for blood glucose in the past 










No known indicator asking if a 





 Men age 35 and 
older 
 Men age 20-35 at 
increased risk 
 Women age 20 and 
older at increased 
risk 
Proportion of adults who 
have had a cholesterol test in 









 Men age 45-79 
when benefit 
greater than risk 
 Women age 55-79 
when benefit 
greater than risk 
Proportion of adults who take 
aspirin daily or every other 














 Interventions to 
prevent initiation of 
tobacco use in 
children and 
adolescents 
Percent of respondents who 
saw a doctor in the last 12 
months, either currently 
smoke but weren’t advised to 
quit or do not currently 
smoke, and were asked if 
they smoke 
80.5%, 2008 (BRFSS 
Supplemental) 
84.5% 
(5% of 80.5% = 
4.0) 
Percent of respondents who 
saw a doctor in the last 12 
months, currently smoke, and 
were advised to quit smoking 
70.1%, 2008 (BRFSS 
Supplemental) 
73.6% 






Ever had a blood stool test, 
sigmoidoscopy or colonoscopy, 










women age 50-74 
years 
Mammogram received in past 




(5% of 73.5% = 
3.7) 
9 
Preventive Screening Gap Analysis October 15, 2013 















 Every 3 years for 
women age 21-65 
(excepting women 
who have had the 
cervix removed, 
except those who 
have a history of 
high-grade 
precancerous 
lesions or cervical 
cancer) 
Pap test in last 3 years, 




(5% of 86.4% = 
4.3) 
Obesity 
 All adults 
 Children age 6 and 
over 
No known indicator asking if a 





Does not recommend 
automatic risk 
assessment 
No known indicator asking if a 





Each of the BRFSS indicators have been examined for trends, indicating where DHSS goals may be met if 
current trends persist, as well as screenings where an increase is not predicted if current trends do not 
continue.  BRFSS methods changed in 2011 and data “is not directly comparable to previous years of 
BRFSS data because of the changes in weighting methodology and the addition of the cell phone 
sampling frame” (CDC BRFSS).  DHSS staff has re-weighted past years to match the 2011 methodology 
change, but further inquiry would be needed to determine how the difference in sampling frame 
impacts the data.  If the data are found to be incomparable, DHSS goal rates may need to be 
recalculated with 2011/2012 rates as baseline data, or alternative indicators may need to be located.  
Further research would be required to investigate whether there are non-BRFSS indicators that measure 
these ten screenings either directly or indirectly, as well as their availability and validity.  Only BRFSS 
indicators have been used in trending data, Alaska indicators, and baseline and goal rates.  However, 
additional indicators or data sources may be needed to fill in the gaps where there is no known tracking 
of the specified screening/guideline. 
 
In each of the figures below, both the low and high confidence intervals are included as dotted lines.  
The space between these confidence intervals indicates the actual estimated rate in Alaska with a 95% 
confidence.  This range accounts for potential variation that may occur because of the sampling size.  
Any rates within a confidence interval for a given time point are not statistically significantly different, 
and may have occurred by random chance. 
 
Further research would be needed to determine trends within a given data set.  For example, there may 
be specific sub-populations, with age, gender, racial/ethnic, geographic, socioeconomic, or other 
characteristics, that have significantly higher or lower screening rates.  An analysis of sub-group 
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Type 2 Diabetes 
Only two years of BRFSS data ask about both high blood pressure and blood glucose tests, and 
consequently only these two data points are available.   
 
Figure 1. Blood Glucose Screening Trends, 2009-2011 
 
The DHSS goal rate of 74.9% is not significantly different than the 2009 baseline rate of 71.3% 
(confidence interval range 65.8%-76.8%), given that the goal rate falls within the confidence interval.  
The two data points are also not significantly different from one another, given that their confidence 
intervals overlap.  However, since there are only two data points, further data would be needed to make 
supported conclusions about trends.   
 
Lipid Disorders 
Adult BRFSS respondents in Alaska have indicated on odd year surveys whether or not they’ve had their 
blood cholesterol checked within the last five years.  The following chart summarizes those trends for 
the USPSTF population recommended to be screened regardless of their risk of cardiovascular disease, 
men age 35 and older.  
 











Blood Glucose Screening 










1997 1999 2001 2003 2005 2007 2009 2011
Year 
Cholesterol Screening 





Preventive Screening Gap Analysis October 15, 2013 









Aspirin to Prevent CVD 
 Men Age 45-79, Women Age 55-79, 2003-2009 
Percentage Not Unsafe to
Take Aspirin
Lower CI (aspirin not unsafe)
Upper CI (aspirin not unsafe)
Percentage Taking Aspirin
Lower CI (taking aspirin)
Upper CI (taking aspirin)
The DHSS goal rate of 80.3% is within the 95% confidence intervals of each rate since 2007, indicating 
that the goal rate is not significantly different from any of these previous rates.  As of 2011, the 
percentage of men age 35 and older who reported having a cholesterol test in the past 5 years was 79% 
(confidence interval range 76%-82%).  If current trends continue, future rates will continue to increase.   
 
USPSTF also recommends lipid disorder screening for both men age 20-35 and women age 20 and older 
who have increased risk for coronary heart disease.  Further research would be required to determine 
what the parameters of “increased risk for coronary heart disease” are, if there are BRFSS indicators for 
those parameters, and whether there is available data to track the screening rates of those populations.  
 
Aspirin for CVD Prevention  
The questions “Do you take aspirin daily or every other day?” and “Do you have a health problem or 
condition that makes taking aspirin unsafe for you?” were both asked on the BRFSS in 2003 and 2009. 
 
Figure 3. Aspirin for the Prevention of Cardiovascular Disease (CVD) Trends, 2003-2009 
In 2009, approximately 87% of BRFSS respondents in the target population did not have a health 
problem or condition where it was unsafe to take aspirin, while approximately 40% of respondents were 
taking aspirin either every day or every other day.  While there is a sizable gap between those two 
percentages, it should be noted that approximately 13% of 2009 BRFSS respondents in the target 
population had health conditions or problems that made it unsafe to take aspirin.  Strategies to increase 
the number of individuals taking aspirin should avoid increasing the number of individuals taking aspirin 
for whom it is unsafe.  Further data analysis would be required to determine the number of BRFSS 
respondents taking aspirin outside of the target population, or those taking aspirin who have indicated 
that it is unsafe for them.  A different baseline rate could also be calculated from the number of BRFSS 
respondents within the target population who have responded that they are both taking aspirin and that 
it is not unsafe for them.     
 
The DHSS goal rate of 41.6% is not statistically significantly different from either the 2003 rate of 40.8% 
(confidence interval range 36.1%-45.4%), or the 2009 baseline rate of 39.6% (confidence interval range 
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2004 2006 2007 2008 2009 2010 2011 2012
Year 





36.4%-42.8%).  With only two points of data, supported information about trends cannot be concluded.  
Further data collection would be needed to determine possible trends.  
 
Tobacco – Ask, Advise 
Supplemental BRFSS respondents were asked questions about their interactions with providers 
regarding tobacco.  However, these questions were not asked of every BRFSS respondent, but only to 
respondents who answered a variety of screening questions, detailed below each graph.    
 
 
Figure 4. Tobacco Trends: Asked About Smoking, 2001-2012 
If a BRFSS respondent had; 
 Seen a healthcare provider in the past 12 months 
AND 
 Was a current smoker, but had not been advised to quit by a provider in the past 12 months 
OR  
 Was not a current smoker 
then the BRFSS respondent was asked whether a provider had asked if they had smoked or not.  
 
The presence of screening questions on this indicator is different from other BRFSS indicators that ask 
the same question to all BRFSS respondents, or all respondents within a given population (i.e. age and 
gender restricted).  Because of these screening questions, this rate measures a different group of 
individuals than other indicators.  However, if the methodology does not change between years, than 
the data is comparable across time points.  The baseline rate in 2008 was 80.5% (confidence interval 
range 77.6% to 83.5%).  As the rate has not changed significantly between 2004-2012, the DHSS goal 
rate of 84.5% is a significant increase from both the goal rate, and every measured rate from 2004-2012.  
If current trends continue, the rate of selected respondents asked by a provider about smoking is not 
expected to increase significantly.  
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Figure 5. Tobacco Trends: Advised to Quit Smoking, 2001-2012 
BRFSS respondents were only asked this indicator if they had: 
 Seen a healthcare provider in the last 12 months  
AND 
 Had reported that they currently smoked 
 
Approximately 70.1% of these respondents were advised to quit by their provider in 2008 (confidence 
interval range 61.8%-78.3%).  The DHSS goal rate of 73.6% is not significantly different from either the 
2008 baseline rate, or from any rate since 2001, except 2006.  Further research would be needed to 
determine potential causes of the significant decrease in 2006.  As the rate has remained relatively 
constant since 2001 (excepting 2006), the rate is not predicted to increase substantially if current trends 
continue.   
 
Colorectal Cancer Screening 
BRFSS respondents were asked two questions related to colorectal cancer screening - whether they had 
ever had a sigmoidoscopy or colonoscopy, and whether they had ever had a blood stool test.  DHSS staff 
sorted the data to provide a rate for the USPSTF recommended population of adults age 50-75 who had 
ever had a colonoscopy, sigmoidoscopy, or a blood stool test.   
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Figure 6. Colorectal Cancer Screening Trends, 1997-2012 
 
While the rate of individuals aged 50-75 who’ve ever been screened for colorectal cancer trended 
upward between 1997 to 2002, it has remained relatively stable from 1999 to 2012.  The 2008 baseline 
rate of colorectal cancer screening for ages 50-75 is 63.3% (confidence interval range 58.7%-68.4%).  The 
DHSS goal rate of 66.5% is not significantly different from the 2008 baseline rate, or from any rate 
recorded since 1999.  However, if current trends continue, the rate of adults age 50-75 who have ever 
received a colonoscopy, sigmoidoscopy, or blood stool test is not predicted to increase substantially.   
 
Breast Cancer Screening 
The BRFSS includes data on how many women have received mammograms in the past two years, 
sorted by DHSS staff to represent the USPSTF recommended population of women ages 50-74.  
 
Figure 7. Breast Cancer Screening Trends, 1997-2002 
 
The rate of women age 50-74 who reported receiving a mammogram in the past two years has 
remained relatively stable since 1997, despite a slight peak in 2000.  Further research would be required 
to determine potential causes of the spike in 2000.  In 2008, a baseline rate of 73.5% was recorded 
(confidence intervals 68.0% to 79.0%), setting the DHSS goal of 77.2%.  This goal rate is not significantly 
different from any recorded rate except for the year 2000.  If current trends continue, the rate is not 
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Cervical Cancer Screening  
Female BRFSS respondents answered women’s health questions about breast and cervical cancer, 
including an indicator asking if the respondent has ever had a Pap test.  DHSS staff adjusted the rate to 
reflect the USPSTF recommended population of women age 21-65.  USPSTF also recommends that 
women without a cervix not be screened unless they have a history of cervical cancer or high-grade 
precancerous lesions.  Further research would be needed to determine if individuals without a cervix 
who are not at increased risk could be adjusted out of the screening rates. 
 
Figure 8. Cervical Cancer Screening Trends, 1997-2012 
 
The rate of women ages 21-65 receiving a pap test in the last three years has trended gradually 
downward since 1997.  The 2008 baseline rate of 86.4% (confidence interval range 82.6%-90.2%) is 
significantly lower than rates at each time point between 1997 and 2004.  The DHSS goal rate of 90.7% is 
significantly higher than both the goal rate and rates in 2010 and 2012.  If current trends continue, the 
rate of pap smears is expected to continue to decrease.  Further research would be required to 
determine if these falling rates reflect the USPSTF recommendations that lengthened the screening 
interval to three years for women age 21-65, and allowed a lengthened interval of up to five years for 
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Current Practices  
Key informants shared their perspectives on current practices in regards to the ten identified key 
screenings/clinical guidelines.  Interviewees communicated ways they disseminated information about 
preventive screenings, how often their patients initiated conversations about each of the ten 
screenings/guidelines, and how often they as providers initiated conversations about each of the ten 
screenings/guidelines.  Emergent themes are contextualized with relevant findings from the literature. 
 
Information Dissemination 
Key informants distributed information to their patients in a variety of ways.  The following table 
summarizes the findings: 
Table 2. Method of Distribution of Preventive Screenings Information from Provider to Patient 
Method of Distribution of Preventive 
Screenings Information 







Verbal 8 (100%) 7 (100%) 15 (100%) 
Brochures 7 (88%) 7 (100%) 14 (93%) 
Websites 7 (88%) 5 (71%) 12 (80%) 
Booklets 5 (63%) 5 (71%) 10 (67%) 
Referral to Nonprofit Organization for 
Additional Information 
5 (63%) 4 (57%) 9 (60%) 
Referral to Specific People, most often to a 
specialist or individual with specialized skills 
6 (75%) 3 (43%) 9 (60%) 
Blogs 1 (13%) 0 (0%) 1 (7%) 
Forums 0 (0%) 0 (0%) 0 (0% 
 
While all interviewed providers disseminated information through one-on-one education (see section on 
One-on-One Education in Best Practices for more information), 93% (14/15) distributed brochures on 
preventive screenings, or had brochures available for patients.  Most key informants, also provided 
information in the form of booklets (67%, 10/15), referrals to nonprofit organizations (60%, 9/15) and 
referrals to specific people (60%, 9/15).  Only one individual referred patients to blogs, and no key 
informants referred their patients to forums.   
 
No thematic differences emerged between Anchorage and non-Anchorage urban providers in regards to 
their methods of disseminating information.  However, non-Anchorage providers noted referring 
patients to specific people less often than in Anchorage, potentially due to a lack of available resources 
or specialists within their communities.  
 
In examining sources of patient information, key informants shared that they valued evidence-based, 
unbiased, up to date, accurate, disease specific, and widely accepted sources.  Key informants requested 
information accessible to their patients, in terms of the reading level, cultural relevancy, and message 
tailored to their patients’ demographic.  Several providers also noted that they printed information for 
patients from websites they trusted, or from their electronic health records.  In mentioning specific 
sources that providers felt were helpful to patients, sources including Mayo Clinic, UpToDate, U.S. 
Preventive Services Task Force (UPSTF), Agency for Healthcare Research and Quality (AHRQ), and 
Centers for Disease Control (CDC) were mentioned.  Several professional organizations and disease 
specific organizations were also mentioned, including the American Cancer Society, American Heart 
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Association, and the American Congress of Obstetrics and Gynecology.  Key informants also referred 
their patients to internal information such as organization specific websites, or material printed from 
those websites. 
 
The complex nature of information from internet searches arose during the interviews.  While key 
informants recommended specific websites to their patients, they also noted that internet searches 
could lead to harmful information for patients.  Key informants articulated the complexity of patients’ 
having so much information available and accessible via the internet that includes anecdotal and biased 
information.  Key informants expressed concern over harmful biases in websites stemming from the 
marketing of products, or political or religious agendas.  
 
While the key informant interviews were conducted only with providers located in Alaska’s urban areas, 
Alaska’s rural areas are served in significantly different ways than the state’s urban centers.  Non-
Anchorage key informants spoke of different needs for rural patients, who they tangentially served in 
their practices.  Alaska’s rural healthcare system is comprised of clinics and hospitals offering services at 
regional and sub-regional hub communities, while approximately 50,000 Alaskans, both Alaska Native 
and non-Native, in 178 communities receive primary care provided by tribally-employed Community 
Health Aides/Practitioners (CHA/Ps) (Golnick et al, 2012).  As the key informants were all based in urban 
areas of Alaska, the perspectives of rural providers are not represented in the key informant interviews.  
Further research would be needed to determine the perspectives and practices of providers in 
Anchorage’s non-urban areas, including providers at regional and sub-regional hubs, as well as 
community health aides as the primary care providers to residents of Alaska’s remote communities. 
 
The literature review revealed some information on the importance of building connections with CHA/Ps 
to promote cancer screening within their communities in rural Alaska.  Efforts to provide cancer 
education and health promotion include the development, implementation, and evaluation of a manual 
and curriculum (M. Cueva, 2011), readers’ theatre scripts (M. Cueva, 2005; M. Cueva, 2010; M. Cueva, 
2012), DVDs, interactive CD-ROMs, brochures, digital stories (M. Cueva, 2013), web-based resources, 
distance-delivered CHAP continuing education, and culturally responsive face-to-face courses (M. Cueva, 
2012; M. Cueva, 2012).   
 
Desired Educational Materials 
All key informants were asked what kind of materials they would like to have to educate patients about 
preventive screenings/guidelines, if those materials were provided.  In response, providers identified 
both the format of desired educational materials, as well as the style of the content in those materials.  
While several key informants expressed that they would prefer written materials, such as a brochure or 
booklet that could be handed to patients, or posters to put in high traffic areas, some expressed a desire 
for DVDs to show in waiting rooms.  However, there was no clear consensus on the format of desired 
material, with some respondents specifically mentioning that they didn’t need more brochures, posters, 
or mailings, and others interested in interactive videos, breast check shower cards, a vetted list of apps 
or website links, or rack cards. 
 
Providers expressed a desire to have accessible educational materials that were evidence-based and 
targeted specific population groups.  They spoke of their diverse patient populations, including 
ethnic/racial variations (Hmong, Vietnamese, Alaska Native, Caucasian, etc.), linguistic diversity, as well 
as differences in age and gender, and asked for materials created in a style that would appeal to specific 
populations that they encountered in their practice.  Providers also mentioned a need to target 
materials to specific types of screenings, mentioning their experiences using different communication 
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techniques to support patients to get different screenings (humorous for colorectal, serious for 
mammograms, etc.).  
 
Patient-Initiated Conversations 
Key informants were invited to share how often their patients initiated conversations with them about 
each of the ten screenings/guidelines.  The findings are summarized in the table below by respondents 
in Anchorage vs. non-Anchorage urban areas: 
 
Table 3. Frequency of Patient-Initiated Conversations 
Preventive 
Screening/Guideline 
Number of Key Informants  
Reporting Frequency of Patient-Initiated Conversation 
Never Rarely/Sometimes Often 
Anc. Non-Anc. Anc. Non-Anc. Anc. Non-Anc. 
Diabetes 0 0 8 7 0 0 
Blood Pressure 1 0 7 6 0 1 
Lipid Disorders 2 0 4 4 2 3 
Aspirin for CVD 2 1 6 6 0 0 
Tobacco 
Prevention/Cessation 
1 0 4 5 3 2 
Colorectal Cancer 2 1 3 3 3 3 
Breast Cancer 1 2 5 1 2 4 
Cervical Cancer 0 0 5 2 3 5 
Obesity 2 1 5 6 1 0 
Falls Prevention 4 2 3 5 1 0 
 
No thematic differences between urban non-Anchorage and Anchorage-based providers emerged, 
however both Anchorage and non-Anchorage urban providers reported that the frequency of 
conversations differed by screening.  Key informants shared that their patients initiated conversations 
with them more often about lipid disorders, tobacco prevention/cessation, colorectal, breast, and 
cervical cancer.  Providers also noted that patients have recently been initiating conversations about 
breast and cervical cancer screenings more frequently, due to the changes in screening guidelines.  
While conversations about cervical cancer screenings were more frequently initiated by patients than 
other screenings/guidelines, this may be due to the relatively high number of women’s health care 
providers who were interviewed as key informants.  Almost all of these women’s health care providers 
reported that their patients’ often initiated conversations about cervical cancer screenings because they 
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Provider Sources of Information 
During the key informant interviews, providers shared how they obtained information on preventive 
screenings and guidelines.  The results are summarized in the table below: 
 
Table 4. Provider Sources of Information 
Information Source Number and Percentage of Key Informants by Sources of Information 
Anchorage Non-Anchorage Total 
Specific Websites 8 (100%) 7 (100%) 15 (100%) 
Continuing Education 7 (88%) 7 (100%) 14 (93%) 
Professional Meetings 6 (75%) 7 (100%) 13 (87%) 
Newsletters/Mailings 6 (75%) 5 (71%) 11 (73%) 
Internet Searches 4 (50%) 6 (85%) 10 (67%) 
Asking Colleagues 4 (50%) 6 (85%) 10 (67%) 
Journals 4 (50%) 2 (29%) 6 (40%) 
Specific Apps 3 (38%) 1 (14%) 4 (27%) 
 
All Anchorage and non-Anchorage urban providers reported using specific websites to obtain 
information on preventive screenings and guidelines.  The most frequently named specific website was 
the US Preventive Services Task Force (USPSTF), although providers also mentioned professional 
websites, such as the American Congress of Obstetricians and Gynecologists (ACOG), as well as CDC, 
MayoClinic, and UpToDate.   
 
While non-Anchorage urban key informants relied on newsletters and mailings a bit less than 
Anchorage-based key informants, they also used Internet searches and asking colleagues a bit more.  
However, key informants in both regions reported the use of professional meetings and continuing 
education with about equal frequency.  They shared that they often relied on specific websites, 
continuing education, professional meetings, journals, and professional organizations to receive updates 
on preventive screenings and guidelines. 
 
A closer look at the U.S. Preventive Services Task Force recommendations reveals that they provide 
recommendations on clinical preventive health services.  Their recommendations are organized in five 
categories: 
 A: Strongly Recommended 
 B: Recommended 
 C: No Recommendation 
 D: Not Recommended 
 I: Insufficient Evidence to Make a Recommendation 
 
Given the high level of key informant trust in the USPSTF recommendations, the following table details 
both the USPSTF recommendations as well as the most recent known Alaska screening rates: 
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USPSTF Grade: Alaska Indicator (BRFSS) 
Type 2 
Diabetes 
Fasting plasma glucose, 2-
hour postload plasma 









Proportion of adults 
without diabetes who have 
had a test for high blood 
sugar in the past 3 years 
Blood 
Pressure 





No known indicator asking 




Blood test for total 
cholesterol or HDL-C 
Men, age 35+ 
A: Strongly 
Recommended 
Proportion of adults who 
have had a cholesterol test 


















Ask, Advise. Optimum 







Proportion of adults who 
take aspirin daily or every 
other day, percentage of 
adults who cannot take 
aspirin due to a health 










D: Not Recommended 
Tobacco- 
Ask, Advise 
Primacy care clinicians 
provide education and 
brief counseling, 
cessation interventions 
for those who use 
tobacco products, and 
pregnancy-tailored 
counseling for pregnant 





Of individuals who report 
seeing a healthcare 
provider in the past year: 
percentage of current 
smokers asked to quit 
smoking by a provider, and 
percentage of individuals 
asked if they smoke by a 
provider (who are not 
current smokers, or were 
not advised to quit by a 
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Ever had a sigmoidoscop, 
colonoscopy, or blood stool 











Mammogram received in past 
















Recommended Pap test in last 3 years, 
women aged 18+ Pap Smear and HPV test 








Clinicians screen patients 
and refer to behavioral 
interventions 
Children, age 
6 and older 
B: Recommended 
No known indicator asking 
if a provider has screened 











No known indicator asking 
if a provider has screened 











likelihood of benefit is 




This table highlights uncertainties that providers may be encountering on their search for preventive 
screening information, as well as gaps in information that would be helpful to determine an increase in 
screening rates.  While the dosage of aspirin for the prevention of cardiovascular disease is unknown, 
the practice is also recommended against for some populations (USPSTF, 2013).  Additionally, no 
screening procedure for falls prevention is recommended for any population, although the practice of 
exercise and Vitamin D supplementation is recommended (USPSTF, 2013).  In informing the increase of 
screening rates, a data gap exists in known rates for several of the indicated screenings/guidelines.  
Some Alaska data must also be adjusted for the USPSTF recommended populations both in calculating 
baseline and goal rates (see section on Screening Rates), as well as in measuring achievement of goals.   
 
                                                          
1
 USPSTF recommends screening women 3 years after beginning sexual activity, or the age of 21, whichever comes 
first.  Annual screening is appropriate until a woman has had 2-3 consecutive normal Pap tests.  
2
USPSTF recommends screening every three years, but five years is permissible if women want to lengthen the 
screening interval 
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Provider-Initiated Conversations 
Key informants were invited to share how often they initiated conversations with their patients about 
each of the ten screenings/guidelines.  The findings are summarized in the table below: 
 
Table 6. Frequency of Provider-Initiated Conversations 
 Number of Key Informants Reporting Frequency of Patient-Initiated 
Conversation 
 Never Rarely/Sometimes Often 
Screening/Guideline Anc. Non-Anc. Anc. Non-Anc. Anc. Non-Anc. 
Diabetes 0 0 2 5 6 2 
Blood Pressure 0 0 1 1 7 6 
Lipid Disorders 1 0 0 3 7 4 
Aspirin for CVD 2 0 3 7 3 0 
Tobacco 
Prevention/Cessation 
0 0 2 1 6 6 
Colorectal Cancer 0 0 1 0 7 7 
Breast Cancer 0 0 1 0 7 7 
Cervical Cancer 1 0 2 1 5 6 
Obesity 0 0 3 3 5 4 
Falls Prevention 2 1 3 5 3 1 
 
Key informants reported communicating with their patients more often about colorectal cancer, breast 
cancer, and blood pressure screenings, while communicating far less frequently with patients on aspirin 
for cardiovascular disease and falls prevention.  Anchorage based providers communicated more often 
with patients than non-Anchorage urban providers about diabetes screenings and lipid disorders, and 
less often on cervical cancer screenings.  Key informants varying frequencies of initiating conversations 
with their patients is consistent with national studies that have found communication inconsistent with 
screening guidelines and recommendations, potentially due to variations in specialty, training, and 
patient demographics.  A study of 3800 university students in North Carolina found that, of those who 
had visited their student health center, only 62% reported being screened for tobacco use (Sutfin, 2012).  
Further, of students who were screened and reported tobacco use, only half reported being advised to 
quit or reduce their tobacco use (Sutfin, 2012).  In a national study of provider practices related to 
breast cancer screening, clinical practice varied by medical specialty and training (Wallace, 2006).  
Family practitioners and internists were discovered to refer patients to mammography on about 20% of 
preventive health care visits, while gynecologists referred patients to mammography approximately 53% 
of preventive health care visits, which may represent adherence to USPSTF recommendations, as well as 
differences in patient demographics (Wallace, 2006).  Key informants interviewed for this report shared 
that several factors mediated their decision on whether or not to discuss a preventive 
screening/guideline with patients, including the patient’s demographic, their role on the healthcare 
team, and their trust of the screening/guideline. 
 
Patient Demographic  
During key informant interviews, a common theme of tailoring conversations to individual patients 
emerged.  Providers shared that they communicated information with patients relevant to patients’ 
specific demographics, as well as in a manner relevant to the patient’s background and values.  Several 
providers spoke specifically about falls prevention, noting that they rarely saw patients within a 
demographic appropriate for the screening, and consequently did not often initiate a conversation 
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about it.  Some providers also noted that they did not often initiate conversations about blood pressure 
screening since the screening is done at every patient visit, and a conversation only happens when it is 
indicated by the screening.   
 
Provider’s Role on the Healthcare Team 
Providers shared that they spoke with patients more about screenings within their purview.  
Consequently, providers in geriatric care facilities initiated conversations with patients more often about 
falls prevention. A couple of the non-physician key informants worked in teams, and consequently did 
not counsel patients on screenings that they felt were the responsibility of the physician.  
 
Provider Trust of Screenings/Guidelines 
Key informants reported a critical awareness of the guideline creation process and a familiarity with 
literature that both supported and disputed the recommended screenings/guidelines.  Illustrated by the 
recent changes in recommended screenings for prostate cancer, breast cancer, and cervical cancer, 
providers shared an awareness that screenings and guidelines are subject to change.  Key informants 
pointed to emerging evidence that may change recommendations, and noted that recommended 
screenings/guidelines may not be appropriate for every patient.   
 
Providers specifically mentioned a lack of convincing literature on recommending aspirin to prevent 
cardiovascular disease, particularly in women, which may reflect USPSTF guidelines against 
recommending aspirin for women under age 55.  In addition, providers shared that Medicare has only 
recently begun reimbursing providers who ask patients questions on falls prevention during an initial 
“Welcome to Medicare” exam and annual wellness visits.  Consequently, while some providers shared 
that falls prevention was not part of their normal recommendations for patients, potentially due to the 
lack of a USPSTF recommendation, a few providers noted that they had recently begun to have those 
conversations due to Medicare’s reimbursement. 
 
Due to the providers heightened awareness of both guideline-related literature and the specificity and 
limitations of USPSTF guidelines, key informants expressed a critical view of a campaign to increase 
across-the-board screening rates.  Despite this wariness towards advocating for increasing 
screenings/guidelines, most key informants mentioned the US Preventive Services Task Force (USPSTF) 
as a source of evidence-based information.  Even the key informants most concerned about potential 
negative effects of increasing screening rates, such as an increase in inappropriate screenings, noted 
that they followed and trusted USPSTF guidelines.  Consequently, a campaign to increase provider 
recommendations for screenings may be more effective if done in adherence to USPSTF guidelines.  As 
noted in the section on Provider Sources of Information, the USPSTF currently does not recommend a 
screening for falls prevention for any population, which may account for the lack of incorporation of falls 
prevention into many providers’ conversations with patients (USPSTF, 2012).  For provider-oriented best 
practices to increase preventive screenings in line with USPSTF guidelines, see the sections on Clinical 
Decision-Support Systems/Provider Reminder Systems and Provider Assessment and Feedback.   
  
24 
Preventive Screening Gap Analysis October 15, 2013 
Institute of Social and Economic Research   
Best Practices to Promote Preventive Screenings/Guidelines 
Initial research on best practices to promote preventive screenings/guidelines began with 
recommendations from systematic reviews conducted by the Community Preventive Services Task Force 
(CPSTF) for each of the ten recommended screenings/guidelines.  A systematic review is a document 
created from a “rigorous, replicable” evaluation of the available scientific literature on a given topic 
(CPSTF, 2013).  In the creation of this report, recommendations from CPSTF, published on The Guide to 
Community Preventive Services website (The Community Guide) were examined in April and August 
2013.  These recommendations are organized in the table below by intervention type and 
screening/guideline.  A check indicates that the intervention has been recommended by The Community 
Guide for the specified screening, and is linked to the specific Community Guide web page for further 
information. 
 
Interventions recommended by the Community Guide for any of the specified ten screenings/clinical 
guidelines are included in the table below.  No recommendations are provided by the community guide 
for falls prevention.  Interventions that were examined, but not recommended by the Community Guide 
for any of the ten specified screenings are not included in the table, including those where insufficient 
evidence was documented.  Interventions that were recommended by The Community Guide, but are 
not specific to increasing preventive screenings rates are also not included, for example, those referring 
to management and control of disease. 
 
The key informants were asked their perceptions of the effectiveness of each of the interventions listed 
on the table below for Alaskan medical providers, as well as whether or not they used each of the 
methods to increase patient preventive screening rates.  A summary of their responses, integrated with 
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Table 7. The Community Guide Recommendations to Promote Selected Screenings/Clinical Guidelines 
 
                                                          
3
 The Community Guide does not provide recommendations pertinent to falls prevention. 
4 The Community Guide does not include recommendations specifically to increase screenings for Type 2 diabetes, the use of aspirin to prevent cardiovascular disease, 
or lipid disorders.  However, recommendations to use a CDSS to prevent cardiovascular disease (CVD) include “Reminders for overdue CVD preventive services including 
screening for CVD risk factors such as high blood pressure, diabetes, and high cholesterol”, while recommendations to reduce out of pocket costs to prevent 
cardiovascular disease include “Reducing out-of-pocket costs for patients was associated with improvements in medication adherence, and blood pressure and 
cholesterol outcomes”. 
 










































Provider Assessment and 
Feedback 
    Insufficient 
Evidence 
   Insufficient 
Evidence 
 
Client Reminders           
Small Media           
One-on-One Education           
Reducing Structural 
Barriers for Clients 
       Insufficient 
Evidence 
  





Mass Reach Health 
Communication 
          
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Clinical Decision Support System or Provider Reminder System 
Nine of the specified ten screenings/clinical guidelines are recommended by The Community Guide to 
be promoted by either a clinical decision support system (CDSS) or a provider reminder system.  A CDSS 
is comprised of computer-based information to assist healthcare providers in implementing clinical 
guidelines at the point of care, based on individual patient data (Guide to Community Preventive 
Services, 2013), and there is strong evidence to support the use of a CDSS to improve the order and 
completion of recommended preventive care (Bright et al, 2012).  While the term “Clinical Decision 
Support System” is used in many of the Community Guide recommendations, the term “Provider 
Reminder and Recall System” is used for a similar system in reference to promoting cancer screenings.  
The Community Guide defines this system as any method that informs providers that a patient is due for 
a screening, termed “reminders”, or that a patient is overdue for a screening, termed “recall”.  While 
this serves the same function as a CDSS in informing providers of needed preventive measures, it does 
not have to be computer-based (The Community Guide, 2006).  A systematic review of clinical decision 
support systems further identified four features as independent predictors of improved clinical practice; 
recommendations rather than assessments, automatic recommendations as part of provider workflow, 
computer-generated decision support, and recommendations at the time and location of decision 
making (Kawamoto, 2005).     
 
Almost all (93%, 14/15) of the key informants used an electronic system to remind them to check with 
patients about specific screenings and guidelines, and all of them felt like such a system would be 
effective with Alaskan medical providers.  However, some providers were concerned about the difficult 
user-interface of their electronic systems, the difficulty of integrating the system into patient care, and 
the potential encouragement of inappropriate screenings.  To address similar concerns, the 
development of one CDSS for cervical cancer screening involved potential end-user care providers who 
were able to provide recommendations and identify CDSS errors that were subsequently corrected 
(Wagholikar, 2013).   
 
Reducing Out of Pocket Costs 
The most prevalent theme from the key informant interviews was the need to reduce costs for patients 
to attain screenings/follow guidelines.  Reducing out of pocket costs is recommended by the Community 
Guide as an effective intervention for both prevention of cardiovascular disease and promoting breast 
cancer screenings, while there is insufficient evidence for its impact on colorectal and cervical cancer 
screenings.   
 
However, the Affordable Care Act mandates coverage for several screenings.  Key informants shared 
that coverage by the Affordable Care Act hasn’t yet been communicated to patients, and when patients 
become aware that the recommended screenings/guidelines are covered, they are much more likely to 
get them.  The following table highlights the US Preventive Services Task Force recommendations per 
screening and the mandated coverage by Marketplace insurance plans.  The Affordable Care Act (ACA) 
creates a Health Insurance Marketplace (Marketplace) where individuals can view available insurance 
plans within their region.  Plans regulated by ACA, including plans available on the Marketplace, are 
subject to providing coverage of specific preventive screenings without charging patients a copayment 
or coinsurance even if the individual hasn’t met their deductible (healthcare.gov).  However, this 
coverage is only guaranteed to specific demographics, and when a consumer uses a network provider, 
so further research would be required to determine the potential impact of this policy on Alaskan 
healthcare consumers, including how many Alaskans become covered as a result of ACA, how many 
become covered with plans regulated by ACA, and how many will access network providers. 
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Table 8. USPSTF Recommendations, ACA Coverage, and Differences Between Coverage and 
Recommendation (USPSTF; healthcare.gov) 
Screening USPSTF Recommended 
Demographic 






Adults with high blood 
pressure 




All adults  All adults 
 Children 0-4 mo., 1-17 yrs. 




 Men age 35 and older 
 Men age 20-35 at 
increased risk 
 Women age 20 and older 
at increased risk 
 Men age 35 and older 
 Men under 35 who have 
heart disease or risk factors  
 Women who have heart 
disease or risk factors 
 Children at higher risk of 
lipid disorders aged 1-17 
yrs. 
Children and men 







 Men age 45-79 when 
benefit greater than risk 
 Women age 55-79 when 
benefit greater than risk 
 Men age 45-79 with doctor 
recommendation 
 Women age 55-79 with 
doctor recommendation 






 Screening for all adults 
 Cessation interventions 
for tobacco users 
 Interventions to prevent 
initiation of tobacco use in 
children and adolescents 
 Screening for all adults 








Age 50-75 Adults over 50 Adults over 75 also 




Biennial mammography for 
women age 50-74 years 
Mammography every 1-2 years 
for women over age 40 
Women 40-50 and 
decreased time interval 




 Every 3 years for women 
age 21-65 years (excepting 
women who have had the 
cervix removed, except 
those who have a history 
of high-grade 
precancerous lesions or 
cervical cancer) 
 Sexually active women 
 Every 3 years age 21-29 
 Every 3-5 years age 30-65 
 Age 66 and older with 
doctor recommendation 
Women under 21, over 




 All adults 
 Children age 6 and over 
 All adults 
 Age of children not 
specified 
Potential difference in 




Does not recommend 
automatic risk assessment 
Not included in covered 
preventive screenings 
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Despite the similarities in what is recommended by the USPSTF and coverage by ACA, key informants 
shared their frustrations with insurance, including Medicare and Medicaid.  Providers noted that, in 
their experience, a preventive screening office visit has not been reimbursable by Medicare, requiring a 
patient to come in with an existing issue for the provider to be reimbursed.  While Medicare may cover 
an annual “Wellness visit” in addition to the “Welcome to Medicare” preventive visit, further inquiry 
would be needed to determine if providers are aware of these benefits, but find them insufficient, or if 
some providers are unaware of this coverage (Medicare.gov).  Providers also shared that a preventive 
visit can quickly turn into an expensive procedure, specifically noting that a colonoscopy is a covered 
preventive screening, but if a polyp is found and removed, the code changes and patients are held liable 
for the billed charges.  Providers also mentioned that under-insured and un-insured populations are 
sometimes the most at risk of not having preventive screenings, and often face some of the highest 
financial barriers to getting screened.  Providers additionally remarked that Alaska’s Breast and Cervical 
Health Check program (BCHC) has improved screening rates for breast and cervical cancer, and that a 
similar program for colorectal screenings may similarly improve screening rates.    
 
Provider Assessment and Feedback 
A review of the literature conducted for The Community Guide concludes that a combination of provider 
feedback and assessment are effective at increasing screening for breast, cervical, and colorectal cancer 
(Sabatino, 2012).  Assessment evaluates provider performance in regards to preventive screenings, 
while feedback offers providers information about that performance (Sabatino, 2012).  While about half 
of key informants shared that they use assessment and feedback to improve their preventive screening 
rates, almost all felt that it would be effective with Alaskan medical providers.  Some key informants 
spoke about internal auditing as assessment, and some referred to patient completed comment cards as 
a method of feedback.  While this best practice is for a combination of provider assessment and 
feedback, comment cards alone have been evaluated in a four-hospital trial  where low response rates 
were documented and reported scores were biased as a result (Nelson, 1991).   
 
Feedback can also be given to providers based on group rates, such as the percentage of an eligible 
population screened within a given area or set of patients, and could be compared to a goal or standard 
(Sabatino, 2012).  Key informants also mentioned that in some clinics providers have been compared to 
each other in a highly visible manner, with the provider having the highest percentage of patients 
screened receiving recognition, in addition to the motivation to not be at the bottom of the list of 
providers at the practice.  While this was spoken of by providers who had used such a system as 
motivating, some key informants also felt concerned about potentially increasing screening rates 
inappropriately, with competition between providers driving them to be less considerate of an individual 
patient.   
 
Client Reminders 
All key informants used client reminders and most felt like they were effective.  Client reminders can be 
text, such as postcards, emails, or letters, or phone calls to patients to remind that that they are due, or 
over-due for a particular screening (Sabatino, 2012).  A review of the literature conducted by Sabatino et 
al. demonstrates strong evidence that client reminders are effective at increasing breast, colorectal, and 
cervical cancer screening rates (Sabatino, 2012).  However, no conclusive literature has been found 
during the preparation of this report testing the link between client reminders and additional 
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Small Media 
Small media is the use of videos or printed materials such as letters, brochures or newsletters to inform 
and motivate people to take preventive measures.  While almost all key informants used small media to 
increase community demand for preventive care, particularly through the dissemination of brochures, 
only about half felt like it was effective.  A systematic review has found strong evidence that small media 
increase breast, colorectal, and cervical cancer screening rates (Baron et al, 2008).  A review of the 
literature conducted for this report produced no published articles examining the link between small 
media and any additional screenings/guidelines.   
 
In both the key informant interviews and literature review, a theme of tailoring health messaging to 
specific demographics emerged.  Key informants mentioned that they felt information for patients was 
most helpful when the patient felt like the message was tailored to the patient.  Alaska Native/American 
Indian individuals have also expressed a desire to see culturally appropriate pictures, models, artwork, 
and stories in health promotion and messaging materials, including developing Native language 
materials if appropriate (Lantz, 2003).   
 
One on One Education and Team-Based Care 
A common theme shared by all of the key informants was their communication of information on 
screenings/guidelines to patients verbally during one-on-one conversations.  All respondents felt that 
one-on-one education was an effective method of delivering information.  Adequate time with a 
healthcare provider to receive explanations has been associated with increased colorectal cancer 
screening rates, particularly in rural areas (Carcaise-Edinboro, 2008; Perkins, 2013; Davis, 2013).  
However, almost all of the key informants (13/15) identified that there is not enough time for a provider 
to spend with each patient.   
 
To address both the need for quality communication between a patient and healthcare provider, as well 
as the lack of physician time, several key informants noted that information on preventive screenings 
could be provided by another member of the medical team.  While key informants were not asked 
specifically about team-based care, comments on this theme emerged in response to prompts on one-
on-one education and longer appointments, as key informants’ voiced their concerns about a lack of 
time for adequate provider-patient interactions.  As Klabunde et. al. notes, a team approach shifts the 
way colorectal screening is delivered “by directly addressing the physician’s lack of time for preventive 
care” (Klabunde, 2007).  Testing this theory in practice, the rate of colorectal cancer screening has been 
documented to increase when nurses were given additional responsibilities, such as the the training of 
rural Alaskan nurse practitioners and physician assistants in flexible sigmoidoscopy (Thompson, 2000; 
Redwood, 2009).  The team approach to encouraging preventive screenings can include educating clinic 
staff, administrators, and support employees about screenings to gain their support (Lantz, 2003).   
 
Care managers providing one-on-one telephone calls to patients has been documented to improve 
breast, cervical, and colorectal cancer screening rates in a large randomized, controlled trial in New York 
City (Dietrich, 2006), and has also been reported as a strategy in Alaska employed to encourage women 
to receive a diagnostic follow-up to cancer screenings by assisting with addressing sociocultural barriers, 
including travel, attitude toward healthcare, and language issues (Lantz, 2003).  
 
During key informant interviews and the literature review, a common theme emerged of tailoring 
conversations to specific patients and demographics.  Providers spoke about sharing personalized 
information with their patients in a conversation that took into account the patient’s health culture, 
literacy, and values.  Providers mentioned that they felt their interactions with patients were more 
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effective if there was a two-way conversation between the patient and provider that built a partnership, 
and motivated patients to take steps towards wellness.  Providers noted the complexity of behavioral 
change (i.e. diet, tobacco use, exercise, or receiving a screening), and the need to consider, and respond 
to, where a patient was on the journey towards behavioral change to effectively support patients.  In a 
national survey examining the association between provider communication and preventive screenings, 
interactive patient-provider communication (as measured by providers asking for patient input on 
decision making and providers asking patients about other treatments they had received) was 
associated with greater adherence to USPSTF recommended preventive screenings (Villani, 2013). 
 
During the literature review, several published articles referenced Alaska’s unique cultural diversity.  
Within an Alaska Native/American Indian context, providing “culturally sensitive care” to build trust 
among patients was identified in 141 key informant interviews, although many of the recommendations 
could be applicable to women of a variety of cultural backgrounds (Lantz, 2003).  Recommendations for 
culturally sensitive care included person-to-person recruitment for screenings and follow-up, hiring 
Native individuals to communicate directly with Native patients, staffing providers who speak the local 
language to serve women who are more comfortable in that language, employing female providers for 
“female-related procedures”, providing private screenings in a space that isn’t overcrowded, being 
flexible with time, using a “soft, gentle communication style”, and allowing at least 30 minutes for a visit 
to allow time for the provider to explain each step of the examination, proceed slowly, and not rush 
procedures or communication with patients (Lantz, 2003).   
 
Reducing Structural Barriers for Clients 
The Community Preventive Services Task Force systematic reviews have found strong evidence linking 
reducing non-monetary structural barriers for patients and increasing breast and colorectal cancer 
screenings (Sabatino, 2012).  Structural barriers include the time or distance to a clinic/hospital, hours of 
service, alternative settings for care, and administrative procedures.  When key informants were asked 
about each of these potential structural barriers, all felt that offering alternative settings for care would 
be effective with Alaskan medical providers.  About 75% (6/8) of Anchorage-based providers felt that 
time/distance to a clinic/hospital was a significant or moderate barrier, contrasting with 86% (6/7) of the 
non-Anchorage urban providers.  This difference was also noticeable in the number of providers who 
saw moderate to significant barriers to care from hours of service (6/7 non-Anchorage vs. 4/8 
Anchorage-based providers) or administrative procedures (5/7 non-Anchorage vs. 3/8 Anchorage-based 
providers). 
 
Time/Distance to the Clinic/Hospital and Alternative Settings for Care 
Key informants in non-Anchorage urban areas noted that distance to care is a larger barrier for residents 
of rural Alaska.  While 75% (6/8) of the key informants based in Anchorage also identified time/distance 
to clinic/hospital as a moderate or significant barrier to care, and spoke about bringing care to patients 
through the use of health fairs or mobile units in patients’ places of employment, many described their 
experiences in rural Alaska when mentioning alternatives settings of care.  Different populations of 
Alaskans receive screening and diagnostic services in different ways, depending on their geography.  
Rural residents struggle with accessing care, as evidenced by the lower colorectal cancer screening rates 
of rural Alaska Native individuals (Schumacher et al, 2008).  To illustrate some of the differences in 
time/distance to care, and the current utilization of alternative care settings; some Alaskans receive 
mammogram information and screenings integrated into their healthcare, such as at the Alaska Native 
Medical Center in Anchorage, while other Alaskans receive mammograms in a specialty clinic, such as in 
Barrow where the Arctic Slope Native Association either flies women from outlying communities in for 
mammography clinics, or flies a radiologic technician and mammography equipment out to North Slope 
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communities (Lantz, 2003).  If a referral is indicated following a mammogram, women on the North 
Slope would need to travel to either Fairbanks or Anchorage for follow-up, although a locally available 
breast ultrasound could make it easier for women who have an abnormal mammogram (Lantz, 2003).  
Initiatives to improve access and annual rescreening rates, including mobile mammography for rural 
areas are suggested to improve breast cancer screening rates in Alaska Native/American Indian women 
(Roubidoux, 2012).  However, distance to care may not be a barrier for all screening rates. In a study of 
cervical cancer screenings in southwest Alaska, no difference in Pap smear prevalence was indicated by 
distance from Bethel on the Y-K Delta (Provost, 1996).  While structural barriers vary throughout the 
state, especially given Alaska’s unique healthcare delivery system and geography, further research 
would be needed to determine the impact of geography on screening rates for each of the ten key 
screenings/guidelines.   
 
Group Education 
Only four key informants currently use group education, and about half of all key informants felt like 
group education would be an effective method for use by Alaskan medical providers.  The Community 
Guide defines “Group Education” as a way to convey information “with the goal of informing, 
encouraging, and motivating participants to seek recommended screenings”, usually conducted by 
health professionals (Guide to Community Preventive Services, 2009).  The Community Preventive 
Services Task Force has found that group education increases the rate of breast cancer screening, but 
insufficient evidence to recommend group education for additional cancer screenings (Sabatino, 2012).  
Key informants spoke about giving lectures and presentations to community groups, school groups, and 
patient groups.  Group education has also been used with and for Alaska’s Community Health Aides and 
Practitioners, who have demonstrated changes in screening behaviors up to four years post-course for 
themselves, their families, and their communities (M. Cueva, ahead of print).  However, a review of the 
literature conducted in the preparation of this report has revealed a gap in literature analyzing the 
association between group education and additional screenings/guidelines.5  
 
Mass Media 
While most key informants felt like mass media could be an effective way of increasing preventive 
screening rates, many were skeptical about the messages communicated by the media.  Several felt that 
media sources do not often provide an accurate interpretation of science, and some noted that media 
can create fear and disseminate misinformation.  Key informants spoke of mass media in terms of 
television, radio, and public service announcements.  The Community Guide defines mass media as 
“mass-reach health communication interventions” that target audiences through television, radio, print, 
billboards, movie theaters, or digital media (Guide to Community Preventive Services, 2013).  A link has 
been documented between mass media campaigns and increasing the use of tobacco cessation services 
(Guide to Community Preventive Services, 2013; Schillo et al, 2011).  In Alaska, a telenovela on 
colorectal cancer screening has been developed and disseminated primarily in Alaska’s rural 
communities, and 71% of viewers (305/428) at showings in Anchorage and seven rural communities 
completed post-movie evaluations (M. Cueva, 2013).  82% of respondents reported an intent to change 
behavior to reduce cancer risk, including 24% who intended to talk to a provider about colon cancer 
screening and 31% reporting an intent to change their behavior and receive a colon cancer screening 
after viewing the telenovela (M. Cueva, 2013).  
    
                                                          
5
 Several articles were discovered in the literature review about the use of group education to prevent or manage 
disease, although their content is outside the scope of this report. 
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Provider Incentives 
While a literature review of systematic reviews demonstrates that there is insufficient evidence linking 
provider incentives with increased screening rates, key informants spoke extensively about financial 
incentives to conducting screenings (Community Preventive Services Task Force, 2012; Brouwers et al, 
2011; Sabatino, 2008).  Although only two key informants mentioned using monetary provider 
incentives, about half felt like they would be effective, and most providers mentioned that 
reimbursements impacted their practice. 
 
Comments on reimbursement or monetary incentives highlighted providers’ desire to be reimbursed for 
longer appointments and appropriate preventive care practices.  While some providers were concerned 
about “monetary provider incentives” as potentially illegal, or a kick-back, several key informants noted 
that they were motivated to ask patients specific questions, or conduct specific procedures because 
they were reimbursable.  One provider mentioned that Medicare and Medicaid reimbursement rates 
are higher for preventive screenings than routine visits, and was consequently financially motivated to 
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Barriers to Utilizing Screenings 
Information on barriers to increasing preventive screening rates were noted in both the key informant 
interviews and from the literature review. 
 
Out of Pocket Expenses 
The most salient theme emerging from the key informant interviews was the financial barrier for 
patients to access and utilize screenings.  Providers noted that they felt specific screenings, such as 
obesity, communication about tobacco, and blood pressure required little financial investment, and 
consequently were frequently conducted.  However, blood draws to screen for lipid disorders and 
diabetes, as well as colorectal cancer screenings were noted as having significant financial barriers.  To 
reduce this barrier, providers mentioned both the state Breast and Cervical Health Check as a program 
that successfully brought more patients in to receive those screenings, as well as proposed increased 
insurance coverage due to the Affordable Care Act.  See the section on Reducing Out of Pocket Costs in 
Best Practices for further information. 
 
Perceived Discomfort/Invasiveness of Procedure 
Key informants shared that colorectal cancer screening is a particularly difficult procedure to encourage 
patients to access due to the invasiveness of the procedure and patients’ perceived discomfort.  While 
fecal occult blood testing (FOBT) was mentioned as a less invasive method of screening, both methods 
of colorectal screening (colonoscopy/sigmoidoscopy and FOBT) were still seen as difficult tests for 
patients to conduct, and a difficult screening for some providers to request of their patients.  Pain and 
discomfort were also identified as major barriers to colonoscopy in an urban US population (Ghevariya 
et al, 2013).  Perceived discomfort was also identified by key informants as a more moderate barrier for 
mammograms, cervical cancer screenings, and blood draws for other preventive screenings. 
 
Time/Process of Screening 
Providers noted the multi-step process of colorectal screening as barrier.  Key informants noted the 
preparation before a colonoscopy, the time of the screening, and the recovery from sedation as a 
significant barrier.  The practice of patients going home to conduct a fecal occult blood test at their 
leisure also arose as a barrier to attaining screening.  Some informants mentioned that colorectal cancer 
screening was more difficult to accomplish because of the length of the process, contrasting colorectal 
cancer screening to the one-stop, but less invasive breast cancer or cervical cancer screenings.  
 
Lack of Education/Awareness 
Key informants noted that a lack of patient education about preventive screenings and guidelines was a 
barrier both in itself, and due to misinformation and a lack of awareness that were noted to accompany 
lower levels of education.  A higher educational level is correlated with higher rates of cervical and 
colorectal cancer screening among Alaska Native individuals (Schumacher et al, 2008).  This finding is 
consistent with national trends indicating a correlation between low socioeconomic status and a lack of 
screening (Chen et al, 2012).  However, knowledge about preventive screenings/guidelines can be 
transmitted through more than formal schooling, demonstrated by Alaska Native individuals with 
knowledge of cancer through a family history being more likely to become screened for colorectal 
cancer (Schumacher et al, 2008). 
 
Fear 
Fear has also been also been noted as a barrier to screening in both the literature and in key informant 
interviews.  These potential fears include the concern about complication during screening, such as 
during a colonoscopy (Ghevariya et al, 2013).  Key informants also shared that a patient’s fear of a 
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positive result can be a barrier to attaining screenings, which was also noted by a national sample of 
directors of managed care organizations as a barrier to attaining mammograms and pap smears 
(Amonkar et al, 1999).   
 
Cultural Differences 
Several key informants noted that preventive screening rates were impacted by their patients’ cultural 
beliefs and values.  These cultural values included differences in motivations, lack of understanding 
between the provider and patient, differences in sense of invasiveness (particularly in regards to blood 
draws, mammograms, pap smears, and colorectal cancer screenings).  Providers spoke of these 
differences being beyond language/translation.  To alleviate these barriers, some providers were 
working with members of their patients’ communities to be cultural liaisons between the patient and 
providers, while some were striving to be culturally sensitive and understanding of each patient’s values 
and background.  Providers also mentioned the need for culturally respectful health messaging 
materials, including multilingual brochures, as well as their appreciation for having culturally responsive 
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Limitations 
This preventive screenings gap analysis strives to inform DHSS’ plan to increase preventive screening 
rates in Alaska for the ten specified screenings/guidelines.  However, there are several limitations 
inherent in the study timeline and methodology.   
 
All key informants were provided by the state of Alaska and are not representative of providers within 
the state.  Key informants were selected based on their knowledge of preventive screenings, DHSS’ 
perception of their willingness to participate, and the availability of their contact information, and not 
from a random sample of all providers in Alaska.  Further, these key informants are based in Anchorage 
and urban areas outside of Anchorage (Fairbanks, Juneau, Palmer).  Consequently, large areas of the 
state are not included by the key informants, including rural Alaska, north and northwestern Alaska, and 
southwest Alaska. 
 
The screenings/guidelines that this report focuses on were chosen by DHSS, and consequently all 
information is limited to those screenings/guidelines.  Key informants expressed a desire to share their 
thoughts on additional preventive measures they felt were important, including vaccines and 
immunizations, osteoporosis, gonorrhea and chlamydia, unintended pregnancy, and prostate cancer.  
However, the scope of this report is limited to the ten screenings/guidelines indicated by DHSS, and 
consequently additional research would be needed to examine current practices, best practices, and 
barriers to any additional preventive measures. 
The research on best practices and barriers to increasing preventive screening rates were limited to key 
informant interviews and a review of the literature.  However, the literature review identified gaps in 
peer-reviewed publications, particularly in regards to national studies of methods to increase providers 
adherence to guidelines on recommending aspirin for the prevention of cardiovascular disease as well as 
methods to increase obesity screening.  Further research would need to be conducted to determine best 
practices and barriers to improving screening rates from primary data collection to supplement the gap 
in literature. 
 
While key informants and the literature both reflect a need to tailor health messages to specific 
population groups, identifying target population groups in Alaska, as well as messaging techniques 
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Conclusions 
This report summarizes findings from key informant interviews with providers in urban Alaska, as well as 
a review of the literature relevant to each of the identified ten screenings/guidelines.  Due to the 
selection of urban key informants, additional research would be needed with comparable rural 
providers to gather information on methods and practices to improve preventive screenings/guidelines 
in rural Alaska.  Themes emerging from both the literature and key informant interviews drew from 
current practices, best practices, barriers to increasing preventive screening rates, as well as from 
discovered gaps.   
 
Findings on current practices included the prevalence of verbal communication between patients and 
providers, and its mediation by patient characteristics, provider characteristics, and screening 
recommendations.  The literature and key informant interviews revealed provider reminder and recall 
systems as a best practice, while findings on barriers demonstrated a strong financial theme.   
Key informants indicated that they most frequently communicate information to patients verbally 
through one-on-one conversations, as well as through brochures.  However, the preventive practices 
that providers and patients discuss during one-on-one conversations is mediated by patient 
characteristics such as culture, health literacy, and values, as well as by the provider’s lack of time, trust 
in the screening/guideline, and their role on the healthcare team.   Key informants identified the U.S. 
Preventive Services Task Force most often as a source of trusted information on preventive 
screenings/guidelines, which recommends against aspirin for the prevention of cardiovascular disease 
for certain demographics, as well as provides no screening recommendation for falls prevention.   
 
Identified best practices from key informant interviews and the literature on provider-oriented practices 
included the use of a system to remind providers about preventive practices at point of care as common 
to all the preventive screenings/guidelines, with the exception of falls prevention.  The strongest theme 
from the key informant interviews was about financial barrier to increasing the rates for preventive 
screenings/guidelines.  Providers also spoke about geographic disparities and cultural differences as 
barriers to increasing preventive screening rates.  This theme is supported by the diversity of age ranges 
and demographics that are included in recommendations from the USPSTF for the ten key 
screenings/guidelines (see Table 5. USPSTF Recommendations and Alaska Rates). 
 
Table 5. USPSTF Recommendations and Alaska Rates also illuminates some of the gaps that have been 
discovered during the creation of this report, namely from the lack of known baseline data on which to 
compare an increase in screening rates for several of the key screenings/guidelines.  Due to the 
selection of urban key informants, a gap also exists in consulting experts in rural Alaska on preventive 
screenings/guidelines.  Further research would be needed to determine baseline Alaska screening rates 
for all specified screenings/guidelines, the target population for increasing screening rates, as well as 
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[Please read the following text to the prospective participant] 
 




Hello, Dr. [Mr/Ms] ________________,[Is this the practice of ______________?] 
 
My name is ____________, from the Institute of Social and Economic Research at the University of 
Alaska Anchorage. We are conducting a small number of interviews with key medical providers. The 
interviews are sponsored by the Alaska Department of Health and Social services, and are part of a 
project to learn how to increase preventive screening rates in Alaska. 
 
 
0 Gatekeeper available (Skip to S1) 
1 Medical Provider available (Skip to A1) 




3 Gatekeeper not available (Set time to call back C3) 
4 Gatekeeper soft refusal  Thank and suggest another time to call back 
5 Gatekeeper hard refusal  Thank and Terminate 
6 Medical Provider soft refusal  Thank and suggest another time to call back 
7 Medical Provider hard refusal  Thank and Terminate 
8 No longer works/lives here (Skip to S2) 




S1. I would like to verify that I have reached _____________________. 
 Yes  No   I’m sorry to have bothered you . . .[Go to S2] 
 
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S2. _______________________ is a very important part of a medical study we are conducting for the 
State Department of Health and Social Services. Do you happen to know if he/she is still in this 
area, or is (he/she) in another city/state? 
 Same area/or another city  Different state   Thank and Terminate  
   [IF OTHER STATE MENTIONED, RECORD 
 ____________________________  ] 
    Don’t know   Thank and Terminate     
   Refused   Thank and Terminate  
      
S2a. Do you have the address or telephone number where I can reach. _________________?  
[ENTER PHONE NUMBER AND ADDRESS.] 
Phone Numbers __________________    ______________________ 
 
Street Address ___________________________________________ 
 
City ____________________________ State______ Zip Code ________ 
 
 
A1. During a TYPICAL week, do you [does  _____________ ] provide at least twenty hours of direct 
patient care? 
[INTERVIEWER NOTE:] (If necessary, say) Direct patient care involves seeing patients 
and patient-related care. (If necessary, say) INCLUDING time spent on patient record-
keeping, patient-related office work, and travel time connected with seeing patients; 
EXCLUDE time spent in training, teaching, or research; any hours on-call when not 
actually working; and travel between home and work at the beginning and end of the 
work day. 
 No  Yes   Continue with A2 
 
Thank and Terminate [delete contact information] 
In this interview, we won’t be interviewing medical providers who typically provide patient 
care for less than 20 hours per week. So it seems we won’t need any further information from 
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INFORMED CONSENT FORM 
 
[Read the consent form.  Emphasize that participation is voluntary; they may decline to answer any 
question or withdraw at any time without penalty. Answer all questions before proceeding.] 
 
Your name and contact information was provided to us by the State of Alaska Department of Health and 
Social Services, Division of Public Health, Chronic Disease Prevention and Health Promotion Section.  
They have identified you as a key medical provider who has available information on best practices, 
barriers, consumer motivation and provider knowledge of preventive health screenings and guidelines.  
This study is sponsored by Alaska Department of Health and Social Services and its results will be used to 
support efforts to improve the number of people using preventive screenings and guidelines. 
The interview takes about 20 to 30 minutes to complete. Your participation is voluntary, and all your 
answers will be kept confidential. In our report your answers will be combined with those of other 
medical providers so that no person's answers can be identified. If there are any questions you do not 
wish to answer, simply tell me that and we will skip that question. You may stop the interview at any 
time. If you have any questions about your rights, I can give you the name and telephone number of the 
person to contact [Dr. Diane Toebe, 786-1099]. If you have questions about this study, I can give you the 
name and number of the person in charge of this study [Rosyland Frazier, 786-5432]. Do you have any 
questions? 
[If YES: Answer their questions, select "Yes" record their question and your response and continue to the 
interview. If you are unable to answer the questions, please get a supervisor for assistance.] 
 Yes 
 No 
 I don't have time for this right now/Call back later [I can conduct the interview now or at another 
time convenient for the medical provider.] 
If No Is Selected, Then Skip To Intro Questions 
If Yes Is Selected, Then Skip To Intro Questions 
If I don't have time for this ... Is Selected, Then Skip To When would be a good time to call back? 
C3. When would be a good time to call back? [Enter time and date in the text boxes. Get a specific time 
and day; suggest a time and day if respondent "doesn't know"] 
Time 
Date 
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A2. We'd like you to think about the practice location at which you [. __________ ] spend(s) the 
greatest amount of time in direct patient care. In what community is your practice located? 
____________________________________ ? 
  
A3. What is your [his/her] primary specialty l___________________. 
[INTERVIEWER NOTE: (If necessary, say) We define primary specialty as that in which the 
most hours are spent weekly.]  
 
A6. Are you currently . . . [Is ________ currently] 
a. a full-time employee of a federal or state agency [PROBE: Do you receive your paychecks from 
a state or federal agency such as the U.S. Public Health Service, VA, or a military service)]? 
  No  Yes 
b. a resident physician?   No  Yes 
c. a full-time contract employee  No  Yes 
 









C2.  What type of practice is this? [PROBE: If needed read the following list] 
 
  Group Practice/Private MD Group Practice 
  Partnership 
  Community Health Center 
  Walk-in/Urgent Care Center 
  Hospital 
  Hospital-affiliated Clinic 
  Tribal Hospital 
  Not-for-profit Organization 





PREVENTIVE SCREENING AND CLINICAL GUIDELINES 
 
This analysis is being used to determine what steps the State Department of Health and Social Services 
needs to take in order to encourage Alaska residents to increase the rate of preventive screenings from 
the current levels to desired levels for the following key screenings/clinical guidelines: 
1. Type 2 Diabetes Screening 
2. Screening for High Blood Pressure  
3. Lipid Disorder Screening 
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4. Aspirin for Prevention of Cardiovascular Disease 
5. Prevention of Tobacco Use and Tobacco Cessation – Ask, Advise 
6. Colorectal Cancer Screenings 
7. Breast Cancer Screenings 
8. Cervical Cancer Screenings 
9. Obesity Screening  
10. Falls Prevention 
We want to learn about the current best practices; 
What you think are the barriers to patients’ access/utilization of screenings and; 
What you think encourages and discourages patients’ motivation to have their preventive screenings or 
follow preventive guidelines 
 
INFORMATION TO PATIENTS PROVIDED BY MEDICAL PROVIDERS 
 
Q1. Does your office provide information to patients on preventive screenings and guidelines? 
 Yes No 
 
Q1.1 If yes 
Which of the following does your office provide? (mark all that apply) 
-referrals to websites 
-Brochures 
-Booklet 
-referrals to Blogs 
-referrals to Forums 
-referrals to Non-profit organizations 




Q2. Do you recommend any particular resources to patients for preventive screenings/guidelines? 
 Yes No 
 
Q2.2. If yes: What do you recommend, and why do you recommend them? 
 
 
Q3. There are a lot of methods recommended to increase patient preventive screenings.  I am going to 
read you list of some of these methods.  Please tell me what you think is the effectiveness of each of 
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Effective, uncertain, ineffective 
Often, sometimes, rarely, never 
How effective are . . . ? 




Frequency of Use: Often, 
Sometimes, Rarely, Never 
Client Incentives   
Client Reminders   
 Printed letters or postcards   
 Telephone calls   
Texting   
Emails   
Small Media, including letters, 
brochures, newsletters 
  
Mass Media, including TV, radio, 
newspapers, and magazine ads 
  
Group Education   
One on One Education   
Alternative settings for care, other 




Q3.1. What other methods do you think are effective in increasing patient preventive screenings? 
 Q. 3.2 How do these vary for different kinds of screenings? 
Q4. There are a number of barriers to increasing patient preventive screenings.  I am going to read you 
list of some of these.  Please tell me how much you think each of these effects patient preventive 
screening rates. 
 
Considerable, Moderate, Slight, None 
 
Q5. What other additional barriers effect preventive screening rates? 
 
 
Q 5.1 How these vary for different kinds of screenings? 
 
 
Structural barriers Considerable Moderate Slight None 
Time/distance to 
clinic/hospital 
    
 Language/translation     
Administrative procedures – 
scheduling, patient navigation 
    
               Hours of service     
 Transportation     
 Child care     
Perceived discomfort     
Out of pocket costs     
Lack of perceived benefit     
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INFORMATION FOR YOURSELF - WHAT DO YOU KNOW? 
 
In this section we would like to learn: 
1. how you, as health care providers, would like to get information about preventive screenings 
2. what you know about preventive screenings,  
3. where you go when you want information on preventive screenings, and   
4. what you think of different kinds of information on preventive screenings  
 
Q6. Which of these would you would you use to find information on preventive screenings/guidelines? 
 Internet searches 
 Specific websites 
 Specific apps 
 Asking colleagues 
 Continuing education 




Q7. Is there someone or someplace that you expect would provide you with updates on preventive 
screenings and guidelines? 
 
 Yes   No 
  
Q7.1 If yes, who or where? 
 
Q9. Information can come from different sources.  Can you tell me the name of an agency or source you 










Preventive Screening Gap Analysis October 15, 2013 
Institute of Social and Economic Research  
Often, Sometimes, Rarely, Never 
 Often Sometimes Rarely Never 
Type 2 Diabetes Screening     
Screening for High Blood 
Pressure  
    
Lipid Disorder Screening     
Aspirin for Prevention of 
Cardiovascular Disease 
    
Prevention of Tobacco 
Use and Tobacco 
Cessation – Ask, Advise, 
Refer 
    
Colorectal Cancer 
Screenings 
    
Breast Cancer Screenings     
Cervical Cancer 
Screenings 
    
Obesity Screening      
Falls Prevention     
 
 
Q10. How often do you initiate discussions about preventive screenings with your patients? [Provider  
initiated.  Ask by screenings.  If there are conditions that they offer record info.  Example I talk with all of 
my female patients 18 yrs. and older about breast cancer. . . . ] 
Often, Sometimes, Rarely, Never 
 
 
 Often Sometimes Rarely Never 
Type 2 Diabetes Screening     
Screening for High Blood 
Pressure  
    
Lipid Disorder Screening     
Aspirin for Prevention of 
Cardiovascular Disease 
    
Prevention of Tobacco 
Use and Tobacco 
Cessation – Ask, Advise, 
Refer 
    
Colorectal Cancer 
Screenings 
    
Breast Cancer Screenings     
Cervical Cancer 
Screenings 
    
Obesity Screening      
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OPINION OF SOURCES OF PATIENT INFORMATION 
 
Q11. Please tell us of any particular sources of information (ex. medical websites, apps) that you feel are 





Q12. If they were provided, what kind of materials do you feel would be the most helpful for you to use 





Q13. Please tell us of any particular sources of information (ex. medical websites, apps) that you feel are 




METHODS TO EFFECT PROVIDERS 
 
Q14. There are some methods recommended to increase provider influence/impact on patients’ use of 
preventive screenings.  I am going to read you a list of some of these methods.  Please tell me how 
effective you think these methods would be with Alaskan medical providers, and whether or not your 
organization uses each method.   
 
Effective, Uncertain, or Ineffective? 
All providers, most, few, none? 
 
 Effectiveness: Effective, 
Uncertain, Ineffective 
Use: All providers, most, few, 
none 
An electronic system to remind you 
when it is time for a patient’s screening 
  
Provider incentives to make appropriate 
referrals 
  
Monetary   
Nonmonetary   
Feedback on how you deliver or offer 
screenings or information on screenings 
  







Q15. Are you male or female? 
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Q16. What is your age? 
 
 
Q17. How long have you been in practice? 
 
 
Q18. How long have you been in practice in Alaska? 
 
 
Q19. Is there anything else you’d like us to know? 
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Appendix B. Initial Literature Review Key Word Searches 
 
An initial search was conducted on PubMed on March 6, 2013.  Article titles were reviewed for 
relevancy, and all potentially relevant articles were exported to EndNote.  The following key word 
searches garnered the specified number of articles: 
  
“diabetes screening” “Alaska” – 0  
“diabetes” “screening” “Alaska” – 35, exported 25 to EndNote 
“blood pressure” “Alaska” – 51, but nothing about screening 
“blood pressure screening” “Alaska” – 0 
“blood pressure” “ask advise” “Alaska” – 0 
“blood pressure” “screening” “Alaska” – 13, exported to EndNote 
“cholesterol” “screening” “Alaska” – 8, exported to EndNote 
“aspirin” “screening” “Alaska” – 0 
“aspirin” “Alaska” – 2 on Kawasaki disease, 1 on acute rheumatic fever/rheumatic heart disease, 1 on 
treating acute MI, 1 on stroke prevention among patients with a-fib 
“aspirin” “cardiovascular disease” “Alaska” – 0 
“tobacco cessation” “Alaska” – 13, 12 exported to EndNote 
“colorectal cancer” “screening” “Alaska” – 26, exported to EndNote 
“breast cancer” “screening” “Alaska” – 25, exported to EndNote 
“cervical cancer” “screening” “Alaska” – 30, 27 exported to EndNote 
“obesity” “screening” “Alaska” – 17, 4 exported to EndNote 
“BMI” “screening” “Alaska” – 6, all duplicates 
“BMI” “Alaska” – 33, 22 exported to EndNote, 6 on genetic contributions to obesity 
“obesity” “Alaska” “prevention” – 42, 4 exported to EndNote 
“falls” “Alaska” – 36, 19 exported to EndNote 
“falls” “prevention” “Alaska” – 17, all duplicates 
 
A total of 185 articles were exported to EndNote as a result of these key word searches.  To attempt to 
fill the gap in literature on aspirin as prevention of cardiovascular disease, an additional search of the 
literature was conducted on PubMed on March 8, 2013, using the key words: “cardiovascular disease” 
“prevention” “alaska”.  This search generated 35 articles.   
 
After reviewing for duplicates, 165 unique articles were identified from these searches. 
 
A review of abstracts for each article revealed 25 articles with a non-Alaska focus (most commonly, the 
term “American Indian/Alaska Native” had been used), 54 articles about disease statistics and not 
screening measures, and 5 articles evaluating different screening techniques.  Removing these three 
groups from the sample resulted in 81 unique articles.  Of these unique articles, 61 (75%) were 
published in the year 2000 or later, while 52 (64%) were Alaska Native specific.  
 
Sorting these 81 articles into relevant screening/clinical categories: 
 Diabetes Screenings – 14 
 BP Screenings – 1 
 Lipid Disorders/Cholesterol Screenings – 7 
 Aspirin for Prevention of Cardiovascular Disease – 10 
 Prevention of Tobacco and Tobacco Cessation - 3 
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 Colorectal Cancer Screenings – 7 
 Breast Cancer Screenings – 14 
 Cervical Cancer Screenings – 12 
 Obesity/BMI Monitoring – 9 
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Appendix C. Initial Literature Review Results: Annotated Bibliography 
 
(2000). "Every encounter is an opportunity for recommending breast and cervical cancer screening in 
women. Alaska Breast & Cervical Cancer Early Detection Program." Alaska Med 42(2): 46-47. 
  
Adler, A. I., et al. (1994). "Lower prevalence of impaired glucose tolerance and diabetes associated with 
daily seal oil or salmon consumption among Alaska Natives." Diabetes Care 17(12): 1498-1501. 
 OBJECTIVE: To examine the association of seal oil and salmon consumption with impaired 
glucose tolerance (IGT) and non-insulin-dependent diabetes mellitus (NIDDM) among Alaska Natives. 
RESEARCH DESIGN AND METHODS: Screening was performed on 666 Yup'ik Eskimos and Athabaskan 
Indians > or = 40 years old in 15 villages. Self-administered questionnaires were used to obtain partial 
food frequency data. A case was defined as IGT or NIDDM, either newly discovered or known. Newly 
discovered cases (11 patients with NIDDM and 17 with IGT) were determined by random blood glucose 
testing followed by a 2-h 75-g oral glucose tolerance test (OGTT) for those with values > or = 6.72 
mmol/l or for subjects with unconfirmed histories of glucose intolerance. Known cases included 26 
patients with NIDDM and 1 with IGT. Control subjects had random blood glucoses < 6.72 or normal 
OGTT results. RESULTS: Compared with less-than-daily consumption, both daily seal oil (odds ratio [OR] 
0.2, 95% confidence interval [CI] 0.1-0.8) and daily salmon consumption (OR 0.5, CI 0.2-1.1) were 
associated with a lower prevalence of glucose intolerance, controlling for age, ethnicity, body mass 
index, and sex. The effects were similar when limited to newly discovered cases: OR 0.3, CI 0.1-1.3 for 
seal oil and OR 0.4, CI 0.1-1.3 for salmon. Consumption of seal oil at least five times per week was 
required to reduce risk. CONCLUSIONS: Consumption of seal oil and salmon, high in omega-3 fatty acids, 
appears to lower the risk of glucose intolerance and is a potentially modifiable risk factor for NIDDM in 
Alaska Natives. 
 
Adler, A. I., et al. (1996). "The negative association between traditional physical activities and the 
prevalence of glucose intolerance in Alaska Natives." Diabet Med 13(6): 555-560. 
 The once low prevalence of non-insulin-dependent (Type 2) diabetes (NIDDM) in Eskimos and 
Indians has risen approximately fourfold over the past 30 years, suggesting the presence of a non-
genetic factor affecting NIDDM prevalence. At the same time, traditional physical activities required of a 
subsistence (self-sufficiency) lifestyle have diminished. Since physical activity has been shown to prevent 
NIDDM in other populations, we performed a case-control study of physical activity and glucose 
intolerance in 666 Yup'ik Eskimos and Athabaskan Indians > or = 40 years old in 15 villages in the Yukon 
Kuskokwim Delta in Alaska. Self-administered questionnaires were used to determine whether subjects 
participated in a number of traditional activities and/or their modern counterpart (for example, dog 
sledding and riding motorized vehicles). Intensity values and a score were defined for the activities. 
Cases included known or newly discovered impaired glucose tolerance or NIDDM. Newly discovered 
cases were defined by oral glucose tolerance testing of those individuals were screening blood glucose 
values > or = 6.7 mmol l-1 by random capillary blood glucose testing. Cases included 11 newly 
discovered (1 with a history of IGT) and 26 known cases of NIDDM, and 17 newly discovered and 1 
known cases of IGT. The results showed that, compared to a reference group with low-level physical 
activity, moderate level physical activity (odds ratio, OR, 0.7, 95% confidence interval [CI] 0.4-1.3) and 
high level activity (OR 0.2, CI 0.1-0.6) were associated with a lower prevalence of glucose intolerance, 
adjusted for age, ethnicity, body mass index, and sex. 
 
Anderson, K. J. and P. D. Speranza (2011). "Procedural and temporal compliance to cervical cancer 
screening guidelines in a CDC-funded program in Alaska." J Low Genit Tract Dis 15(2): 98-104. 
 
54 
Preventive Screening Gap Analysis October 15, 2013 
Institute of Social and Economic Research  
 OBJECTIVE: To estimate changes in clinical practice in a cervical cancer screening program after 
the American Society for Colposcopy and Cervical Pathology's issuance of 2006 consensus guidelines 
(2006CG) for managing abnormal Pap tests. METHODS: Screening and diagnostic procedure records 
were extracted from the operational database of a Centers for Disease Control and Prevention-funded 
cervical cancer screening program in Alaska. New software was developed to compare these records to 
the American Society for Colposcopy and Cervical Pathology algorithms. Of the 16 algorithms, 11 were 
encoded, and results of patients with abnormal Pap results in 2 study windows (cohort A: 2005-2006: n 
= 1,431; cohort B: October 2007 to September 2008: n = 1,369) were compared with 2006CG 
recommendations. Comparisons between the practices in the 2 study windows were made using the 
Fisher exact test. RESULTS: Among adolescents with low-grade squamous intraepithelial lesion or 
atypical squamous cells of undetermined significance Pap results, 117 (48%) of 243 in cohort A were 
given colposcopies compared with 28 (23%) of 192 in cohort B (p < .0001). There was no difference in 
the rate of human papillomavirus testing between cohorts A and B (23% vs 26%, p = .449). Among adults 
with low-grade squamous intraepithelial lesion, 63 (16%) of 402 in cohort A were given repeat Pap tests 
instead of colposcopies compared with 25 (7%) of 367 in cohort B (p < .0001). Temporal compliance was 
significantly improved (p = .025), with 75% in cohort A and 91% in cohort B being graded as timely or 
early. CONCLUSIONS: Clinical practice has moved toward 2006CG recommendations in this program, 
although gaps remain. This evaluation will be used to inform a compliance improvement program. The 
software can be easily modified as 2006CG evolves and can be ported to other algorithmic practice 
guidelines. 
 
Annuzzi, G., et al. (2012). "Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of 
Coronary Artery Disease in Alaska Natives study." Am J Clin Nutr 95(6): 1315-1322. 
 BACKGROUND: Few studies have compared lipoprotein composition with dietary intake. 
OBJECTIVE: The lipoprotein subfraction profile was evaluated in relation to diet in Alaska Eskimos at high 
cardiovascular risk but with a low frequency of hyperlipidemia and high intake of n-3 (omega-3) fatty 
acids. DESIGN: A population-based sample (n = 1214) from the Norton Sound Region of Alaska 
underwent a physical examination and blood sampling. Analyses were from 977 individuals who did not 
have diabetes or use lipid-lowering medications and had complete dietary information (food-frequency 
questionnaire) and a lipoprotein subfraction profile (nuclear magnetic resonance spectroscopy). 
RESULTS: After adjustment for age, BMI, total energy intake, and percentage of energy from fat, the 
intake of n-3 fatty acids was significantly associated with fewer large VLDLs (P = 0.022 in women, P = 
0.064 in men), a smaller VLDL size (P = 0.018 and P = 0.036), more large HDLs (P = 0.179 and P = 0.021), 
and a larger HDL size (P = 0.004 and P = 0.001). After adjustment for carbohydrate and sugar intakes, 
large VLDLs (P = 0.042 and 0.018) and VLDL size (P = 0.011 and 0.025) remained negatively associated 
with n-3 fatty acid intake in women and men, and large HDLs (P = 0.067 and 0.005) and HDL size (P = 
0.001 in both) remained positively associated with n-3 fatty acid intake in women and men. In addition, 
large LDLs (P = 0.040 and P = 0.025) were positively associated in both sexes, and LDL size (P = 0.006) 
showed a positive association in women. There were no significant relations with total LDL particles in 
either model. CONCLUSIONS: Dietary n-3 fatty acids, independent of the reciprocal changes in 
carbohydrate and sugar intakes, are associated with an overall favorable lipoprotein profile in terms of 
cardiovascular risk. Because there are no relations with total LDL particles, the benefit may be related to 
cardiovascular processes other than atherosclerosis. 
 
Beebe, J. A., et al. (2012). "An Isokinetic Training Program for Reducing Falls in a Community-Dwelling 
Older Adult: A Case Report." J Geriatr Phys Ther. 
 BACKGROUND:: With the population older than 65 years, projected to double by the year 2030, 
falls in older adults are a substantial health concern. Muscle strength deficits are one of the 
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multifactorial components linked to increased fall risk, and decreasing these deficits has been one of the 
goals of interventions designed to decrease fall risk. These interventions have traditionally focused on 
improving peak torque; however, recent research suggests that exercise protocols that focus on the rate 
of torque development (RTD) may be more effective in decreasing fall risk. PURPOSE:: This case report 
examines clinical outcomes following implementation of an isokinetic strengthening protocol coupled 
with a balance program designed to reduce fall risk in a community-dwelling older adult. METHODS:: 
The individual was a 70-year-old woman with a history of 3 falls over the past 8 months and no related 
medical etiology who had self-limited her activities because of fear of another fall. She was classified as 
having substantial risk for future falls because of fall history, increased fear of falling, and below age 
norms on the Berg Balance Scale (BBS), and the Timed Up and Go (TUG). The treatment program 
consisted of 12 weeks of high-intensity isokinetic knee extensor training, high challenge dynamic gait 
and balance activities, and core strengthening. The isokinetic protocol consisted of 4 sets of 10 
concentric-only repetitions at speeds of 240 degrees /sec and 300 degrees /sec for a total of 8 work sets. 
Dynamic gait activities incorporating directional and obstacle drills, and rocker and balance boards were 
used for balance training activities. Progressive theraband exercises were used for core strengthening. 
As her home program, the participant was encouraged to return to line dancing twice per week. During 
the 12-week protocol, the participant completed two 90-minute therapy sessions and two 90-minute 
dance classes per week. RESULTS:: After the 12 weeks of treatment, knee extensor peak torque at 150 
ms improved on the right from 67.8 N to 107.1 N (57.9% increase), and on the left from 65.1 N to 97.6 N 
(49.9% increase). The BBS score improved from 45 to 52; and the TUG improved from 14.0 to 8.6 
seconds. Both final scores exceeded fall risk cutoffs (BBS = 48; TUG = 13.5 seconds) and the change score 
exceeded minimal detectable change (BBS = 7; TUG 5.4 seconds). CONCLUSIONS:: The treatment 
program produced improvements in knee extensor peak torque and RTD, but more importantly, the 
final scores on the clinical outcome measures placed the participant above established fall-risk cutoff 
scores. Although future research with increased numbers of participants and a control group should be 
conducted to confirm this study's results, these findings support the use of isokinetic training to reduce 
fall risk in older adults. 
 
Bersamin, A., et al. (2013). "Enculturation, perceived stress, and physical activity: implications for 
metabolic risk among the Yup'ik - The Center for Alaska Native Health Research Study." Ethn Health. 
 Objectives. American Indians and Alaska Natives (ANs) report among the lowest levels of 
physical activity in the USA, but there is very little systematic research examining the determinants of 
physical activity patterns in these populations. This study investigated the relationships between 
enculturation (or cultural traditionality), psychosocial stress, and physical activity in a community-based 
sample of Yup'ik women and men living in rural AN communities. Associations between these variables 
and several metabolic risk factors were also examined. Design. A sample of 488 Yup'ik participants (284 
women and 204 men) from six villages in the Yukon-Kuskokwim Delta region completed a wellness 
survey and an array of physiological assessments [e.g., body mass index (BMI), blood pressure]. A subset 
of 179 participants also completed a 3-day pedometer assessment of physical activity. Results. 
Multivariate linear regression models indicated that participants who were more enculturated (i.e., 
living more of a traditional lifestyle) and who experienced lower levels of psychosocial stress were 
significantly more physically active. In turn, both lower levels of psychosocial stress and higher levels of 
physical activity were associated with lower BMI, lower percent body fat, and lower waist 
circumference. Conclusions. Findings underscore the importance of gaining a culturally specific 
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Boles, M., et al. (2009). "Effectiveness of a tobacco quitline in an indigenous population: a comparison 
between Alaska Native people and other first-time quitline callers who set a quit date." Int J Circumpolar 
Health 68(2): 170-181. 
 OBJECTIVES: To conduct a descriptive, comparative study of the acceptability and effectiveness 
of a tobacco cessation quitline (QL) among Alaska Native people and non-Alaska Native people. STUDY 
DESIGN: From January 2006 to January 2007, we conducted telephone surveys of first-time Alaska QL 
callers who set a quit date. We attempted to reach them by phone about 3 months after their call to the 
QL. METHODS: Analyses compared 7-day point prevalence quit rates, satisfaction measures, experiences 
and general perceptions of QLs by Alaska Native and non-Alaska Native callers. RESULTS: We surveyed 
39.8% (n = 772) of the 1,941 adult tobacco users we attempted to contact. The 7-day point prevalence 
quit rate among Alaska Native survey participants at the 3-month follow-up was 22.2% (CI: 14.8% - 
32.0%), compared to 40.7% (CI: 36.7% - 44.9%) for non-Alaska Native survey participants. Eighty-three 
percent (CI: 74.6% - 89.3%) were somewhat/very satisfied overall with the QL program compared to 
90.3% (CI: 87.6% - 92.4%) for non-Alaska Native participants. CONCLUSIONS: Although the QL was less 
effective for Alaska Native callers than other QL callers, Alaska Native peoples' quit rates and satisfaction 
were still quite good. Despite this, more effort should be made to address specific Alaska Native values 
and social and cultural barriers to quitting tobacco. 
 
Brega, A. G., et al. (2011). "Cardiovascular knowledge among urban American Indians and Alaska 
Natives: first steps in addressing cardiovascular health." Prog Community Health Partnersh 5(3): 273-
279. 
 BACKGROUND: Cardiovascular disease (CVD) is common among American Indians/Alaska 
Natives (AI/ANs). Given limited access to health care, urban AI/ANs may be at particular risk. Lack of 
available data, however, limits our understanding of cardiovascular health in this population. 
OBJECTIVES: We conducted a survey to characterize CVD-related knowledge, behavior, and risk of urban 
AI/ANs. Results related to knowledge are reported. METHODS: In collaboration with the Indian clinics in 
two urban communities, we surveyed 298 AI/ANs. RESULTS: Respondents recognized approximately half 
of the symptoms of heart attack and stroke, and were significantly less likely to recognize each symptom 
than reported in national studies using the same items. General CVD knowledge (e.g., risks of high blood 
pressure) was stronger, although areas for improvement were noted. CONCLUSIONS: Urban AI/ANs 
would benefit from efforts to enhance CVD knowledge. These preliminary data are providing the 
foundation for community-based efforts to address CVD risk among urban AI/ANs. 
 
Burhansstipanov, L., et al. (2005). "A review of effective strategies for native women's breast health 
outreach and education." J Cancer Educ 20(1 Suppl): 71-79. 
 BACKGROUND: This commentary provides a summary of a pilot study designed to assist the 
American Cancer Society in revising the Circle of Life breast health program for American Indians and 
Alaska Natives (AIANs). METHODS: Included are analyses of a literature review focusing on breast health 
outreach strategies among AIANs and in-depth interviews with breast health focus group facilitators. 
Over 70 AIAN breast or cervix cancer screening articles were reviewed, and approximately 20 focus 
group facilitators were interviewed. RESULTS AND CONCLUSIONS: A primary finding was that AIAN 
breast cancer outreach, education, and screening programs are most effective when community-driven 
and culturally relevant to local tribal nations and geographic regions. 
 
Conway, G. A., et al. (1998). "Preventing deaths in Alaska's commercial fishing industry." Int J 
Circumpolar Health 57 Suppl 1: 503-509. 
 BACKGROUND AND PURPOSE: The arctic and sub-arctic waters of Alaska provide a very 
hazardous work setting, with special hazards posed by great distances, seasonal darkness, cold waters, 
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high winds, brief fishing seasons, and icing. Our intent is to reduce the remarkably high occupational 
fatality rate (200/100,000/year in 1991-1992) among Alaska's commercial fishing workers. Over 90% of 
these deaths have been due to drowning or drowning plus hypothermia, primarily associated with vessel 
capsizings and sinkings. METHODS: Comprehensive surveillance for commercial fishing occupational 
fatalities was established during 1991 in Alaska. During 1990 through 1994, the U.S. Commercial Fishing 
Industry Vessel Safety Act of 1988 required the implementation of comprehensive prevention measures 
for all fishing vessels in offshore cold waters, including immersion suits and other personal flotation 
devices, survival craft (life rafts), emergency position-indicating radio beacons, and crew training in 
emergency response and first aid. Parallel to this, voluntary training efforts by nonprofit organizations 
have greatly increased. RESULTS: During 1990-1994, drowning was the leading cause of occupational 
death in Alaska. During this period, 117 fishers died, 101 of them from drowning or 
drowning/hypothermia. During 1991-1994, there was a substantial decrease in Alaskan commercial 
fishing-related deaths, from 34 in 1991 to 35 in 1992, 22 in 1993, and 10 in 1994. While man-overboard 
drownings and some other categories of deaths (falls, fires) have continued to occur, the most marked 
progress has been in vessel-related events. CONCLUSION: Specific measures tailored to prevent 
drowning in vessel capsizings and sinkings in Alaska's commercial fishing industry have been very 
successful so far. Additional efforts must be made to reduce the frequency of vessel events and to 
prevent man-overboard events and drownings associated with them. 
 
Coughlin, S. S., et al. (1999). "Breast and cervical cancer screening practices among American Indian and 
Alaska Native women in the United States, 1992-1997." Prev Med 29(4): 287-295. 
 BACKGROUND: Recent studies suggest that American Indian and Alaska Native women have 
important barriers to cancer screening and underuse cancer screening tests. METHODS: We examined 
the breast and cervical cancer screening practices of 4,961 American Indian and Alaska Native women in 
47 states from 1992 through 1997 by using data from the Behavioral Risk Factor Surveillance System. 
RESULTS: About 65.1% [95% confidence interval (CI) 60.2 to 69.9%] of women in this sample aged 50 
years or older had received a mammogram in the past 2 years. About 82.6% (95% CI 80.1 to 85.2%) of 
women aged 18 years or older who had not undergone a hysterectomy had received a Papanicolaou test 
in the past 3 years. Older women and those with less education were less likely to be screened. Women 
who had seen a physician in the past year were much more likely to have been screened. CONCLUSIONS: 
These results underscore the need for continued efforts to ensure that American Indian and Alaska 
Native women who are elderly or medically underserved have access to cancer screening services. 
 
Cueva, M. (2010). "Readers' theatre as cancer education: an organic inquiry in Alaska awakening 
possibilities in a living spiral of understanding." J Cancer Educ 25(1): 3-8. 
 Organic inquiry, as the qualitative research design method, provided for a richness of data to 
more fully appreciate how 24 diverse adult learners in Alaska described their experience with Readers' 
Theatre as cancer education both during a workshop and over time that allowed for reflection and 
contemplation. Readers' Theatre, as a pathway for cancer education, nurtured healing, renewal, 
affirmation, and shifts in knowledge, attitudes, and beliefs, which empowered action. Readers' Theatre 
created a respectful environment for adult learners from diverse ethnic and cultural backgrounds in 
Alaska to engage in meaningful conversations that awakened possibilities in a living spiral of 
understanding. 
 
Cueva, M., et al. (2012). "Readers' theatre: a communication tool for colorectal cancer screening." J 
Cancer Educ 27(2): 281-286. 
 Colorectal cancer (CRC) is the second leading cause of cancer mortality for Alaska Native people, 
yet it can be almost totally prevented through colonoscopy screenings. PURPOSE: A 25-minute Readers' 
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Theatre script was developed with and for Alaska Native and American Indian Community Health 
Workers (CHWs) and the people in their communities to provide CRC screening information, model ways 
to talk about CRC screening, increase comfort with talking about CRC, and encourage healthy lifestyle 
choices. METHODS: Grounded in Indigenous methodologies, this paper describes the collaborative 
development, implementation, and evaluation of a CRC Readers' Theatre. RESULTS: 94% (161/172) of 
participants from 11 Readers' Theatre completed a written evaluation. 90% (145) of participants 
reported feeling more comfortable talking about CRC and 77% (124) described healthy changes they 
planned to make. Readers' Theatre was associated with increased knowledge, comfort talking about 
CRC, and served as a catalyst for positive intent to change behavior. 
 
Cueva, M., et al. (2005). "Using theater to promote cancer education in Alaska." J Cancer Educ 20(1): 45-
48. 
 BACKGROUND: Cancer, a rare disease in the 1950s, is now the leading cause of death among 
Alaska Natives (AN). METHODS: Building on AN rich traditions of storytelling to share knowledge and 
wisdom, a 45 minute play, Understanding, was developed to address cancer-related issues specific to 
AN. RESULTS: Written audience evaluations assessed the impact of this theater-based education. After 
seeing the play, 327 (94.5%) people reported feeling more comfortable talking about cancer, 265 
(66.1%) shared that they had learned about cancer, and 234 (61.7%) wrote healthy ways they intended 
to change their behavior. CONCLUSION: A postplay discussion provided an opportunity for the audience 
to share their stories, concerns, beliefs, and feelings. 
 
Cueva, M., et al. (2013). "Telenovela: an innovative colorectal cancer screening health messaging tool." 
Int J Circumpolar Health 72: 21301. 
 BACKGROUND: Alaska Native people have nearly twice the rate of colorectal cancer (CRC) 
incidence and mortality as the US White population. OBJECTIVE: Building upon storytelling as a culturally 
respectful way to share information among Alaska Native people, a 25-minute telenovela-style movie, 
What's the Big Deal?, was developed to increase CRC screening awareness and knowledge, role-model 
CRC conversations, and support wellness choices. DESIGN: Alaska Native cultural values of family, 
community, storytelling, and humor were woven into seven, 3-4 minute movie vignettes. Written post-
movie viewing evaluations completed by 71.3% of viewers (305/428) were collected at several venues, 
including the premiere of the movie in the urban city of Anchorage at a local movie theater, seven rural 
Alaska community movie nights, and five cancer education trainings with Community Health Workers. 
Paper and pencil evaluations included check box and open-ended questions to learn participants' 
response to a telenovela-style movie. RESULTS: On written-post movie viewing evaluations, viewers 
reported an increase in CRC knowledge and comfort with talking about recommended CRC screening 
exams. Notably, 81.6% of respondents (249/305) wrote positive intent to change behavior. Multiple 
responses included: 65% talking with family and friends about colon screening (162), 24% talking with 
their provider about colon screening (59), 31% having a colon screening (76), and 44% increasing 
physical activity (110). CONCLUSIONS: Written evaluations revealed the telenovela genre to be an 
innovative way to communicate colorectal cancer health messages with Alaska Native, American Indian, 
and Caucasian people both in an urban and rural setting to empower conversations and action related 
to colorectal cancer screening. Telenovela is a promising health communication tool to shift community 
norms by generating enthusiasm and conversations about the importance of having recommended 
colorectal cancer screening exams. 
 
Cueva, M., et al. (2005). "Cancer education for Community Health Aides/Practitioners (CHA/Ps) in Alaska 
assessing comfort with cancer." J Cancer Educ 20(2): 85-88. 
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 BACKGROUND: Village-based Community Health Aides and Community Health Practitioners 
(CHA/Ps) are the primary providers of health care in rural Alaska. METHODS: We discuss the 
development and results of a CHA/P cancer self-assessment survey, which assessed comfort with cancer 
knowledge and providing cancer information. RESULTS: A total of 402 responses were received from a 
mailed questionnaire to 477 CHA/Ps. Respondents were predominantly Alaska Native women. Using a 5-
point Likert scale from don't know to very comfortable, approximately 50% of CHA/Ps reported feeling 
"OK" when providing information about cancer risk factors, cancer screening, surviving cancer, and 
providing care and support. CHA/Ps reported feeling less comfortable with discussing cancer diagnosis, 
treatment, pain, and loss and grief. 
 
Daley, C. M., et al. (2012). "American Indian community leader and provider views of needs and barriers 
to mammography." J Community Health 37(2): 307-315. 
 Breast cancer incidence is rising and mortality is disproportionately high among American 
Indians and Alaska Natives, yet screening rates remain low. Using community-based participatory 
research, we conducted interviews with community leaders (n = 13) and providers from the Indian 
Health Service, tribal clinics, and urban safety-net clinics (n = 17). Participants in both groups identified 
similar needs, including culturally-appropriate mammography education, use of Native elders as patient 
navigators, and an emphasis on preventive care. Pertinent barriers included culturally-specific issues 
(e.g., historic mistrust and gender roles), cost, transportation, and fear of mammography and potential 
results. The results reflect the struggles of promoting mammography across diverse populations. 
 
Daley, C. M., et al. (2012). "American Indian Community Leader and Provider Views of Needs and 
Barriers to Colorectal Cancer Screening." J Health Dispar Res Pract 5(2). 
 Colorectal cancer is a great concern for the American Indian/Alaska Native (AI/AN) community, 
as incidence and mortality rates remain high and screening rates stay low. We conducted interviews 
with community leaders (n=13) and with providers from the Indian Health Service (IHS), tribal clinics, 
and urban safety-net clinics (n=17) in Northeast Kansas and the Kansas City Metro Area to determine 
their understanding of needs and barriers to colorectal cancer screening among American Indians. Using 
a community-based participatory research (CBPR) approach for this pilot study, community leaders and 
providers identified similar needs, including: culturally-appropriate education about colorectal cancer 
and screenings, the potential use of Native elders as patient navigators, and an emphasis on preventive 
care, particularly through the IHS. Barriers included culturally specific issues such as historic mistrust and 
gender roles. Other barriers are similar to members of other ethnic groups, such as cost, transportation, 
fear, and repulsion toward the screening process. 
 
Davidson, M., et al. (1994). "Incidence of invasive cervical cancer preceded by negative screening in 
high-risk Alaska Native women." Int J Epidemiol 23(2): 238-245. 
 BACKGROUND: Alaska Native women experience higher invasive cervical cancer incidence and 
mortality rates than US whites despite a long-standing cancer screening programme including 
recommendations for annual Pap smears. METHODS: To determine the frequency and results of 
cytological screening preceding their diagnoses, a histological and medical record review was completed 
for 44 of 46 Alaska Native cases of invasive cervical cancer from a defined population. An interval cancer 
(no prior dysplasia and a negative screening report within 3 years of diagnosis) was determined for 23 
women. Mean number of negative reports during the 3- and 5-year intervals before diagnosis was 1.7 
and 2.6 respectively. The age-adjusted incidence rate for all cervical cancer was 24.0/100,000 
women/year and for interval cancer with single and multiple negative reports during the 3-year interval 
before diagnosis it was 11.6, and 9.6 respectively. Sensitivity of a Pap smear to demonstrate dysplasia 
during the year before diagnosis was 51%. CONCLUSIONS: Annual cytological screening of all Alaska 
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Native women with current methods would provide earlier diagnoses for only an additional 15% of 
cervical cancer cases. Plausible but unproven explanations include rapid progression through precursor 
stages of neoplasia or random screening errors. Improved or ancillary screening methods appear 
necessary. 
 
Ebbesson, S. O. (2011). "The legacy of the Alaska Siberia Medical Research Program: a historical 
perspective." Int J Circumpolar Health 70(5): 584-593. 
 BACKGROUND: The Alaska Siberia Medical Research Program was established at the University 
of Alaska (UA) at a time when there was no research funded by the National Institutes of Health (NIH) 
that was concerned with Alaska Native health issues. The program grew out of a dire need for an 
understanding of the apparently rapidly growing health problems in the Native community. The initial 
plan included the following objectives. OBJECTIVES: The objectives are to develop a self-sustaining 
infrastructure for biomedical research by gaining support from Alaska Natives, UA, national political 
leaders, NIH and the Russian Academy of Medical Science (RAMS); to identify researchers committed to 
helping Alaska Natives; to develop meaningful, Native-driven participatory research; to carry out 
necessary research to form the foundation for future research; and to develop circumpolar 
collaborations. RESULTS: The objectives were achieved because of the extraordinary and cheerful 
contributions by all participants in the program. The collaborative research resulted in some 70 
published manuscripts identifying and characterizing research-neglected health problems. Unique risk 
factors for diabetes, cardiovascular disease, alcoholism and seasonal affective disorders were 
characterized and institutionalized prevention programs were established. The effort of the program led 
to U.S. Congressional action establishing the University of Alaska as a minority institution, leading to the 
funding of a variety of successful NIH-funded research centres and programs at the university that are 
concerned with Native health problems. CONCLUSION: A small, visionary investment by the University of 
Alaska for establishing the program led to a co-operative effort by the UA, RAMS, Alaska Native Health 
communities and the NIH that resulted in the development of self-sustaining medical research efforts in 
Alaska and Siberia. The program spawned pilot studies, leading to NIH-funded research that has 
provided fundamental insights into the etiology of health problems and their reduction by research-
based intervention and prevention programs. 
 
Ebbesson, S. O., et al. (2005). "A successful diabetes prevention study in Eskimos: the Alaska Siberia 
project." Int J Circumpolar Health 64(4): 409-424. 
 OBJECTIVES: To test the efficacy of a simple intervention method to reduce risk factors for type 
2 diabetes (DM) and cardiovascular disease (CVD) in Alaskan Eskimos. STUDY DESIGN: The study 
consisted of 1) a comprehensive screening for risk factors of 454 individuals in 4 villages, 2) a 4-year 
intervention and 3) a repetition of the screening in year 5 to test the efficacy of the intervention. 
METHODS: Personal counseling (1hr/year) stressed the consumption of more traditional foods high in 
omega-3 fatty acids and less of certain specific store-bought foods high in palmitic acid, which was 
identified as being associated with glucose intolerance. RESULTS: The intervention resulted in significant 
reductions in plasma concentrations of total cholesterol (p = 0.0001), LDL cholesterol (p = 0.0001), 
fasting glucose (p = 0.0001), diastolic blood pressure (p = 0.0007) and improved glucose tolerance (p = 
0.0006). This occurred without loss of body weight. Sixty percent of the participants had improved 
glucose tolerance; only one of the 44 originally identified with impaired glucose tolerance (IGT) 
developed DM during the study. CONCLUSIONS: Dramatic improvements of risk factors for DM and CVD 
were achieved in the intervention by primarily stressing the need for changes in the consumption of 
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Ebbesson, S. O., et al. (1998). "Diabetes and impaired glucose tolerance in three Alaskan Eskimo 
populations. The Alaska-Siberia Project." Diabetes Care 21(4): 563-569. 
 OBJECTIVE: The objectives of this study were to determine the prevalence of diabetes and 
impaired glucose tolerance (IGT) in three Alaskan Eskimo populations, using standardized diagnostic 
criteria, and to evaluate family history and obesity as risk factors. RESEARCH DESIGN AND METHODS: 
This cross-sectional study involved men and women > or = 25 years of age from three Eskimo ethnic 
groups (Siberian Yupik, Central Yupik, and Inupiat) residing in northwestern Alaska. Glucose tolerance 
status was defined by World Health Organization criteria and was based on a 75-g oral glucose tolerance 
test. Data on age, family history of diabetes, and degree of Eskimo ancestry were obtained from a 
personal interview. Obesity was assessed using BMI. RESULTS: A total of 454 of 899 (50.5%) eligible 
participants were examined for diabetic status (239 Siberian Yupik, 106 Central Yupik, and 109 Inupiat 
participants). The prevalence of diabetes was more than twice as high among the Siberian Yupik (9.6%) 
as among the Central Yupik (2.8%) and Inupiat participants (3.7%). Diabetes was more prevalent in 
women than men (8.8 vs. 4.2%). IGT was found in an additional 11.7% of the women and 4.7% of the 
men. The combined prevalence of diabetes and IGT in the population > or = 55 years of age was 30.4% 
(diabetes 12.0%, IGT 18.4%). Of the people identified with diabetes, 47% had not been previously 
diagnosed. Age-specific prevalences were similar to those found in U.S. whites in the National Health 
and Nutrition Examination Survey II. After adjustment for age, family history of diabetes was associated 
with diabetes in study participants with an odds ratio of 4.4, while obesity was associated with diabetes 
with an odds ratio of 2.6. CONCLUSIONS: These prevalences of diabetes are the highest yet reported 
among Eskimo populations. Obesity and family history of diabetes are associated with increased odds of 
developing diabetes. These data underscore the need to further examine risk factors and to design 
effective interventions. 
 
Ebbesson, S. O., et al. (2010). "Individual saturated fatty acids are associated with different components 
of insulin resistance and glucose metabolism: the GOCADAN study." Int J Circumpolar Health 69(4): 344-
351. 
 OBJECTIVES: Type 2 diabetes and the consumption of saturated fatty acids (FAs) are on the rise 
among Alaska Inuits. This analysis, based on a cross-sectional study, explores the possible associations of 
saturated FA content in red blood cells (RBCs) and parameters of glucose metabolism in a sample of 
Alaska Natives. STUDY DESIGN AND METHODS: The sample included 343 women and 282 men aged 35-
74. Statistical analyses explored the associations of selected RBC (myristic, palmitic and stearic acids) FAs 
with fasting glucose (plasma), fasting insulin (plasma), 2h glucose (2-hour glucose tolerance test), 2h 
insulin and homeostasis model assessment (HOMA) index. The models included sex and glucose 
metabolism status as fixed factors and age, body mass index (BMI), waist circumference, physical 
activity (METS) and FA content in RBCs as covariates. Measures of insulin, glucose and HOMA index were 
used as dependent variables. RESULTS: Myristic acid was positively associated with fasting insulin 
(beta=0.47, p<0.001), 2h insulin (beta=0.53, p=0.02) and HOMA index (beta=0.455, p<0.001). Palmitic 
acid was associated with 2h glucose (beta=2.3x10(-2), p<0.001) and 2h insulin (beta=5.6x10(-2), 
p=0.002) and stearic acid was associated with fasting glucose (beta=4.8x10(-3), p=0.006). CONCLUSIONS: 
These results strongly support the hypothesis that saturated fatty acids are associated with insulin 
resistance and glucose intolerance and that saturated fatty acids are significant risk factors for type 2 
diabetes. 
 
Fenn, D. C., et al. (2007). "Southcentral Foundation tobacco cessation initiative." Int J Circumpolar 
Health 66 Suppl 1: 23-28. 
 OBJECTIVES: To describe the development of a comprehensive tobacco cessation program for 
Alaska Native and American Indian patients in a primary care setting utilizing current evidence-based 
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guidelines. STUDY DESIGN: Cross-sectional. METHODS: A multidisciplinary team was assembled with 
representation from various departments including customers of the health care system to develop the 
tobacco cessation program. Feedback and guidance from the team were implemented and quit rates 
were calculated. RESULTS: In April 2005 the point prevalence of quitting among the 322 patients 
enrolled in the tobacco cessation program for 6 months was 21.1%. CONCLUSIONS: Recognized clinical 
interventions that reduce tobacco use were effective in reducing tobacco use among the Alaska Native 
and American Indian patients enrolled in the tobacco cessation program. Initial results with respect to 
the quit rate and tobacco use screening rate provide a baseline for future work. 
 
Finkelstein, E. A., et al. (2004). "Racial/ethnic disparities in coronary heart disease risk factors among 
WISEWOMAN enrollees." J Womens Health (Larchmt) 13(5): 503-518. 
 BACKGROUND: We used the baseline data collected for the Well-integrated Screening and 
Evaluation for Women Across the Nation (WISEWOMAN) participants to provide a snapshot of 
cardiovascular disease (CVD) risk on enrollment and to address racial/ethnic disparities in the following 
CVD risk factors: body mass index (BMI), systolic and diastolic blood pressure, high-density lipoprotein 
(HDL) and total cholesterol, diabetes and smoking prevalence, 10-year coronary heart disease (CHD) risk, 
and treatment and awareness of high cholesterol, hypertension, and diabetes. METHODS: We used 
linear regression analysis to (1) assess the presence of racial/ethnic disparities and test whether existing 
disparities can be explained by (2) differences in individual characteristics or by (3) differences in 
individual and community characteristics. RESULTS: Our results reveal a high degree of CVD risk among 
the WISEWOMAN participants and statistically significant racial/ethnic disparities in risk factors. Black 
participants were at the greatest risk of CVD, and Hispanic and Alaska Native participants were healthier 
in terms of CVD risk than white participants. Some racial/ethnic disparities were explained by 
differences in individual and community characteristics, but other disparities persisted even after 
controlling for these factors. CONCLUSIONS: Because differences in community characteristics explain 
many of the racial/ethnic disparities in CVD risk factors, eliminating disparities may require community-
wide interventions. Successful WISEWOMAN projects are likely to not only reduce CVD risk factors 
overall but also to lessen racial/ethnic disparities in these risk factors. 
 
Frisch, L. L., et al. (2000). "Social influences on Pap smear screening frequency." Alaska Med 42(2): 41-
45, 47. 
 Incidence and mortality rates of cervical cancer among Native American women is two to five 
times that of comparable Whites. Social and cultural differences contribute to this problem. We studied 
thirty age 40 and older American Indian women, half of whom had obtained at least one Pap in the past 
three years, the other half of whom had not. We asked: Do the two groups differ in their attitudes 
concerning Pap tests and those with whom they interact concerning Pap tests? and: Do they interact 
differently with different social groups concerning Pap tests? Data were obtained from chart audits and 
Given's Health Belief Questionnaire. The groups did not differ as to who they discussed Pap tests with or 
whose opinions they respected. They respected healthcare professionals most, family/friends less, and 
co-workers/others least. These findings suggest that the advanced practice nurse has an opportunity to 
improve Pap screening rates in this population. 
 
Gahagan, S. and J. Silverstein (2003). "Prevention and treatment of type 2 diabetes mellitus in children, 
with special emphasis on American Indian and Alaska Native children. American Academy of Pediatrics 
Committee on Native American Child Health." Pediatrics 112(4): e328. 
 The emergence of type 2 diabetes mellitus in the American Indian/Alaska Native pediatric 
population presents a new challenge for pediatricians and other health care professionals. This chronic 
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disease requires preventive efforts, early diagnosis, and collaborative care of the patient and family 
within the context of a medical home. 
 
Galloway, J. M. (2005). "Cardiovascular health among American Indians and Alaska Natives: successes, 
challenges, and potentials." Am J Prev Med 29(5 Suppl 1): 11-17. 
 With low rates of the risk factors for cardiovascular disease as recently as 40 years ago, the rates 
of cardiovascular disease (CVD) in American Indians and Alaska Natives were exceedingly low. Despite 
recent large-scale efforts to eliminate health disparities in ethnic and minority populations, the impact 
among American Indian and Alaska Natives to date has been relatively limited. Indeed, over the past 
several decades the incidence and prevalence of cardiovascular risk factors has risen significantly, 
including the development of an epidemic of diabetes. Evidence suggests that these higher rates of 
cardiovascular risk factors, including tobacco abuse, diabetes, high blood pressure, and elevated 
cholesterol levels, may be placing an inordinate burden of cardiovascular disease on the American 
Indian and Alaska Native population. The rates of heart disease and stroke among American Indians and 
Alaska Natives are now higher than in the general U.S. population as well as in U.S. whites. Recent 
evaluations suggest that these rates are also higher than among other ethnic or racial populations in the 
United States. Additionally, American Indians and Alaska Natives have been found to have a 
substantially higher proportion of premature death from heart disease when compared with other 
ethnic and racial populations. A number of recent prevention initiatives and focused clinical efforts are 
making promising strides toward reduced disparities in cardiovascular health with primordial, primary, 
and secondary cardiovascular prevention efforts along with enhanced early identification and 
therapeutic intervention for more favorable cardiovascular outcomes in the future. In order to reach our 
goals of heart-healthy and stroke-free American Indians and Alaska Natives, implementation of an 
aggressive, reasonably resourced, systemic plan of coordinated health promotion, risk reduction, and 
disease control efforts are necessary, with appropriate policy and legislative support. 
 
Gilbert, T. J., et al. (1995). "Abnormal Papanicolaou smears and colposcopic follow-up among American 
Indian and Alaska Native women in the Pacific northwest." J Am Board Fam Pract 8(3): 183-188. 
 BACKGROUND: Mortality that is due to cervical cancer among American Indian and Alaska 
Native women in the Pacific Northwest exceeds that among women of other races. Nevertheless, little 
information is available regarding the prevalence and follow-up of abnormal Papanicolaou smears 
among American Indian and Alaska Native women in the region. METHODS: We conducted a 
retrospective review of medical records of American Indian and Alaska Native women seen at 12 Indian 
Health Service and tribally operated clinics in Washington, Oregon, and Idaho who had an abnormal 
Papanicolaou smear in 1992. RESULTS: Of 4547 Papanicolaou smear results reviewed, 280 (6.2 percent) 
had an abnormal result (dysplasia or carcinoma in situ). Of the recommended colposcopies, 167 of 224 
(75 percent) were completed. Women with high-grade squamous intraepithelial lesions were more 
likely to obtain recommended colposcopy than were women with low-grade squamous intraepithelial 
lesions. Women treated at clinics that referred patients to outside providers for colposcopy were more 
likely to have colposcopy than were those who were offered the procedure on site. CONCLUSIONS: The 
proportion of Pacific Northwest American Indian and Alaska Native women in Indian Health Service and 
tribal clinics with abnormal Papanicolaou smears and the proportion who receive colposcopy are similar 
to those in other populations. The higher rate of cervical cancer mortality among American Indian and 
Alaska Native women could be due to failure to screen high-risk women. Cytologic screening rates, 
methods to improve adherence to colposcopy recommendations, and the contribution of other factors 
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Haverkamp, D., et al. (2011). "A survey of Indian Health Service and tribal health providers' colorectal 
cancer screening knowledge, perceptions, and practices." J Health Care Poor Underserved 22(1): 243-
257. 
 BACKGROUND: Provider recommendation is critical for colorectal cancer (CRC) screening 
participation, yet few data exist on practices of providers serving American Indians and Alaska Natives. 
We examined Indian Health Service (IHS) and tribal provider practices, beliefs about screening efficacy, 
and perceptions of barriers. METHODS: We developed a Web-based questionnaire and recruited 
respondents via electronic distribution lists. We generated descriptive statistics by region, provider type, 
and workplace setting. RESULTS: Most respondents (77%) recommend starting CRC screening of 
average-risk patients at age 50; however, 22% recommend flexible sigmoidoscopy and 43% colonoscopy 
at intervals inconsistent with national guidelines. Of those recommending fecal occult blood test (FOBT), 
23% use a single, in-office FOBT card as their only FOBT method. Respondents reported barriers to 
screening to include underutilized reminder systems and inadequate resources. CONCLUSIONS: Indian 
Health Service/tribal providers are knowledgeable about when to begin CRC screening; however, 
education about the appropriate use and frequency of CRC tests is needed. 
 
Hensel, M. R., et al. (1995). "Quit rates at one year follow-up of Alaska Native Medical Center Tobacco 
Cessation Program." Alaska Med 37(2): 43-47. 
 The prevalence of tobacco use in the Alaska Native population is unusually high, as high as 50% 
in both adult men and women. In June of 1992, the Alaska Native Medical Center and the Alaska Area 
Native Health Service began a tobacco cessation program using behavioral modification classes and 
transdermal nicotine patches. Patients were subsequently followed at three month intervals for a year 
to assess smoking status. To date, 193 people have completed the program with at least three months 
having elapsed since completion of classes. The quit rates at three, six, nine, and twelve months were 
31%, 30%, 24%, 21% respectively. The long-term quit rates for this tobacco cessation program are 
comparable to the rates of other studies which have included both behavioral modification and 
transdermal nicotine. 
 
Hiratsuka, V. Y., et al. (2007). "Cardiovascular disease risk factor screening among Alaska Native women: 
the traditions of the heart project." Int J Circumpolar Health 66 Suppl 1: 39-44. 
 OBJECTIVES: To describe tobacco use, obesity and overweight, high blood pressure, high blood 
cholesterol and impaired glucose tolerance in Alaska Native and American Indian women living in the 
Anchorage area. STUDY DESIGN: Cross-sectional evaluation of women enrolled in the Traditions of the 
Heart program. METHODS: Traditions of the Heart was a randomized controlled trial of an intervention 
to reduce risk factors for cardiovascular disease. Starting in October 2000, Southcentral Foundation 
provided a 12-week group lifestyle intervention to eligible Alaska Native and American Indian women 
aged 40 to 64 residing in the Anchorage area. The study included assessment of biochemical and 
behavioral risk factors for cardiovascular disease. RESULTS: Of the 1334 women who enrolled between 
October 2000 and July 2005, 33.5% were current smokers, 78.8% were overweight or obese, 10.9% were 
hypertensive, 21.4% had elevated total cholesterol, and 5.6% had fasting glucose concentrations > or = 
126 mg/dL. CONCLUSIONS: The women in this study had many risk factors for cardiovascular disease. 
Interventions are needed to reduce these risk factors among Alaska Native women. 
 
Howard, B. V., et al. (2005). "A genetic and epidemiologic study of cardiovascular disease in Alaska 
natives (GOCADAN): design and methods." Int J Circumpolar Health 64(3): 206-221. 
 This article is a report of the design and methods of the Genetics of Coronary Artery Disease in 
Alaska Natives (GOCADAN) Study. This longitudinal, population-based study was initiated to investigate 
the genetic determinants of cardiovascular disease and its risk factors. Between October 2000 and April 
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2004, this family study enrolled 1,214 Eskimos from several coastal villages in the Norton Sound region 
of Western Alaska. Examinations included a physical, laboratory determinations, and measures of 
subclinical disease. This study will generate a genome-wide scan for loci influencing cardiovascular 
disease-related traits. Relations between subclinical atherosclerosis and markers of inflammation will be 
examined using historic and newly drawn samples. The study will provide data on CVD prevalence, risk 
factors and the relative contribution of genetic and environmental determinants in Alaska Native 
peoples. Data from this study will contribute to the delivery of health-care and prevention of CVD in 
Alaska Eskimos and other populations. 
 
Jim, C. C., et al. (2012). "Human papillomavirus vaccination practices among providers in Indian health 
service, tribal and urban Indian healthcare facilities." J Womens Health (Larchmt) 21(4): 372-378. 
 PURPOSE: The human papillomavirus (HPV) vaccine is of particular importance in American 
Indian/Alaska Native women because of the higher rate of cervical cancer incidence compared to non-
Hispanic white women. To better understand HPV vaccine knowledge, attitudes, and practices among 
providers working with American Indian/Alaska Native populations, we conducted a provider survey in 
Indian Health Service, Tribal and Urban Indian (I/T/U) facilities. METHODS: During December 2009 and 
January 2010, we distributed an on-line survey to providers working in I/T/U facilities. We also 
conducted semistructured interviews with a subset of providers. RESULTS: There were 268 surveys and 
51 provider interviews completed. Providers were more likely to administer vaccine to 13-18-year-olds 
(96%) than to other recommended age groups (89% to 11-12-year-olds and 64% to 19-26-year-olds). 
Perceived barriers to HPV vaccination for 9-18-year-olds included parental safety and moral/religious 
concerns. Funding was the main barrier for 19-26-year-olds. Overall, providers were very knowledgeable 
about HPV, although nearly half of all providers and most obstetricians/gynecologists thought that a 
pregnancy test should precede vaccination. Sixty-four percent of providers of patients receiving the 
vaccine do not routinely discuss the importance of cervical cancer screening. CONCLUSIONS: 
Recommendations for HPV vaccination have been broadly implemented in I/T/U settings. Vaccination 
barriers identified by I/T/U providers are similar to those reported in other provider surveys. Provider 
education efforts should stress that pregnancy testing is not needed before vaccination and the 
importance of communicating the need for continued cervical cancer screening. 
 
Joe, J. R. (1996). "The health of American Indian and Alaska Native women." J Am Med Womens Assoc 
51(4): 141-145. 
 By a number of quantity and quality of life measurements, the health and well-being of many 
American Indian and Alaska Native women falls short of that reported for other women in the United 
States. Poor socioeconomic conditions, lack of education, cultural barriers, and other factors (some not 
easily measured) contribute to the enduring poor health status of this population-despite the availability 
of free health care for many. Free health care alone does not promise a healthy population, especially 
when the types of free health care are limited, inadequately funded, or have limited focus on preventive 
care. This paper attempts to pinpoint some of these issues as it relates to the health status of American 
Indian and Alaska Native women. 
 
Johnson, J. S., et al. (2012). "Factors related to fruit, vegetable and traditional food consumption which 
may affect health among Alaska Native People in Western Alaska." Int J Circumpolar Health 71: 17345. 
 OBJECTIVES: Determine intake of fruits, vegetables and traditional foods (TF), availability of 
foods, and attitudes towards increasing their consumption. STUDY DESIGN: Establish community 
baseline through a cross-sectional sample of residents who were weighed, measured and interviewed. 
Village stores were surveyed for food availability, price and quality. METHODS: Eighty-eight respondents 
self-identified as the household member primarily responsible for food shopping and cooking were 
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surveyed in 3 Western Alaska Native villages using a food frequency questionnaire, and village stores 
were evaluated using food environment surveys. RESULTS: Overweight (BMI[kg/m(2)] > 25) was present 
in 68% of participants. Fruit and vegetable intake (3.3 median servings/day) was low in comparison to 
recommended intakes of 5-9 servings/d. Seventy-two per cent were eating less than 5 servings/d of 
fruits and vegetables combined. Thirty-four per cent of respondents were trying to eat more vegetables; 
41% were trying to eat more fruits. The median number of servings of TF was 3.2/d (mean 4.3/d). 
Seventy-seven per cent of respondents reported that they ate enough TF. CONCLUSION: 
Recommendations to continue use of TF and increase intake of fruits and vegetables are consistent with 
local attitudes. Our findings indicate that increasing the availability of fruits and vegetables would be 
well received. Information from this study provides a basis for nutrition education and food supplement 
programs that is responsive to the needs and perceptions of the residents. Continued TF intake and 
increased fruit and vegetable intake have the potential to benefit the health of rural residents. 
 
Johnson, R. M., et al. (2008). "Breast cancer screening in an adult literacy program." Alaska Med 49(4): 
126-130. 
 OBJECTIVES: Individuals with limited literacy have low rates of cancer screening and more 
advanced cancer when cancer is detected. We implemented breast cancer screening at an adult literacy 
center to see if students would participate and determine the rate of abnormalities detected. 
METHODS: The Anchorage Literacy Project (ALP), in collaboration with Providence Cancer Center (PCC), 
offered breast cancer screening, including mammograms, on site at ALP to all 40 female ALP students 
aged > or =40. Prior to screening, PCC and ALP staff provided education to students about breast cancer 
screening and mammograms, and information about the Alaska Breast and Cervical Health Check 
program that would pay for treatment if cancer was detected. RESULTS: Twenty-one women underwent 
screening. Three (14%) had significant abnormalities. CONCLUSIONS: Cancer screening can be provided 
on site in adult literacy programs. The rate of abnormalities detected through such screening may be 
higher than the rate in the general population. 
 
Jolly, S. E., et al. (2011). "Sex-specific associations of nutrition with hypertension and systolic blood 
pressure in Alaska Natives findings from the GOCADAN study." Int J Circumpolar Health 70(3): 254-265. 
 OBJECTIVES: To examine sex-specific associations of nutritional factors with prevalent 
hypertension (HTN) and systolic blood pressure (SBP) in Alaska Natives. Diet is known to affect SBP, a 
major risk factor for cardiovascular disease. STUDY DESIGN: Cross-sectional analysis of participants 
without diabetes in the Genetics of Coronary Artery Disease in Alaska Natives study. METHODS: 
Macronutrients such as fat, carbohydrate and protein and micronutrients such as sodium were 
investigated. HTN was defined as SBP>/=140 mmHg, diastolic blood pressure>/=90 mmHg and/or taking 
anti-HTN medication. Analyses were stratified by sex and covariates included age, body mass index 
(BMI), energy intake, smoking and physical activity. RESULTS: Mean age was 42 years for men (n=456) 
and women (n=602). Men with HTN (n=106) compared to men without HTN consumed a higher 
proportion of calories from total (p=0.01), saturated (p<0.01) and trans fatty acid (p=0.03) fats. Women 
with HTN (n=99) compared to women without HTN consumed more total (p=0.03) and 
monounsaturated (p=0.04) fat, higher protein (p=0.02) and lower total (p<0.01) and simple (p<0.01) 
carbohydrates. After covariate adjustment, men not on anti-HTN medications (n=407) had significantly 
higher average SBP with increasing quartiles of trans fatty acid intake (p for linear trend=0.01) and 
sodium intake (p for linear trend=0.02). For women not on anti-HTN medications (n=528), after 
covariate adjustment, average SBP decreased with increasing quartiles of omega 3 fatty acid intake (p 
for linear trend <0.01). CONCLUSIONS: Prospective evaluation of the sex-specific associations of 
nutritional factors with HTN and SBP on outcomes is needed along with novel interventions to lower the 
risk of cardiovascular disease. 
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Kaur, J. S. (1999). "Native women and cancer." Health Care Women Int 20(5): 445-453. 
 Literature regarding cancer patterns in American Indians and Alaska Native women is reviewed 
and attention is paid to promising research initiatives to improve cancer prevention and control as well 
as approaches to enhance exchange of knowledge through a new national resource center. Lung, breast, 
and colorectal cancer are the leading cause of cancer deaths in American Indians and Alaska Native 
women. There continues to be a disproportionate death rate from cervical cancer. Enhanced availability 
for breast and cervical cancer screening in conjunction with community education is showing promising 
trends toward reversing the patterns of late diagnosis. Communities can benefit from sharing their 
collective resources in a new national resource center called "Native C.I.R.C.L.E." housed in the Mayo 
Cancer Center. 
 
Kuhnley, R. and M. Cueva (2011). "Learning about cancer has brightened my light: cancer education for 
Alaska Community Health Aides and Community Health Practitioners (CHA/Ps)." J Cancer Educ 26(3): 
522-529. 
 In response to Alaska's Community Health Aides/Practitioners (CHA/Ps) request for cancer 
information, the "Path to Understanding Cancer" course was developed, implemented, and extensively 
evaluated. Using a qualitative approach as one evaluation component, 128 of 168 course participants 
engaged in post-course telephone interviews. Of these, 116 (81%) CHA/Ps felt more comfortable in 
talking about cancer and 57% had increased cancer screening referrals for patients. Additionally, 28% of 
110 CHA/P respondents and 21% of 114 CHA/Ps' family members sought and received cancer screening; 
they had also made lifestyle changes to reduce cancer risk, including tobacco cessation and healthy 
changes in nutrition and exercise. Through qualitative design, we gained insight into CHA/Ps' lived 
experience of cancer and an understanding of ways the course made a difference in patient care as well 
as cancer risk reduction, cancer screening, and prevention for themselves, their families, and people in 
their communities. 
 
Lanier, A. P., et al. (1999). "Pap prevalence and cervical cancer prevention among Alaska Native 
women." Health Care Women Int 20(5): 471-486. 
 The goals of the Alaska Native Women's Health Project (WHP) were to determine the following: 
(1) Pap prevalence based on chart review before and during an intervention period; (2) the level of 
understanding of cancer and cancer screening services with emphasis on cervical cancer; (3) use and 
satisfaction with current health maintenance services; and (4) improvement in knowledge and cancer 
screening rates following intervention. A random sample of 481 Alaska Native (Eskimo, Aleut, Indian) 
women living in Anchorage were interviewed face to face about their understanding of cancer risk 
factors (tobacco use, sexually transmitted diseases (STDs), reproductive issues), cancer screening 
examinations (Pap test, breast self-examination (BSE), breast exam by a provider, mammography), and 
their attitudes about health care and health care services. Sixty-two percent of control women were 
documented to have had at least one Pap test within the 3-year period prior to the beginning of the 
study; however, only 9% were documented to have had annual Pap screening. The intervention included 
distribution of educational materials, counseling on any woman's health issue, special evening clinics, 
and reminders (mail/phone call) of scheduled Pap appointments. 
 
Lanier, A. P. and E. N. Mostow (1991). "Screening for cancer in remotely populated regions--lessons 
from mammography and breast cancer." Arctic Med Res Suppl: 462-464. 
  
Lantz, P. M., et al. (2003). "Implementing women's cancer screening programs in American Indian and 
Alaska Native populations." Health Care Women Int 24(8): 674-696. 
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 The National Breast and Cervical Cancer Early Detection Program provides funding to tribes and 
tribal organizations to implement comprehensive cancer screening programs using a program model 
developed for state health departments. We conducted a multiple-site case study using a participatory 
research process to describe how 5 tribal programs implemented screening services, and to identify 
strategies used to address challenges in delivering services to American Indian and Alaska Native 
women. We analyzed data from semistructured interviews with 141 key informants, 16 focus groups 
with 132 program-eligible women, and program documents. Several challenges regarding the delivery of 
services were revealed, including implementing screening programs in busy acute-care environments, 
access to mammography, providing culturally sensitive care, and providing diagnostic/treatment 
services in rural and remote locations. Strategies perceived as successful in meeting program challenges 
included identifying a "champion" or main supporter of the program in each clinical setting, using 
mobile mammography, using female providers, and increasing the capacity to provide diagnostic 
services at screening sites. The results should be of interest to an international audience, including those 
who work with health-related programs targeting indigenous women or groups that are marginalized 
because of culture, geographic isolation, and/or socioeconomic position. 
 
Liao, Y., et al. (2010). "Decreasing disparity in cholesterol screening in minority communities--findings 
from the racial and ethnic approaches to community health 2010." J Epidemiol Community Health 64(4): 
292-299. 
 BACKGROUND: Highly controlled research projects demonstrated success in preventing and 
controlling cardiovascular diseases. Community-based programs have yet to demonstrate significant 
influence. Data on large-scale community-level interventions targeting minority communities are 
limited. The aim of this study is to measure the impact of the Racial and Ethnic Approaches to 
Community Health (REACH 2010) project, a community-based intervention to eliminate racial/ethnic 
disparities in blood cholesterol screening in minority communities. METHODS: Annual survey data from 
2001 to 2006 were gathered in 22 communities. Trends in the prevalence of age-standardised blood 
cholesterol screening were examined for four racial/ethnic groups (black, Hispanic, Asian and American 
Indian/Alaska Native), stratified by education level, and compared with national data from the 
Behavioral Risk Factor Surveillance System. RESULTS: The prevalence of cholesterol screening increased 
among persons in black, Hispanic and Asian REACH communities (p<0.001), whereas prevalence 
decreased in the total US and Hispanic populations (p<0.001) and remained similar among blacks and 
Asians nationwide. The relative disparity between the total US population and most REACH communities 
decreased (p<0.05). Relative disparity in cholesterol screening related to education level decreased 
(p<0.05) within REACH communities, whereas relative disparity related to education level nationwide 
remained similar in blacks and increased (p<0.001) in Hispanics. CONCLUSION: The REACH project 
decreased racial and ethnic disparities in cholesterol screening between REACH communities and the 
total US population, as well as disparities related to education level within REACH communities. 
 
Liburd, L. C., et al. (2005). "Intervening on the social determinants of cardiovascular disease and 
diabetes." Am J Prev Med 29(5 Suppl 1): 18-24. 
 Heart disease, cerebrovascular diseases, and type 2 diabetes ranked first, third, and sixth, 
respectively, among the leading causes of death and disability in the United States in 2000. Racial and 
ethnic communities (i.e., African Americans, Hispanic-Latino Americans, Native Americans and Alaska 
Natives, and Asian Americans and Pacific Islanders) disproportionately suffer from these chronic 
conditions. Traditional behavior change strategies have had some positive, but limited effects and will 
not likely be sufficient to eliminate these health disparities at the population level. In this commentary, 
the authors argue for greater intervention research directed at the social determinants of cardiovascular 
disease and diabetes if we are to reverse current trends in chronic disease prevalence in communities of 
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color. The authors also call for new research questions and study designs that will increase our 
understanding of the social, policy, and historic context in which disparities are created as a necessary 
first step in developing interventions aimed at social-contextual and psychosocial risk factors. Promising 
programs supported by the Centers for Disease Control and Prevention's Racial and Ethnic Approaches 
to Community Health (REACH 2010) program and the Division of Diabetes Translation are highlighted. 
 
Lopez-Alvarenga, J. C., et al. (2010). "Polyunsaturated fatty acids effect on serum triglycerides 
concentration in the presence of metabolic syndrome components. The Alaska-Siberia Project." 
Metabolism 59(1): 86-92. 
 Serum fatty acids (FAs) have wide effects on metabolism: Serum saturated fatty acids (SFAs) 
increase triglyceride (TG) levels in plasma, whereas polyunsaturated fatty acids (PUFAs) reduce them. 
Traditionally, Eskimos have a high consumption of omega-3 fatty acids (omega3 FAs); but the 
Westernization of their food habits has increased their dietary SFAs, partly reflected in their serum 
concentrations. We studied the joint effect of serum SFAs and PUFAs on circulating levels of TGs in the 
presence of metabolic syndrome components. We included 212 men and 240 women (age, 47.9 +/- 15.7 
years; body mass index [BMI], 26.9 +/- 5.3) from 4 villages located in Alaska for a cross-sectional study. 
Generalized linear models were used to build surface responses of TG as functions of SFAs and PUFAs 
measured in blood samples adjusting by sex, BMI, and village. The effects of individual FAs were 
assessed by multiple linear regression analysis, and partial correlations (r) were calculated. The most 
important predictors for TG levels were glucose tolerance (r = 0.116, P = .018) and BMI (r = 0.42, P < 
.001). Triglyceride concentration showed negative associations with 20:3omega6 (r = -0.16, P = .001), 
20:4omega6 (r = -0.14, P = .005), 20:5omega3 (r = -0.17, P < .001), and 22:5omega3 (r = -0.26, P < .001), 
and positive associations with palmitic acid (r = 0.16, P < .001) and 18:3omega3 (r = 0.15, P < .001). The 
surface response analysis suggested that the effect of palmitic acid on TG is blunted in different degrees 
according to the PUFA chemical structure. The long-chain omega3, even in the presence of high levels of 
saturated fat, was associated with lower TG levels. Eicosapentaenoic acid (20:5omega3) had the 
strongest effect against palmitic acid on TG. The total FA showed moderate association with levels of TG, 
whereas SFA was positively associated and large-chain PUFA was negatively associated. The 
Westernized dietary habits among Eskimos are likely to change their metabolic profile and increase 
comorbidities related to metabolic disease. 
 
Lucas, D. L. and J. M. Lincoln (2007). "Fatal falls overboard on commercial fishing vessels in Alaska." Am J 
Ind Med 50(12): 962-968. 
 BACKGROUND: Falls overboard are a major contributor to commercial fishing fatalities in Alaska. 
The National Institute for Occupational Safety and Health has repeatedly identified falls overboard as a 
critical issue in commercial fishing safety. This article describes the problem of falls overboard and 
discusses possible ways to reduce the risk factors. METHODS: Data from the Alaska Occupational Injury 
Surveillance System on fatal falls overboard in Alaska between 1990 and 2005 were used. An in-depth 
descriptive analysis of these fatalities was performed to identify areas for intervention. RESULTS: There 
were 71 fatal falls overboard on commercial fishing vessels in Alaska during the 16-year time period. 
Falls overboard did not decline significantly during those years. The most common circumstances 
associated with falling overboard were working with fishing gear, being alone on deck, losing balance or 
slipping, heavy weather, gear entanglement, and alcohol. The level of involvement of those 
circumstances varied by region and gear type. SUMMARY: Many fatal falls overboard may be prevented 
by understanding the circumstances involved and targeting interventions at those specific risk factors. 
Interventions include creating more enclosed work spaces, managing lines, avoiding fishing alone, 
wearing personal flotation devices and man overboard alarms, and reducing alcohol use. Subsequent 
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research should identify further interventions for each circumstance and evaluate the effectiveness of 
these interventions with the fishing industry. 
 
Martinek, K., et al. (1998). "Development and implementation of a breast and cervical cancer screening 
program in urban and rural Alaska." Int J Circumpolar Health 57 Suppl 1: 399-405. 
 Early detection of breast and cervical cancers represents the single best strategy to effect the 
reduction of associated morbidity and mortality. The State of Alaska identified a need to establish a 
service delivery system which would assure the availability of breast and cervical cancer screening 
services for women who are low income, under- and uninsured, and from racial/ethnic minorities. In 
March 1995 the Alaska Breast and Cervical Cancer Early Detection Program (AK-BCCEDP) began funding 
breast and cervical cancer screening services through the Centers for Disease Control and Prevention, 
National Breast and Cervical Cancer Early Detection Program. The purpose of AK-BCCEDP is to establish 
a comprehensive service delivery strategy which includes screening, tracking, referral, follow-up, public 
education, quality assurance, surveillance, coalition building/partnering, and evaluation. During the first 
year of services (March 1, 1995, to February 29, 1996) 651 women were screened for breast and cervical 
cancer. Higher than expected numbers of breast cancer were detected. Of the 651 women screened, 
four were diagnosed with invasive breast cancer and three were diagnosed with high-grade squamous 
intraepithelial lesions. 
 
McIntosh, S. E., et al. (2008). "Mountaineering fatalities on Denali." High Alt Med Biol 9(1): 89-95. 
 Mount McKinley, or Denali, is the tallest mountain in North America and attracts over 1,000 
climbers annually from around the world. Since Denali is located within a national park, the National 
Park Service (NPS) manages mountaineering activities and attempts to maintain a balance of an 
adventurous experience while promoting safety. We retrospectively reviewed the fatalities on Denali 
from 1903 to 2006 to assist the NPS, medical personnel, and mountaineers improve safety and reduce 
fatalities on the mountain. Historical records and the NPS climber database were reviewed. 
Demographics, mechanisms, and circumstances surrounding each fatality were examined. Fatality rates 
and odds ratios for country of origin were calculated. From 1903 through the end of the 2006 climbing 
season, 96 individuals died on Denali. The fatality rate is declining and is 3.08/1,000 summit attempts. 
Of the 96 deaths, 92% were male, 51% occurred on the West Buttress route, and 45% were due to 
injuries sustained from falls. Sixty-one percent occurred on the descent and the largest number of 
deaths in 1 year occurred in 1992. Climbers from Asia had the highest odds of dying on the mountain. 
Fatalities were decreased by 53% after a NPS registration system was established in 1995. Although 
mountaineering remains a high-risk activity, safety on Denali is improving. Certain groups have a 
significantly higher chance of dying. Registration systems and screening methods provide ways to target 
at-risk groups and improve safety on high altitude mountains such as Denali. 
 
McLaughlin, J., et al. (2005). "Adipose tissue triglyceride fatty acids and atherosclerosis in Alaska Natives 
and non-Natives." Atherosclerosis 181(2): 353-362. 
 Essential polyunsaturated fatty acids (PUFA) of the omega-3 family are believed to protect 
against cardiovascular disease. A rich source of omega-3 PUFA is found in fish and marine mammals 
(seal, walrus, whale), which are a large part of the traditional diet of Alaska Natives (Eskimo, American 
Indians, Aleuts), a group that has been reported to have a lower mortality rate from cardiovascular 
disease than non-Natives. An autopsy study using standardized methods to evaluate the extent of 
atherosclerosis and its risk factors, and analyses of stored triglyceride fatty acids was conducted in a 
sample of Alaska Native subjects and non-Native subjects living in Alaska. Findings indicate that Alaska 
Natives had less advanced atherosclerosis in coronary arteries, along with higher proportions of omega-
3 and lower proportions of omega-6 PUFA in adipose tissue, than did non-Natives. We conclude that 
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high dietary intake of omega-3 PUFA may account for the lower extent of coronary artery 
atherosclerosis, contributing to the reported lower heart disease mortality among Alaska Natives. 
 
Mohatt, G. V., et al. (2007). "The Center for Alaska Native Health Research Study: a community-based 
participatory research study of obesity and chronic disease-related protective and risk factors." Int J 
Circumpolar Health 66(1): 8-18. 
 OBJECTIVES: To describe the background, approach and general results of the Center for Alaska 
Native Health Research (CANHR) study. STUDY DESIGN: This was a cross-sectional Community-Based 
Participatory Research (CBPR) study with one tribal group to assess risk and protection for obesity and 
the risk factors related to chronic disease, diabetes and cardiovascular disease. METHODS: A 
combination of biological, genetic, nutritional and psychosocial measurements were taken on 922 
Alaska Native participants in ten communities in Southwestern Alaska. The paper reports on data from 
753 adult participants. RESULTS: The prevalence of type 2 diabetes is 3.3% in the sample population. 
Metabolic syndrome is significantly lower among the males and equal for females when compared with 
Caucasians in the NHANES III sample. Obesity among adults is now at the national average. Risk factors 
for chronic disease include a shift to a Westernized diet, stress, obesity and impaired fasting glucose and 
protective factors include high levels of polyunsaturated fatty acid dietary intake. Articles in this issue 
present specific results in these areas. CONCLUSIONS: The data strongly indicate that, in general, Yup'ik 
people in our study are metabolically healthy and that diet and life style provide a delicate combination 
of protective and risk factors. The results strongly indicate that solution focused research utilizing 
primary and secondary prevention strategies may provide evidence for how to intervene to prevent 
further increases of chronic diseases. Research that focuses on relating the intrinsic strengths of 
indigenous worldviews and practices with basic research may contribute to positive transformations in 
community health. 
 
Mouratoff, G. J., et al. (1967). "Diabetes mellitus in Eskimos." JAMA 199(13): 107-112. 
  
Murphy, N. J., et al. (1992). "Diabetes mellitus in Alaskan Yup'ik Eskimos and Athabascan Indians after 25 
yr." Diabetes Care 15(10): 1390-1392. 
 OBJECTIVE: To estimate the prevalence of diabetes mellitus and overweight in two populations 
of Alaska Natives and to compare the results with previous data. RESEARCH DESIGN AND METHODS: 
Participants' heights, weights, and random plasma glucose levels were determined. Those with a glucose 
of greater than or equal to 6.72 mM received a follow-up glucose-tolerance test, interpreted by WHO 
criteria. Overweight was defined by National Center for Health Statistics criteria and also by criteria used 
in previous studies. The subjects were Eskimo and Athabascan residents greater than or equal to 40 yr of 
age in 15 villages in southwestern Alaska. RESULTS: Diabetes prevalence was 4.7% for Eskimos and 
10.0% for Indians. Among Eskimo men and women, the prevalence of overweight was 34 and 56%, 
respectively, among Indian men and women, it was 29 and 55%, respectively. Comparisons with past 
data indicate that the prevalence of diabetes has increased from 1.7% in 1962 for Eskimos and 1.8% in 
1969 for Indians. CONCLUSIONS: The prevalence of diabetes appears to have increased among Eskimos 
and Indians in Alaska. Overweight appears to be a significant problem in both groups. 
 
Murphy, N. J., et al. (1995). "Dietary change and obesity associated with glucose intolerance in Alaska 
Natives." J Am Diet Assoc 95(6): 676-682. 
 OBJECTIVE: To investigate frequency of food intake, body weight, and glucose intolerance in 
Alaska Natives. DESIGN: Height, weight, and random blood glucose levels were measured and a 
frequency-of-food-intake questionnaire was obtained. This questionnaire classified persons as 
consumers of indigenous foods or nonindigenous foods within three food groups. Those with a random 
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blood glucose measurement > or = 6.72 mmol/L received an oral glucose tolerance test. SETTING: 
Community screening in 15 villages in Alaska. SUBJECTS: Nutrition screenings were done for 1,124 
Alaska Native residents aged 20 years or older. An oral glucose tolerance test was done for 202 subjects. 
OUTCOMES MEASURED: Subjects were classified as consumers of indigenous or nonindigenous foods 
within three food groups. A diagnosis of non-insulin-dependent diabetes mellitus (NIDDM) was made on 
the basis of World Health Organization criteria. A determination of overweight was made on the basis of 
National Center for Health Statistics criteria. STATISTICAL ANALYSIS: A chi 2 test with Yates correction, t 
test, and linear regression, with two-sided P values. RESULTS: Athabascan Indians had twice the rate of 
NIDDM as Yup'ik Eskimos with significantly higher frequency of nonindigenous food intake, plus lower 
frequency of indigenous carbohydrate and fat intake. Subjects < or = 30 years old consumed significantly 
more nonindigenous protein and fat and low-nutrient-density carbohydrates than those > or = 60 years 
old. Persons who had glucose intolerance reported significantly greater consumption of nonindigenous 
protein and less seal oil. Incidence of overweight was significantly higher than was found 25 years ago. 
Participants with glucose intolerance were significantly more overweight than others. CONCLUSION: A 
pattern of increased frequency of nonindigenous protein, low-nutrient-density carbohydrate, and fat 
intake with less indigenous carbohydrate and fat consumption was found in subjects < or = 30 years old 
and in association with the higher rate of NIDDM found in the Athabascan Indians. Persons with glucose 
intolerance were significantly more overweight than others. APPLICATIONS: Although the nutritional 
value of indigenous foods for reducing disease risk should be promoted, nutrition education, especially 
among young adults, should also include building skills to select and prepare nonindigenous foods to 
attain a healthful diet. Although snacking is a concern, dietary fat was the most significant factor in 
obesity and NIDDM. 
 
Muus, K. J., et al. (2009). "Body mass index and cancer screening in older American Indian and Alaska 
Native men." J Rural Health 25(1): 104-108. 
 CONTEXT: Regular screenings are important for reducing cancer morbidity and mortality. There 
are several barriers to receiving timely cancer screening, including overweight/obesity. No study has 
examined the relationship between overweight/obesity and cancer screening among American 
Indian/Alaska Natives (AI/ANs). PURPOSE: To describe the prevalence of fecal occult blood testing 
(FOBT) and prostate-specific antigen (PSA) testing among AI/AN men within the past year by age and 
rurality, and determine if body mass index (BMI) is associated with screening. METHODS: A national 
cross-sectional survey was administered face-to-face to 2,447 AI/AN men at least 55 years of age in 
2004-2005. Participants were asked when they last had FOBT and PSA testing. BMI was derived from 
self-reported height and weight, and rurality of residence was defined by rural-urban commuting area 
codes. We assessed the association of cancer screening and BMI with logistic regression models, 
adjusting for demographic and health factors. FINDINGS: Prevalence of up-to-date FOBT and PSA testing 
were 23% and 40%, respectively. Older men were more likely than younger men to have FOBT and PSA 
testing. BMI was not associated with receipt of FOBT or PSA testing. CONCLUSIONS: This is the first study 
to examine obesity and health care in AI/ANs. As in other populations, FOBT and PSA testing were 
suboptimal. Screening was not associated with BMI. Studies of AI/AN men are needed to understand the 
barriers to receiving timely screenings for prostate and colorectal cancer. 
 
Narva, A. S. (2008). "Reducing the burden of chronic kidney disease among American Indians." Adv 
Chronic Kidney Dis 15(2): 168-173. 
 American Indians (AIs) and Alaska Natives (ANs) have experienced a dramatic rise in type 2 
diabetes and associated complications, including chronic kidney disease (CKD) over the past half 
century. At the end of 2005, the national prevalence of end-stage renal disease (ESRD) in AIs/ANs was 
2.5 times greater than that for white Americans, with rates significantly higher among communities of 
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the southwest United States. Evidence of CKD among AIs/ANs with diabetes includes abnormal protein 
excretion in 30% and estimated glomerular filtration rate (eGFR) <60 mL/min/m(2) in 17%. In order to 
address the growing burden of CKD, the Indian Health Service established the Kidney Disease Program 
to improve the screening of and the management of diabetics with CKD. Routine reporting of eGFR, 
yearly monitoring of protein excretion, utilization of renin-angiotensin system (RAS) antagonists, and 
aggressive control of blood pressure were implemented in association with enhanced patient and 
provider education. By 2006, 82% of hypertensive diabetics were receiving a RAS antagonist. 
Implementation of these efforts has been associated with a 31% decrease in ESRD incidence among 
AIs/ANs with diabetes. This program of improvements in CKD care implemented by a federal agency 
serving a high-risk population with limited resources may be a useful model for others. 
 
Naylor, J. L., et al. (2003). "Diabetes among Alaska Natives: a review." Int J Circumpolar Health 62(4): 
363-387. 
 This review summarizes the published information on diabetes mellitus and gestational diabetes 
among Alaska Natives. The most recently published age-adjusted prevalence was 28.3/1000 in 1998. 
There is evidence of a steadily increasing prevalence, documented both by cross sectional screening 
studies and patient registry methods. The overall incidence rates in 1986-1998 of lower extremity 
amputation (6.1/1000) and renal replacement therapy (2.1/1000) appear to be lower than those in 
other Native American populations in the United States. Incidence of stroke and MI in 1986-1998 varied 
widely by ethnic group and gender with Eskimo women having the highest rate of stroke (19.6/1000), 
and Aleut men the highest rate of MI (14/1000). The overall mortality among diabetic Alaska Native 
people in 1986-1993 (43.2/1000) was somewhat lower than that in other US diabetic populations, with 
heart disease being the most common cause of death. A high rate of gestational diabetes (6.7%) was 
reported in one region in 1987-88, but this appeared to decline following nutritional education 
intervention. In screening studies, the prevalence of abnormal glucose tolerance has been found to be 
positively associated with body mass index and negatively associated with daily seal oil or salmon 
consumption and higher levels of physical activity. Observations on the prevalence and relationships 
among other factors in the insulin resistance syndrome are summarized. Suggestions for prevention of 
diabetes and further studies are presented. 
 
Nobmann, E. D., et al. (1999). "Associations between dietary factors and plasma lipids related to 
cardiovascular disease among Siberian Yupiks of Alaska." Int J Circumpolar Health 58(4): 254-271. 
 The diet of northern Native people has been postulated to protect against cardiovascular 
disease. We asked whether nutrient and food intakes of Eskimos were correlated with their plasma 
cholesterol, LDL, HDL, triglycerides and LDL-HDL ratio. Frequency of consumption of 91 foods among 64 
Siberian Yupik adults was measured during home-based interviews. Intake of monounsaturated fat by 
men was negatively correlated with LDL. Foods and nutrients that contribute to the LDL-HDL ratio 
explained 42% of its variation among all subjects. Inclusion of the body mass index (BMI) explained 59% 
of the variation in the LDL-HDL ratio. Coefficients were negative for alpha-tocopherol, fresh bird, 
evaporated milk and cheese, and positive for BMI, syrup and pizza. BMI had a positive effect on the LDL-
HDL ratio among younger adults, women and the entire sample, but did not contribute to explaining the 
variation among older adults or men. This emphasizes the importance of weight control among younger 
Siberian Yupik women. While coefficients were both positive and negative for traditional and western 
foods, the presence of traditional foods that were negatively correlated in the regression supports the 
hypothesis that consumption of traditional foods is important for maintaining cardiovascular health 
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Patten, C. A. (2012). "Tobacco cessation intervention during pregnancy among Alaska Native women." J 
Cancer Educ 27 Suppl 1: S86-90. 
 This paper describes a community-based participatory research program with Alaska Native 
people addressing a community need to reduce tobacco use among pregnant women and children. 
Tobacco use during pregnancy among Alaska Native women is described along with development of a 
community partnership, findings from a pilot tobacco cessation intervention, current work, and future 
directions. Among Alaska Native women residing in the Yukon Kuskokwim Delta region of western 
Alaska, the prevalence of tobacco use (cigarette smoking and/or use of smokeless tobacco) during 
pregnancy is 79%. Results from a pilot intervention study targeting pregnant women indicated low rates 
of participation and less than optimal tobacco abstinence outcomes. Developing alternative strategies to 
reach pregnant women and to enhance the efficacy of interventions is a community priority, and future 
directions are offered. 
 
Patten, C. A., et al. (2008). "Evaluation of a Tobacco Educational Intervention for Pregnant Alaska Native 
Women." J Health Dispar Res Pract 2(3): 33-50. 
 Tobacco cessation interventions developed and evaluated for Alaska Native women do not exist. 
As part of routine clinical care provided at a prenatal visit, a brief tobacco educational intervention for 
Alaska Native pregnant women (N=100; mean +/- SD age = 25.9+/-6.2 years; mean 6.3+/-2.6 months 
gestation) was piloted at the Y-K Delta Regional Hospital in Bethel, Alaska. This retrospective study 
reports on the evaluation of this clinical program. The intervention was consistent with the clinical 
practice guidelines (i.e., 5 A's - ask, advise, assess, assist, arrange), with an average duration of 20.2 +/- 
6.8 minutes. The self-reported tobacco abstinence rate following the intervention was 11% at the last 
prenatal visit and 12% at delivery. Delivering a tobacco cessation intervention at a prenatal visit is 
feasible, but there is a need to identify more effective interventions for Alaska Native pregnant women. 
 
Patten, C. A., et al. (2009). "Focus groups of Alaska Native adolescent tobacco users: preferences for 
tobacco cessation interventions and barriers to participation." Health Educ Behav 36(4): 711-723. 
 Tobacco cessation interventions developed for Alaska Native adolescents do not exist. This 
study employed focus group methodology to explore preferences for tobacco cessation interventions 
and barriers to participation among 49 Alaska Natives (61% female) with a mean age of 14.6 (SD = 1.6) 
who resided in western Alaska. Using content analysis, themes from the 12 focus groups were found to 
be consistent across village, gender, and age groups. Program location or site (e.g., away from the 
village, hunting, fishing), a group-based format, and inclusion of medication and personal stories were 
reported to be important attributes of cessation programs. Motivators to quit tobacco were the 
perceived adverse health effects of tobacco, improved self-image and appearance, and the potential to 
be a future role model as a non-tobacco user for family and friends. Parents were perceived as 
potentially supportive to the adolescent in quitting tobacco. The findings will be used to develop 
tobacco cessation programs for Alaska Native youth. 
 
Patten, C. A., et al. (2010). "Feasibility of a tobacco cessation intervention for pregnant Alaska Native 
women." Nicotine Tob Res 12(2): 79-87. 
 BACKGROUND: Among Alaska Native women residing in the Yukon-Kuskokwim (Y-K) Delta 
region of Western Alaska, about 79% smoke cigarettes or use smokeless tobacco during pregnancy. 
Treatment methods developed and evaluated among Alaska Native pregnant tobacco users do not exist. 
This pilot study used a randomized two-group design to assess the feasibility and acceptability of a 
targeted cessation intervention for Alaska Native pregnant women. METHODS: Recruitment occurred 
over an 8-month period. Enrolled participants were randomly assigned to the control group (n = 18; 
brief face-to-face counseling at the first visit and written materials) or to the intervention group (n = 17) 
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consisting of face-to-face counseling at the first visit, four telephone calls, a video highlighting personal 
stories, and a cessation guide. Interview-based assessments were conducted at baseline and follow-up 
during pregnancy (>or=60 days postrandomization). Feasibility was determined by the recruitment and 
retention rates. RESULTS: The participation rate was very low with only 12% of eligible women (35/293) 
enrolled. Among enrolled participants, the study retention rates were high in both the intervention 
(71%) and control (94%) groups. The biochemically confirmed abstinence rates at follow-up were 0% 
and 6% for the intervention and control groups, respectively. DISCUSSION: The low enrollment rate 
suggests that the program was not feasible or acceptable. Alternative approaches are needed to 
improve the reach and efficacy of cessation interventions for Alaska Native women. 
 
Petersen, W. O., et al. (2002). "Outcomes of training nurses to conduct breast and cervical cancer 
screening of Native American women." Holist Nurs Pract 16(2): 58-79. 
 Native WEB (Women Enjoying the Benefit) is a unique training program for nurses employed by 
the Indian Health Service (IHS), tribal clinics, and other clinics with large, underserved populations. It 
teaches nurses breast and cervix cancer screening techniques and trains them to administer and 
maintain high-quality screening programs that include patient outreach, education, and training. We 
review American Indian (AI)/Alaska Native (AN) women's need for screening services, identify some of 
the obstacles to screening, and present our evaluation of the Native WEB's impact on clinics, nurses, and 
patients. Findings show that Native WEB training is associated with increased screening activity at all 
three levels. 
 
Provost, E. M. (1996). "Cervical cancer screening on the Yukon-Kuskokwim Delta, Southwest Alaska. A 
population-based study." Cancer 78(7 Suppl): 1598-1602. 
 BACKGROUND: Alaska Native women suffer excess morbidity and mortality due to cervical 
cancer. This population-based study analyzed data from a regional Pap smear registry to describe the 2-
year prevalence of cervical cancer screening for the women who live in remotely located villages in the 
Yukon-Kuskokwim Delta region. METHODS: All women older than 18 years of age who lived in one of the 
villages of the Yukon-Kuskokwim Delta were included (n = 6916). A 2-year Pap prevalence rate for each 
village was estimated by counting the number of women who had at least one Pap smear between 
September 1, 1992, and August 31, 1994, using the computer-based Pap registry located at the regional 
medical center in Bethel, Alaska. Population estimates for each village were obtained from a database 
maintained by the local office of the State of Alaska's Public Health Nurses. RESULTS: The overall 2-year 
Pap prevalence rate for the population was 62%. By age group, 2-year prevalence rates were as follows: 
women 18 to 44 years, 64%; women 45 to 64 years, 58%; and women 65 years and older, 52%. 
CONCLUSION: This study demonstrated that there is a significant need to improve access to and use of 
cervical cancer screening in this region to achieve national and state objectives. Village-based clinic staff 
are underutilized for cancer prevention service delivery; with additional training and supervision, staff 
members may serve as a means to improve this preventive health care service. 
 
Redwood, D., et al. (2011). "Collaboration to increase colorectal cancer screening among low-income 
uninsured patients." Prev Chronic Dis 8(3): A69. 
 BACKGROUND: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in 
the United States. CRC screening allows for prevention through the removal of precancerous lesions and 
early detection of cancer. COMMUNITY CONTEXT: Ride for Life Alaska (RFL), a nonprofit organization 
that raises funds to fight cancer, and the Anchorage Neighborhood Health Center (ANHC), which is 
Alaska's largest community health center, joined efforts to provide CRC screening and outreach to an 
ethnically diverse group of low-income underinsured or uninsured patients residing in and around 
Anchorage, Alaska. METHODS: RFL and ANHC worked with gastroenterologists, medical practices, and 
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pathology services to contribute pro bono and reduced-fee services for CRC screening. Information to 
patients was distributed through signs in the clinic, flyers, and the ANHC website. OUTCOMES: CRC 
screening was increased in this population. During 2007-2009, there were 2,561 immunochemical fecal 
occult blood tests given to patients, and 1,558 were completed (61%); 24% were positive. Sixteen 
gastroenterologists, 4 medical practices, and 2 laboratories provided 111 follow-up colonoscopies and 
pathology services to patients identified through the CRC screening program who did not have other 
funding resources available for follow-up care. INTERPRETATION: This program provides a model for 
leveraging scarce screening resources by drawing on multiple partners to increase CRC screening. 
Recommendations for those seeking to initiate similar programs are to have memoranda of agreement 
in place and a clear scope of work for all participating people and organizations to avoid delays in 
program implementation; hire a screening care coordinator to manage patient care and collaborate with 
medical practices; and identify program champions who have the energy and persistence to craft such 
partnerships. 
 
Redwood, D., et al. (2009). "Development of a flexible sigmoidoscopy training program for rural nurse 
practitioners and physician assistants to increase colorectal cancer screening among Alaska Native 
people." J Health Care Poor Underserved 20(4): 1041-1048. 
 At the Alaska Native Medical Center in Anchorage, colorectal cancer screening rates improved 
dramatically with the initiation of a dedicated flexible sigmoidoscopy screening program staffed by mid-
level providers. We describe the development and implementation of a program to train rural nurse 
practitioners and physician assistants in flexible sigmoidoscopy. 
 
Redwood, D., et al. (2012). "The last frontier: innovative efforts to reduce colorectal cancer disparities 
among the remote Alaska Native population." Gastrointest Endosc 75(3): 474-480. 
 BACKGROUND: The Alaska Native (AN) population experiences twice the incidence and mortality 
of colorectal cancer (CRC) as does the U.S. white population. CRC screening allows early detection and 
prevention of cancer. OBJECTIVE: We describe pilot projects conducted from 2005 to 2010 to increase 
CRC screening rates among AN populations living in rural and remote Alaska. DESIGN: Projects included 
training rural mid-level providers in flexible sigmoidoscopy, provision of itinerant endoscopy services at 
rural tribal health facilities, the creation and use of a CRC first-degree relative database to identify and 
screen individuals at increased risk, and support and implementation of screening navigator services. 
SETTING: Alaska Tribal Health System. PATIENTS: AN population. INTERVENTIONS: Itinerant endoscopy, 
patient navigation. MAIN OUTCOME MEASUREMENTS: AN patients screened for CRC, colonoscopy 
quality measures. RESULTS: As a result of these ongoing efforts, statewide AN CRC screening rates 
increased from 29% in 2000 to 41% in 2005 before the initiation of these projects and increased to 55% 
in 2010. The provision of itinerant CRC screening clinics increased rural screening rates, as did outreach 
to average-risk and increased-risk (family history) ANs by patient navigators. However, health care 
system barriers were identified as major obstacles to screening completion, even in the presence of 
dedicated patient navigators. LIMITATIONS: Continuing challenges include geography, limited health 
system capacity, high staff turnover, and difficulty getting patients to screening appointments. 
CONCLUSIONS: The projects described here aimed to increase CRC screening rates in an innovative and 
sustainable fashion. The issues and solutions described may provide insight for others working to 
increase screening rates among geographically dispersed and diverse populations. 
 
Roubideaux, Y., et al. (2008). "Relation between the level of American Indian and Alaska Native diabetes 
education program services and quality-of-care indicators." Am J Public Health 98(11): 2079-2084. 
 OBJECTIVES: We examined the relation between the level of diabetes education program 
services in the Indian Health Service (IHS) and indicators of the quality of diabetes care to determine if 
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more-comprehensive diabetes services were associated with better quality of diabetes care. METHODS: 
In this cross-sectional study, we used the IHS Integrated Diabetes Education Recognition Program to 
rank program services into 1 of 3 levels of comprehensiveness, ranging from lowest (developmental) to 
highest (integrated). We compared quality-of-care indicators among programs of differing levels with 
the 2001 IHS Diabetes Care and Outcomes Audit. Quality indicators included patients having 
recommended yearly examinations, education, and laboratory tests and achieving recommended levels 
of intermediate outcomes of care. RESULTS: Most of the 86 participating programs were classified at or 
below the developmental level; only 9 programs (11%) were ranked at higher levels. After adjusting for 
patient characteristics, program factors, and correlation of patients within programs, we associated 
programs that were more comprehensive with higher completion rates of yearly lipid and hemoglobin 
A1C tests (P < .05). CONCLUSIONS: System-wide improvements in diabetes education are associated 
with better diabetes care. The results can help inform the development of diabetes education programs. 
 
Roubidoux, M. A. (2012). "Breast cancer and screening in American Indian and Alaska Native women." J 
Cancer Educ 27 Suppl 1: S66-72. 
 Data relative to breast cancer among American Indian and Alaska native (AI/AN) women are 
limited and vary by regions. Despite national decreases in breast cancer incidence and mortality rates, 
declines in these measures have not yet appeared among AI/AN women. Health disparities in breast 
cancer persist, manifest by higher stage at diagnosis, and lower screening rates compared to other racial 
and ethnic groups. Disproportionately more AI/AN are younger at diagnosis. Screening beginning at age 
40, improving access, annual rescreening, community education and outreach, and mobile 
mammography for rural areas are ways to improve these disparities in breast cancer. 
 
Roubidoux, M. A., et al. (2003). "Relationship of mammographic parenchymal patterns to breast cancer 
risk factors and smoking in Alaska Native women." Cancer Epidemiol Biomarkers Prev 12(10): 1081-
1086. 
 The purpose is to determine breast cancer risk factors and correlates of mammographic 
parenchymal patterns among Alaska Native women. A retrospective review was performed of 
mammograms and mammogram records among 528 sequential screening mammogram examinations 
performed in Anchorage, Alaska. Mammogram density was classified by American College of Radiology 
(Breast Imaging Reporting and Data System) density patterns 1-4 (fat-->dense) and by percent density. 
Clinical data, including risk factors, ethnic group (Indian, Aleut, or Eskimo), and smoking status were 
obtained. Results were analyzed by univariate and multivariate analyses. Of 528 women, 164 were 
Indian, 155 were Aleut, and 209 were Eskimo. Mean age at first birth was lower and parity higher 
compared with published data in white women. Breast cancer risk factors were similar across ethnic 
groups. In multivariate analysis, patient age, parity, hormone replacement therapy, hysterectomy, and 
history of biopsy were associated, and smoking was not associated with density scores. Aleut and Indian 
women were less likely to have high-density mammograms than were Eskimo women (P = 0.0448). No 
significant differences were found between ethnic group for conventional breast cancer risk factors. 
Mammogram density was associated with age at screening, parity, hormone replacement therapy, 
hysterectomy, history of biopsy, and ethnicity but not smoking status. Eskimo women had higher 
mammogram density than Aleuts or Indians. 
 
Schumacher, M. C., et al. (2008). "Prevalence and predictors of cancer screening among American Indian 
and Alaska native people: the EARTH study." Cancer Causes Control 19(7): 725-737. 
 PURPOSE: The purpose of this study was to examine the prevalence rates for cervical, breast, 
and colorectal cancer screening among American Indian and Alaska Native people living in Alaska and in 
the Southwest US, and to investigate predictive factors associated with receiving each of the cancer 
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screening tests. METHODS: We used the Education and Research Towards Health (EARTH) Study to 
measure self-reported cancer screening prevalence rates among 11,358 study participants enrolled in 
2004-2007. We used prevalence odds ratios to examine demographic, lifestyle and medical factors 
associated with receiving age- and sex-appropriate cancer screening tests. RESULTS: The prevalence 
rates of all the screening tests were higher in Alaska than in the Southwest. Pap test in the past 3 years 
was reported by 75.1% of women in Alaska and 64.6% of women in the Southwest. Mammography in 
the past 2 years was reported by 64.6% of women aged 40 years and older in Alaska and 44.0% of those 
in the Southwest. Colonoscopy or sigmoidoscopy in the past 5 years was reported by 41.1% of study 
participants aged 50 years and older in Alaska and by 11.7% of those in the Southwest US. Multivariate 
analysis found that location (Alaska versus the Southwest), higher educational status, income and the 
presence of one or more chronic medical condition predicted each of the three screening tests. 
Additional predictors of Pap test were age (women aged 25-39 years more likely to be screened than 
older or younger women), marital status (ever married more likely to be screened), and language 
spoken at home (speakers of American Indian Alaska Native language only less likely to be screened). 
Additional predictors of mammography were age (women aged 50 years and older were more likely to 
be screened than those aged 40-49 years), positive family history of breast cancer, use of smokeless 
tobacco (never users more likely to be screened), and urban/rural residency (urban residents more likely 
to be screened). Additional predictors of colonoscopy/sigmoidoscopy were age (men and women aged 
60 years and older slightly more likely to be screened than those aged 50-59 years), family history of any 
cancer, family history of colorectal cancer, former smoking, language spoken at home (speakers of 
American Indian Alaska Native language less likely to be screened), and urban/rural residence (urban 
residents more likely to be screened). CONCLUSION: Programs to improve screening among American 
Indian and Alaska Native people should include efforts to reach individuals of lower socioeconomic 
status and who do not have regular contact with the medical care system. Special attention should be 
made to identify and provide needed services to those who live in rural areas, and to those living in the 
Southwest US. 
 
Stefanich, C. A., et al. (2005). "Development, adaptation, and implementation of a cardiovascular health 
program for Alaska native women." Health Promot Pract 6(4): 472-481. 
 Southcentral Foundation's Traditions of the Heart program is an innovative cardiovascular 
disease prevention program for women designed to build on the strengths of the Alaska Native culture 
as a way to support and encourage positive lifestyle behaviors that focus on healthy eating, active living, 
stress management, and tobacco cessation. After conducting assessments of existing intervention 
programs and formative data collection, we adapted two existing programs, Native Nutrition Circles and 
A New Leaf... Choices for Healthy Living, to develop the Traditions of the Heart program. We 
implemented and evaluated a pilot intervention study to determine the program's acceptance among 
Alaska Native women. We used the evaluation results to further refine our study protocol. This article 
describes the adaptation of these programs to the cultural needs and strengths of Alaska Native women 
and the results of the formative evaluation used to improve the program design. The complete pilot 
study outcomes will be published separately. 
 
Thomas, T. K., et al. (2001). "Is it safe on deck? Fatal and non-fatal workplace injuries among Alaskan 
commercial fishermen." Am J Ind Med 40(6): 693-702. 
 BACKGROUND: Commercial fishing in Alaska accounts for an occupational fatality rate that is 28 
times the rate for all U.S. workers. Most deaths are attributed to vessel sinking or capsizing. However, 
many deaths and most non-fatal injuries are not related to vessel loss. This paper describes injuries that 
occur on the dock or on the fishing vessel. METHODS: Data from fishing fatalities and non-fatal injuries 
between 1991-1998 were analyzed using the Alaska Occupational Injury Surveillance System and the 
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Alaska Trauma Registry. RESULTS: There were 60 workplace deaths unrelated to vessel loss; most from 
falls overboard, others from trauma caused by equipment on deck. There were 574 hospitalized injuries, 
often from falls on deck, entanglement in machinery, or being struck by an object. SUMMARY: Fishing 
boats are hazardous working environments. Further efforts are required to prevent falls overboard and 
on deck, and to redesign or install safety features on fishing machinery and equipment. 
 
Vaid, I., et al. (2011). "WISEWOMAN: addressing the needs of women at high risk for cardiovascular 
disease." J Womens Health (Larchmt) 20(7): 977-982. 
 In the United States, the cardiovascular health of women is affected by the disparate impact of 
cardiovascular diseases (CVDs) on many minority ethnic and racial groups. Women with low income also 
endure a disproportionate impact of the burden of CVD. The Centers for Disease Control and 
Prevention's (CDC's) Well-Integrated Screening and Evaluation for Women Across the Nation 
(WISEWOMAN) Program was authorized by Congress in 1993 to extend the preventive health services 
offered to participants of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). 
These are low-income, uninsured, and underinsured women. The intent was to expand services of an 
existing federal program to address cardiovascular health concerns in this vulnerable, high-risk 
population. CDC funds 19 state health departments and 2 tribal organizations (both in Alaska) to 
implement WISEWOMAN. In the first 2 years of the current 5-year funding cycle, which began in June 
2008, the WISEWOMAN grantees succeeded in providing almost 78,000 screenings, of which 46% were 
to women of minority racial and ethnic groups. The individual successes are important, and the 
WISEWOMAN Program also has achieved success in the broader arenas of healthcare and the 
communities in which WISEWOMAN is implemented. WISEWOMAN impacts clinical systems of care, 
provider education, physician extenders, and the broader community and will continue to play an 
important role in connecting low-income, uninsured, and underinsured women with clinical systems of 
care and other community resources that will result in the prevention, treatment, and management of 
their CVD risk. 
 
Van Camp, R. O. (1990). "Heart Day. An experience in cardiovascular risk factor detection in a rural 
Alaskan population." Alaska Med 32(4): 141-145. 
 This is a summary of the results of a project to influence cardiovascular risk factors in a rural 
population using a community based clinic with very limited financial and staffing resources. The 
project, which was well received by the community, was successful in influencing community-wide 
awareness of cardiovascular risk factors and in screening many people who would otherwise not receive 
medical care. A significant number of correctable risk factors for cardiovascular disease were discovered. 
 
von Friederichs-Fitzwater, M. M., et al. (2010). "A value-based approach to increase breast cancer 
screening and health-directed behaviors among American Indian women." J Cancer Educ 25(4): 582-587. 
 American Indian/Alaska Native (AI/AN) women have the lowest cancer-screening rate of any 
ethnic or racial group; AI/AN women in all regions are less likely than non-Hispanic white women to be 
diagnosed with localized breast cancer; and those AI/AN women presenting with breast cancer have the 
lowest 5-year survival rate compared to other ethnic groups. This study found that cultural beliefs are 
more of a factor in mammography screening behavior than other barriers such as access; and that a 
more holistic educational intervention designed by AI/AN women prompted individual intent and 
actions to seek mammograms among AI/AN women >40 and to change unhealthy eating and sedentary 
lifestyles. 
 
Watson-Johnson, L. C., et al. (2011). "Mammography adherence: a qualitative study." J Womens Health 
(Larchmt) 20(12): 1887-1894. 
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 BACKGROUND: Regular mammography accounts for half of the recent declines in breast cancer 
mortality. Mammography use declined significantly in 2008. Given the success of regular breast cancer 
screening, understanding why mammography use decreased is important. We undertook a focus group 
study to explore reasons women who were previously adherent with regular mammography no longer 
were screened. METHODS: We conducted 20 focus groups with white non-Hispanic, black non-Hispanic, 
Hispanic, Japanese American, and American Indian/Alaska Native women, and segmented the groups by 
age, race/ethnicity, and health insurance status. A conceptual framework, based on existing research, 
informed the development of the focus group guide. Discussion topics included previous mammography 
experiences, perceptions of personal breast cancer risk, barriers to mammography, and risks and 
benefits associated with undergoing mammography. Atlas.ti was used to facilitate data analysis. 
RESULTS: All focus groups (n=128 women) were completed in 2009 in five cities across the United 
States. Half of the groups were held with white non-Hispanic women and the remainder with other 
racial/ethnic groups. Major barriers to routine mammography included (1) concerns about test efficacy, 
(2) personal concerns about the procedure, (3) access to screening services, (4) psychosocial issues, and 
(5) cultural factors. For uninsured women, lack of health insurance was the primary barrier to 
mammography. CONCLUSIONS: Multilevel interventions at the health-care provider and system levels 
are needed to address barriers women experience to undergoing regular mammography screening. 
Ultimately, breast cancer screening with mammography is an individual behavior; therefore, individual 
behavioral change strategies will continue to be needed. 
 
Weber, D. (2012). "That others may live: lessons learned from the 2011 Denali climbing season." 
Wilderness Environ Med 23(2): 104-105. 
  
Witmer, J. M., et al. (2004). "Heart disease prevention for Alaska Native women: a review of pilot study 
findings." J Womens Health (Larchmt) 13(5): 569-578. 
 BACKGROUND: Although historically Alaska Native women have had a relatively low incidence of 
cardiovascular disease (CVD), this pattern has changed dramatically in recent years. Alaska Native 
leaders have identified decreasing cardiovascular risk as an intervention priority. METHODS: From 
October 2000 to April 2001, Southcentral Foundation, an Alaska Native-owned and managed health 
corporation in Anchorage, conducted a pilot randomized controlled trial of a heart disease prevention 
program tailored for Alaska Native women. The aim was to assess feasibility and cultural acceptability 
and to develop enrollment procedures. Of 76 women who enrolled, 44 were randomized to the 
intervention group. Thirty-seven of 44 attended at least two intervention sessions, 23 completed 
prequestionnaires and postquestionnaires, and 27 returned for 12-month follow-up screening. Thirty of 
32 control group participants returned for 12-month follow-up screening. The intervention included 12 
weekly sessions on lifestyle change and goal setting. At baseline and 12 months, participants' height, 
weight, resting blood pressure, fasting lipid levels, and blood glucose were measured. At sessions 1 and 
12, participants completed assessments regarding diet, physical activity, tobacco use, and psychosocial 
status. RESULTS: At 12 weeks, significant improvements were noted in moderate walking and physical 
activity self-efficacy. Also observed was substantial movement from the contemplation and preparation 
stages to the action stage regarding physical activity and heart-healthy eating. CONCLUSIONS: Although 
the small sample size precludes drawing conclusions about the intervention's effect, participants 
reported lifestyle and psychosocial changes. The pilot study resulted in protocol changes that improved 
the design and implementation of a subsequent large-scale study. 
 
Young, T. K., et al. (2007). "Prevalence of obesity and its metabolic correlates among the circumpolar 
inuit in 3 countries." Am J Public Health 97(4): 691-695. 
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 OBJECTIVES: We investigated the prevalence of obesity and the metabolic correlates of different 
levels of body mass index (BMI) and waist circumference among the Inuit in 3 countries. METHODS: Data 
from 4 surveys of Inuit in Canada, Greenland, and Alaska conducted during 1990-2001 were pooled, 
with a total sample size of 2545 participants. These data were compared with data from a Canadian 
population of predominantly European origin. RESULTS: Using the World Health Organization criteria for 
overweight and obesity, we found that the crude prevalence of overweight among Inuit men and 
women was 36.6% and 32.5%, respectively, and obesity was 15.8% and 25.5%, respectively. Inuit 
prevalences were similar to those of the highly developed countries of Europe and North America. As 
levels of obesity increased, as measured by BMI or waist circumference, the mean values of various 
metabolic indicators-lipid, glucose, and insulin levels and blood pressure-also increased. However, at 
each level of BMI or waist circumference, the Inuit had lower blood pressure and lipid levels than did 
Euro-Canadians. CONCLUSIONS: Our data indicate that universal criteria for obesity may not reflect the 
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Appendix D. Additional Literature Review Key Word Searches  
 
To expand the available national literature and contextualize emergent themes identified during the 
key informant interviews, a second literature review was conducted during September, 2013.  Key 
words were searched on PubMed, and article titles were reviewed for relevancy.  Abstracts of all 
potentially relevant articles were reviewed, and only those pertinent were read and incorporated into 
the report.  The following key word searches garnered the specified number of articles: 
  
“CDSS” “evaluation” “screening” – 7, 1 incorporated 
“provider communication” “screening” rate – 4, 1 incorporated 
“provider” “screening guidelines” following – 3, 1 incorporated 
“team-based care” “screening” – 3, 0 incorporated 
“support staff” “provider” “screening” – 3, 1 incorporated 
“tobacco screening” – 23, 2 incorporated 
“colorectal cancer screening” “barrier” – 64, 3 incorporated 
“screening” “one on one education” – 9, 4 incorporated 
“cancer screening” “telephone outreach” – 7, 1 incorporated  
“preventive screening” “barrier” – 7, 1 incorporated 
 
This search generated 130 additional articles.  After a review of abstracts, 15 articles were read and 
incorporated into the body of the report. 
 
In addition, specific guidelines, recommendations, and screening rates were referenced from the 
USPSTF (3), CPSTF (4), healthcare.gov (1), and Alaska DHSS (2) websites.  Systematic reviews were 
consulted from each of the CPSTF relevant screening categories: 
 Cardiovascular Disease - 1 
 Tobacco – 0 published 
 Cancer - 3 
 
 
In response to DHSS comments on a draft of this report, additional key word searches were conducted 
in PubMed on Oct. 8, 2013.  Titles and abstracts of all potentially relevant articles were reviewed, and 
only those pertinent were read and incorporated into the report where appropriate.  The following key 
word searches garnered the specified number of articles: 
“comment card” – 2, 1 incorporated  
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Appendix E. Additional Literature Review Results: Annotated Bibliography  
 
(2012). "Updated recommendations for client- and provider-oriented interventions to increase breast, 
cervical, and colorectal cancer screening." Am J Prev Med 43(1): 92-96. 
 The Community Preventive Services Task Force (Task Force) recommends increasing screening 
for breast cancer through use of group education, one-on-one education, client reminders, reducing 
client out-of-pocket costs, and provider assessment and feedback; increasing screening for cervical 
cancer through use of one-on-one education, client reminders, and provider assessment and feedback; 
and increasing screening for colorectal cancer through use of one-on-one education, client reminders, 
reducing structural barriers to screening, and provider assessment and feedback. The Task Force found 
insufficient evidence to determine the effectiveness of increasing screening for breast cancer through 
use of client incentives, mass media, or provider incentives; for cervical cancer screening through use of 
group education, client incentives, mass media, reducing client out-of-pocket costs, reducing structural 
barriers, or provider incentives; and for colorectal cancer screening through use of group education, 
client incentives, mass media, reducing client out-of-pocket costs, or provider incentives. Details of 
these findings, and some considerations for use, are provided in this article. 
 
Amonkar, M. M., et al. (1999). "Barriers and facilitators to providing common preventive screening 
services in managed care settings." J Community Health 24(3): 229-247. 
 Despite increasing emphasis on disease prevention and health promotion, and ample evidence 
demonstrating the effectiveness of preventive services, such services are underutilized in the United 
States. The current trend of health care toward health maintenance organizations and other managed 
care systems opens the door, perhaps to more effective control of heart disease, cancers and other 
chronic diseases through preventive care. This warrants attention to the barriers/facilitators to the 
provision/utilization of preventive screening services in such settings. Overall goal of this study was to 
assess barriers/facilitators to the provision/utilization of preventive services in managed care 
organizations (MCOs). This was accomplished by a) identifying barriers/facilitators to the 
provision/utilization of three common preventive screening services (cholesterol screenings, 
mammograms, and Pap smears); and b) profiling typical MCO recipients of these three preventive 
screening services. A self-administered, mail questionnaire was used to obtain information from a 
national sample of 1,200 Directors of MCOs associated with preventive care. A total of 175 usable 
responses were received resulting in a 17.3 percent net response rate. The strongest barrier to the 
provision of all three screening services is the inability of them to generate short term savings for the 
MCO. Other barriers include high disenrollment rates, conflicting recommendations about effectiveness 
(for mammograms and cholesterol screenings), and patients' fears of getting a positive result (for 
mammograms and Pap smears). The improved health status as a result of early intervention, high 
consumer awareness (for mammograms and Pap smears), and long term savings are important 
facilitators to the provision/utilization of these screening services. Comparing barriers and facilitators 
across the three services shows the stronger barriers affecting the provision/utilization of 
mammograms. For all three screening services, typical managed care recipients are those in the high 
income groups with greater education levels. However, with the increasing enrollment of Medicaid 
beneficiaries into managed care, MCOs may find themselves selectively targeting these high risk low 
income and less educated individuals to receive the preventive screening services. Study findings should 
be useful to health planners, policymakers and researchers at all levels in their efforts to encourage and 
promote healthier lifestyle choices among U.S. residents. Future studies should address receipt of 
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Baron, R. C., et al. (2008). "Client-directed interventions to increase community demand for breast, 
cervical, and colorectal cancer screening a systematic review." Am J Prev Med 35(1 Suppl): S34-55. 
 Most major medical organizations recommend routine screening for breast, cervical, and 
colorectal cancers. Screening can lead to early detection of these cancers, resulting in reduced mortality. 
Yet not all people who should be screened are screened, either regularly or, in some cases, ever. This 
report presents the results of systematic reviews of effectiveness, applicability, economic efficiency, 
barriers to implementation, and other harms or benefits of interventions designed to increase screening 
for breast, cervical, and colorectal cancers by increasing community demand for these services. Evidence 
from these reviews indicates that screening for breast cancer (mammography) and cervical cancer (Pap 
test) has been effectively increased by use of client reminders, small media, and one-on-one education. 
Screening for colorectal cancer by fecal occult blood test has been increased effectively by use of client 
reminders and small media. Additional research is needed to determine whether client incentives, group 
education, and mass media are effective in increasing use of any of the three screening tests; whether 
one-on-one education increases screening for colorectal cancer; and whether any demand-enhancing 
interventions are effective in increasing the use of other colorectal cancer screening procedures (i.e., 
flexible sigmoidoscopy, colonoscopy, double contrast barium enema). Specific areas for further research 
are also suggested in this report. 
 
Bright, T. J., et al. (2012). "Effect of clinical decision-support systems: a systematic review." Ann Intern 
Med 157(1): 29-43. 
 BACKGROUND: Despite increasing emphasis on the role of clinical decision-support systems 
(CDSSs) for improving care and reducing costs, evidence to support widespread use is lacking. PURPOSE: 
To evaluate the effect of CDSSs on clinical outcomes, health care processes, workload and efficiency, 
patient satisfaction, cost, and provider use and implementation. DATA SOURCES: MEDLINE, CINAHL, 
PsycINFO, and Web of Science through January 2011. STUDY SELECTION: Investigators independently 
screened reports to identify randomized trials published in English of electronic CDSSs that were 
implemented in clinical settings; used by providers to aid decision making at the point of care; and 
reported clinical, health care process, workload, relationship-centered, economic, or provider use 
outcomes. DATA EXTRACTION: Investigators extracted data about study design, participant 
characteristics, interventions, outcomes, and quality. DATA SYNTHESIS: 148 randomized, controlled 
trials were included. A total of 128 (86%) assessed health care process measures, 29 (20%) assessed 
clinical outcomes, and 22 (15%) measured costs. Both commercially and locally developed CDSSs 
improved health care process measures related to performing preventive services (n= 25; odds ratio 
[OR], 1.42 [95% CI, 1.27 to 1.58]), ordering clinical studies (n= 20; OR, 1.72 [CI, 1.47 to 2.00]), and 
prescribing therapies (n= 46; OR, 1.57 [CI, 1.35 to 1.82]). Few studies measured potential unintended 
consequences or adverse effects. LIMITATIONS: Studies were heterogeneous in interventions, 
populations, settings, and outcomes. Publication bias and selective reporting cannot be excluded. 
CONCLUSION: Both commercially and locally developed CDSSs are effective at improving health care 
process measures across diverse settings, but evidence for clinical, economic, workload, and efficiency 
outcomes remains sparse. This review expands knowledge in the field by demonstrating the benefits of 
CDSSs outside of experienced academic centers. PRIMARY FUNDING SOURCE: Agency for Healthcare 
Research and Quality. 
 
Brouwers, M. C., et al. (2011). "What implementation interventions increase cancer screening rates? a 
systematic review." Implement Sci 6: 111. 
 BACKGROUND: Appropriate screening may reduce the mortality and morbidity of colorectal, 
breast, and cervical cancers. However, effective implementation strategies are warranted if the full 
benefits of screening are to be realized. As part of a larger agenda to create an implementation 
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guideline, we conducted a systematic review to evaluate interventions designed to increase the rate of 
breast, cervical, and colorectal cancer (CRC) screening. The interventions considered were: client 
reminders, client incentives, mass media, small media, group education, one-on-one education, 
reduction in structural barriers, reduction in out-of-pocket costs, provider assessment and feedback 
interventions, and provider incentives. Our primary outcome, screening completion, was calculated as 
the overall median post-intervention absolute percentage point (PP) change in completed screening 
tests. METHODS: Our first step was to conduct an iterative scoping review in the research area. This 
yielded three relevant high-quality systematic reviews. Serving as our evidentiary foundation, we 
conducted a formal update. Randomized controlled trials and cluster randomized controlled trials, 
published between 2004 and 2010, were searched in MEDLINE, EMBASE and PSYCHinfo. RESULTS: The 
update yielded 66 studies new eligible studies with 74 comparisons. The new studies ranged 
considerably in quality. Client reminders, small media, and provider audit and feedback appear to be 
effective interventions to increase the uptake of screening for three cancers. One-on-one education and 
reduction of structural barriers also appears effective, but their roles with CRC and cervical screening, 
respectively, are less established. More study is required to assess client incentives, mass media, group 
education, reduction of out-of-pocket costs, and provider incentive interventions. CONCLUSION: The 
new evidence generally aligns with the evidence and conclusions from the original systematic reviews. 
This review served as the evidentiary foundation for an implementation guideline. Poor reporting, lack 
of precision and consistency in defining operational elements, and insufficient consideration of context 
and differences among populations are areas for additional research. 
 
Carcaise-Edinboro, P. and C. J. Bradley (2008). "Influence of patient-provider communication on 
colorectal cancer screening." Med Care 46(7): 738-745. 
 BACKGROUND: Screening reduces incidence and mortality from colorectal cancer (CRC). Despite 
improved access, screening is suboptimal and disparate among minority groups. Quality of patient-
provider communication may impact CRC screening. OBJECTIVES: We examined the relationship 
between patient-provider communication and socioeconomic variables on the receipt of CRC screening 
using data from the Medical Expenditure Panel Survey. SUBJECTS: All persons age 50 years or older (N = 
8488). MEASURES: Dependent measures were receipt of CRC screening, fecal occult blood testing, and 
colonoscopy or sigmoidoscopy. Independent variables included demographic characteristics, patient 
language, and patient-provider communication measures from the Consumer Assessment of Health Plan 
survey. RESULTS: Patients who felt they had sufficient time with their healthcare provider were more 
likely to be screened for CRC. Receiving adequate explanation of healthcare needs from provider was a 
significant predictor of fecal occult blood testing screening. In addition, persons with less than a high 
school education, the uninsured, or those with low income were associated with reduced likelihood of 
receiving CRC screening. Asians and Hispanics had a significantly reduced likelihood of receiving 
screening in comparison with whites; however, after adjusting for language, no significant differences 
for race or ethnicity were observed. CONCLUSIONS: Adequate time with a healthcare provider and 
receiving sufficient explanation of the healthcare processes by providers may improve screening rates. 
Patient-provider communication may be improved by addressing language needs of non-English 
speaking patients. Overall improved communication may increase CRC screening rates in underserved 
populations. 
 
Chen, H. Y., et al. (2012). "Cervical cancer screening in the United States, 1993-2010: characteristics of 
women who are never screened." J Womens Health (Larchmt) 21(11): 1132-1138. 
 BACKGROUND: Regular Pap test screening has contributed to decreasing cervical cancer 
incidence and mortality over the past decades, yet half of the women diagnosed with cervical cancer 
have never had a Pap test. Our study aims to examine the cervical cancer screening rate, identify 
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socioeconomic and demographic risk factors associated with adult women who have never had a Pap 
test, and examine the relationship of screening with use of related health services. METHODS: Using 
Behavioral Risk Factor Surveillance System data (1993-2010), a multivariable survey logistic regression 
model was fitted to estimate odds ratios for associations between risk factors and the outcome of never 
screened. RESULTS: Between 1993 and 2010, 81.3% of respondents reported they had a Pap test within 
3 years; 6.2% were never screened. For women who had a recent checkup, 5.5% were never screened. 
Among women who had a hysterectomy, 69.4% had a Pap test within 3 years. The multivariable analysis 
showed that age, race/ethnicity, education, annual household income, never married, and currently 
uninsured were significantly (p<0.001) associated with never screened. CONCLUSIONS: Screening 
programs accompanied by adequate treatment options should target women at high risk for never being 
screened, which could decrease cervical cancer incidence and mortality. 
 
Davis, T. C., et al. (2013). "Contrasts in rural and urban barriers to colorectal cancer screening." Am J 
Health Behav 37(3): 289-298. 
 OBJECTIVES: To contrast barriers to colon cancer (CRC) screening and Fecal Occult Blood Test 
(FOBT) completion between rural and urban safety-net patients. METHODS: Interviews were 
administered to 972 patients who were not up-to-date with screening. RESULTS: Rural patients were 
more likely to believe it was helpful to find CRC early (89.7% vs 66.1%, p < .0001), yet were less likely to 
have received a screening recommendation (36.4% vs. 45.8%, p = .03) or FOBT information (14.5% vs 
32.3%, p < .0001) or to have completed an FOBT (22.0% vs 45.8%, p < .0001). CONCLUSIONS: 
Interventions are needed to increase screening recommendation, education and completion, 
particularly in rural areas. 
 
Dietrich, A. J., et al. (2013). "Telephone outreach to increase colon cancer screening in medicaid 
managed care organizations: a randomized controlled trial." Ann Fam Med 11(4): 335-343. 
 PURPOSE: Health Plans are uniquely positioned to deliver outreach to members. We explored 
whether telephone outreach, delivered by Medicaid managed care organization (MMCO) staff, could 
increase colorectal cancer (CRC) screening among publicly insured urban women, potentially reducing 
disparities. METHODS: We conducted an 18-month randomized clinical trial in 3 MMCOs in New York 
City in 2008-2010, randomizing 2,240 MMCO-insured women, aged 50 to 63 years, who received care at 
a participating practice and were overdue for CRC screening. MMCO outreach staff provided cancer 
screening telephone support, educating patients and helping overcome barriers. The primary outcome 
was the number of women screened for CRC during the 18-month intervention, assessed using claims. 
RESULTS: MMCO staff reached 60% of women in the intervention arm by telephone. Although 
significantly more women in the intervention (36.7%) than in the usual care (30.6%) arm received CRC 
screening (odds ratio [OR] = 1.32; 95% CI, 1.08-1.62), increases varied from 1.1% to 13.7% across the 
participating MMCOs, and the overall increase was driven by increases at 1 MMCO. In an as-treated 
comparison, 41.8% of women in the intervention arm who were reached by telephone received CRC 
screening compared with 26.8% of women in the usual care arm who were not contacted during the 
study (OR = 1.84; 95% CI, 1.38, 2.44); 7 women needed to be reached by telephone for 1 to become 
screened. CONCLUSIONS: The telephone outreach intervention delivered by MMCO staff increased CRC 
screening by 6% more than usual care among randomized women, and by 15.1% more than usual care 
among previously overdue women reached by the intervention. Our research-based intervention was 
successfully translated to the health plan arena, with variable effects in the participating MMCOs. 
 
Kawamoto, K., et al. (2005). "Improving clinical practice using clinical decision support systems: a 
systematic review of trials to identify features critical to success." BMJ 330(7494): 765. 
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 OBJECTIVE: To identify features of clinical decision support systems critical for improving clinical 
practice. DESIGN: Systematic review of randomised controlled trials. DATA SOURCES: Literature searches 
via Medline, CINAHL, and the Cochrane Controlled Trials Register up to 2003; and searches of reference 
lists of included studies and relevant reviews. STUDY SELECTION: Studies had to evaluate the ability of 
decision support systems to improve clinical practice. DATA EXTRACTION: Studies were assessed for 
statistically and clinically significant improvement in clinical practice and for the presence of 15 decision 
support system features whose importance had been repeatedly suggested in the literature. RESULTS: 
Seventy studies were included. Decision support systems significantly improved clinical practice in 68% 
of trials. Univariate analyses revealed that, for five of the system features, interventions possessing the 
feature were significantly more likely to improve clinical practice than interventions lacking the feature. 
Multiple logistic regression analysis identified four features as independent predictors of improved 
clinical practice: automatic provision of decision support as part of clinician workflow (P < 0.00001), 
provision of recommendations rather than just assessments (P = 0.0187), provision of decision support 
at the time and location of decision making (P = 0.0263), and computer based decision support (P = 
0.0294). Of 32 systems possessing all four features, 30 (94%) significantly improved clinical practice. 
Furthermore, direct experimental justification was found for providing periodic performance feedback, 
sharing recommendations with patients, and requesting documentation of reasons for not following 
recommendations. CONCLUSIONS: Several features were closely correlated with decision support 
systems' ability to improve patient care significantly. Clinicians and other stakeholders should 
implement clinical decision support systems that incorporate these features whenever feasible and 
appropriate. 
 
Klabunde, C. N., et al. (2007). "Improving colorectal cancer screening in primary care practice: innovative 
strategies and future directions." J Gen Intern Med 22(8): 1195-1205. 
 Colorectal cancer (CRC) screening has been supported by strong research evidence and 
recommended in clinical practice guidelines for more than a decade. Yet screening rates in the United 
States remain low, especially relative to other preventable diseases such as breast and cervical cancer. 
To understand the reasons, the National Cancer Institute and Agency for Healthcare Research and 
Quality sponsored a review of CRC screening implementation in primary care and a program of research 
funded by these organizations. The evidence base for improving CRC screening supports the value of a 
New Model of Primary Care Delivery: 1. a team approach, in which responsibility for screening tasks is 
shared among other members of the practice, would help address physicians' lack of time for preventive 
care; 2. information systems can identify eligible patients and remind them when screening is due; 3. 
involving patients in decisions about their own care may enhance screening participation; 4. monitoring 
practice performance, supported by information systems, can help target patients at increased risk 
because of family history or social disadvantage; 5. reimbursement for services outside the traditional 
provider-patient encounter, such as telephone and e-mail contacts, may foster enhanced screening 
delivery; 6. training opportunities in communication, cultural competence, and use of information 
technologies would improve provider competence in core elements of screening programs. 
Improvement in CRC screening rates largely depends on the efforts of primary care practices to 
implement effective systems and procedures for screening delivery. Active engagement and support of 
practices are essential for the enormous potential of CRC screening to be realized. 
 
Nelson, E. C., et al. (1991). "The patient comment card: a system to gather customer feedback." QRB 
Qual Rev Bull 17(9): 278-286. 
 Continuous patient feedback can give important information to hospitals about the quality of 
care they provide. The Patient Comment Card (PCC), a brief form that can be used to gather open-ended 
comments from patients and to measure quality, was developed during a two-year period and was 
 
88 
Preventive Screening Gap Analysis October 15, 2013 
Institute of Social and Economic Research  
extensively evaluated in a series of three pilot tests involving more than 2,000 patients discharged from 
five hospitals. Evaluation results demonstrate that the questionnaire elicits useful comments from 
patients and can generate statistically reliable scores and valid quality measures. However, in a field trial 
in four hospitals, low response rates (15%-27%) reflected, first, lack of follow-up of non-respondents, 
and second, the fact that most of the PCC quality scores were upwardly biased; these inflated scores 
were likely to reflect the low response rate. Tools such as the PCC should be used judiciously, given the 
possible abuses and misinterpretations of hospital quality scores. 
 
Perkins, A., et al. (2013). "Attitudes toward colorectal cancer screening in the digital age: a survey of 
practices and attitudes among screening-eligible Alabamians." South Med J 106(8): 462-467. 
 OBJECTIVES: To ascertain barriers to colorectal cancer screening in an environment of changing 
recommendations, payment structures, and information access, and to develop strategies for 
overcoming these barriers by undertaking a population survey of colorectal cancer (CRC) screening 
knowledge and attitudes in Alabama. METHODS: An 80-item questionnaire focused on cancer screening, 
specifically CRC screening, was developed and pretested. A random sample of Alabama residents was 
generated using random-digit dial methods and interviews of 615 participants aged 50 and older were 
conducted in March 2012 and April 2012. Screened and unscreened groups were compared using chi 
statistics. RESULTS: Sixty-one percent of Alabamians who participated in this survey reported being 
screened for CRC, the majority (95%) of these by colonoscopy. Both screened and unscreened 
participants reported using the Internet for health information more often if they were younger than 65 
years. Those screened often reported feeling well informed regarding the guidelines, often to have 
discussed CRC screening with their family physician, and often to have had other cancer screenings. All 
of the respondents, screened and unscreened, reported financial considerations to be the most 
significant barriers to screening. CONCLUSIONS: Although educating the general population could be 
helpful, a physician championing screening is key. Home stool testing is underused in Alabama in part 
because physicians are not fully aware of its utility. As financial barriers diminish, it is important to offer 
multiple effective modalities when available, and insurance reform, which includes payment for 
preventive care, may improve screening rates. 
 
Sabatino, S. A., et al. (2012). "Effectiveness of interventions to increase screening for breast, cervical, 
and colorectal cancers: nine updated systematic reviews for the guide to community preventive 
services." Am J Prev Med 43(1): 97-118. 
 CONTEXT: Screening reduces mortality from breast, cervical, and colorectal cancers. The Guide 
to Community Preventive Services previously conducted systematic reviews on the effectiveness of 11 
interventions to increase screening for these cancers. This article presents results of updated systematic 
reviews for nine of these interventions. EVIDENCE ACQUISITION: Five databases were searched for 
studies published during January 2004-October 2008. Studies had to (1) be a primary investigation of 
one or more intervention category; (2) be conducted in a country with a high-income economy; (3) 
provide information on at least one cancer screening outcome of interest; and (4) include screening use 
prior to intervention implementation or a concurrent group unexposed to the intervention category of 
interest. Forty-five studies were included in the reviews. EVIDENCE SYNTHESIS: Recommendations were 
added for one-on-one education to increase screening with fecal occult blood testing (FOBT) and group 
education to increase mammography screening. Strength of evidence for client reminder interventions 
to increase FOBT screening was upgraded from sufficient to strong. Previous findings and 
recommendations for reducing out-of-pocket costs (breast cancer screening); provider assessment and 
feedback (breast, cervical, and FOBT screening); one-on-one education and client reminders (breast and 
cervical cancer screening); and reducing structural barriers (breast cancer and FOBT screening) were 
reaffirmed or unchanged. Evidence remains insufficient to determine effectiveness for the remaining 
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screening tests and intervention categories. CONCLUSIONS: Findings indicate new and reaffirmed 
interventions effective in promoting recommended cancer screening, including colorectal cancer 
screening. Findings can be used in community and healthcare settings to promote recommended care. 
Important research gaps also are described. 
 
Schillo, B. A., et al. (2011). "The relation between media promotions and service volume for a statewide 
tobacco quitline and a web-based cessation program." BMC Public Health 11: 939. 
 BACKGROUND: This observational study assessed the relation between mass media campaigns 
and service volume for a statewide tobacco cessation quitline and stand-alone web-based cessation 
program. METHODS: Multivariate regression analysis was used to identify how weekly calls to a 
cessation quitline and weekly registrations to a web-based cessation program are related to levels of 
broadcast media, media campaigns, and media types, controlling for the impact of external and earned 
media events. RESULTS: There was a positive relation between weekly broadcast targeted rating points 
and the number of weekly calls to a cessation quitline and the number of weekly registrations to a web-
based cessation program. Additionally, print secondhand smoke ads and online cessation ads were 
positively related to weekly quitline calls. Television and radio cessation ads and radio smoke-free law 
ads were positively related to web program registration levels. There was a positive relation between 
the number of web registrations and the number of calls to the cessation quitline, with increases in 
registrations to the web in 1 week corresponding to increases in calls to the quitline in the subsequent 
week. Web program registration levels were more highly influenced by earned media and other external 
events than were quitline call volumes. CONCLUSION: Overall, broadcast advertising had a greater 
impact on registrations for the web program than calls to the quitline. Furthermore, registrations for the 
web program influenced calls to the quitline. These two findings suggest the evolving roles of web-based 
cessation programs and Internet-use practices should be considered when creating cessation programs 
and media campaigns to promote them. Additionally, because different types of media and campaigns 
were positively associated with calls to the quitline and web registrations, developing mass media 
campaigns that offer a variety of messages and communicate through different types of media to 
motivate tobacco users to seek services appears important to reach tobacco users. Further research is 
needed to better understand the complexities and opportunities involved in simultaneous promotion of 
quitline and web-based cessation services. 
 
Sutfin, E. L., et al. (2012). "Screening and brief intervention for tobacco use by student health providers 
on college campuses." J Am Coll Health 60(1): 66-73. 
 OBJECTIVE: This study assessed college students' reports of tobacco screening and brief 
intervention by student health center providers. PARTICIPANTS: Participants were 3,800 students from 8 
universities in North Carolina. METHODS: Web-based survey of a stratified random sample of 
undergraduates. RESULTS: Fifty-three percent reported ever visiting their student health center. Of 
those, 62% reported being screened for tobacco use. Logistic regression revealed screening was higher 
among females and smokers, compared to nonsmokers. Among students who were screened and who 
reported tobacco use, 50% reported being advised to quit or reduce use. Brief intervention was more 
likely among current daily smokers compared to current nondaily smokers, as well as at schools with 
higher smoking rates. Screening and brief intervention were more likely at schools with lower clinic 
caseloads. CONCLUSIONS: Results highlight the need to encourage college health providers to screen 
every patient at every visit and to provide brief intervention for tobacco users. 
 
Thompson, N. J., et al. (2000). "A randomized controlled trial of a clinic-based support staff intervention 
to increase the rate of fecal occult blood test ordering." Prev Med 30(3): 244-251. 
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 BACKGROUND: Colorectal cancer is the second most common fatal malignancy in the United 
States. Early detection using fecal occult blood tests has been shown to reduce mortality, but these tests 
are underutilized among those eligible for this screening. Attempts to increase use of fecal occult blood 
tests in eligible populations have focused on the provider, patient, or system. But none have examined 
whether a support-staff intervention is effective in achieving this aim. We therefore conducted a 
randomized controlled trial to test the impact of authorizing support staff to order fecal occult blood 
tests in a general internal medicine clinic organized into four teams. METHODS: A total of 1,109 patients 
were included in the study, 545 of whom were in the two teams randomized to treatment. Univariate 
and multivariate regression analyses were used to evaluate the impact of the intervention. RESULTS: 
The intervention resulted in significantly more fecal occult blood test ordering in the treatment group 
than in the control group for all patients (52% vs 15%, P < 0.001). Treatment fecal occult blood test cards 
were returned as frequently as the control cards for all patients (44% vs 48%, P = 0.571). CONCLUSION: 
Delegation of selected screening tasks to support staff can enhance patient access to preventive care. 
 
Villani, J. and K. Mortensen (2013). "Patient-provider communication and timely receipt of preventive 
services." Prev Med. 
 OBJECTIVE: To estimate the association between how patients rate their health care provider's 
communication and the receipt of six clinical preventive services recommended by the U.S. Preventive 
Services Task Force (USPSTF) and the Advisory Committee on Immunization Practices (ACIP). METHODS: 
This study used national data from the 2009 Medical Expenditure Panel Survey (MEPS). The samples 
(sizes vary by service) included individuals aged 18years and older who have a usual source of care 
(USC). The outcomes indicated whether or not individuals received screening for breast cancer, cervical 
cancer, colon cancer, high cholesterol, hypertension, or were vaccinated against influenza per clinical 
guidelines. Multivariate logistic regression models were created for each dependent variable. The main 
independent variables consisted of ratings of four patient-provider communication behaviors. RESULTS: 
In unadjusted analyses, respondents who rated their providers' communication higher reported greater 
utilization of preventive services. After controlling for confounding variables, only receipt of 
mammograms remained significantly associated with better communication (p<0.05). Screening for 
cervical cancer, colon cancer, high cholesterol, and influenza vaccination approached significance with 
better communication (p<0.10). CONCLUSIONS: Patient-provider communication is associated with 
receipt of regular mammograms. Clinicians should consider their medical dialogue with patients as a 
stimulus for appropriate screenings and vaccinations. 
 
Wagholikar, K. B., et al. (2013). "Formative evaluation of the accuracy of a clinical decision support 
system for cervical cancer screening." J Am Med Inform Assoc 20(4): 749-757. 
 OBJECTIVES: We previously developed and reported on a prototype clinical decision support 
system (CDSS) for cervical cancer screening. However, the system is complex as it is based on multiple 
guidelines and free-text processing. Therefore, the system is susceptible to failures. This report 
describes a formative evaluation of the system, which is a necessary step to ensure deployment 
readiness of the system. MATERIALS AND METHODS: Care providers who are potential end-users of the 
CDSS were invited to provide their recommendations for a random set of patients that represented 
diverse decision scenarios. The recommendations of the care providers and those generated by the 
CDSS were compared. Mismatched recommendations were reviewed by two independent experts. 
RESULTS: A total of 25 users participated in this study and provided recommendations for 175 cases. The 
CDSS had an accuracy of 87% and 12 types of CDSS errors were identified, which were mainly due to 
deficiencies in the system's guideline rules. When the deficiencies were rectified, the CDSS generated 
optimal recommendations for all failure cases, except one with incomplete documentation. DISCUSSION 
AND CONCLUSIONS: The crowd-sourcing approach for construction of the reference set, coupled with 
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the expert review of mismatched recommendations, facilitated an effective evaluation and 
enhancement of the system, by identifying decision scenarios that were missed by the system's 
developers. The described methodology will be useful for other researchers who seek rapidly to 
evaluate and enhance the deployment readiness of complex decision support systems. 
 
Wallace, A. E., et al. (2006). "Women's primary care providers and breast cancer screening: who's 
following the guidelines?" Am J Obstet Gynecol 194(3): 744-748. 
 OBJECTIVE: Screening mammography for woman ages 50 to 69 years has resulted in early breast 
cancer detection and reduced mortality rates. However, the providers who are responsible for women's 
preventive health care differ in breast cancer screening guideline adherence. We compared screening 
practices across provider specialty and training degree types. STUDY DESIGN: Using a retrospective 
cohort design, we examined 472 patient records that represented 16 million preventive health care 
visits among women ages 50 to 69 years from the 2000 National Ambulatory Medical Care Survey. We 
calculated relative risk ratios for breast examination and mammography during preventive visits across 
provider specialty and training types. RESULTS: Among specialists, gynecologists are more likely than 
internists or general/family practitioners to follow breast cancer screening guidelines. Across training 
degree types, mid-level providers are more likely than medical doctors or osteopaths to adhere to 
guidelines. CONCLUSION: Regardless of specialty type or training degree, women's health care providers 
should adhere to breast cancer screening guidelines during preventive care visits. 
 
 
